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Cells and Cytokines in Lung Inflammation
Role of TH cells in the genesis of atopic
asthma and mechanisms involved in their
development
S. Romagnani
Division of Clinical Immunology and Allergy, University
of Florence, Italy.
The cellular and cytokine network that regulates the hu-
man IgE synthesis has recently been clarified. In contrast
to intracellular bacteria, that induce the activation of helper
T cells producing IFN-,, but not IL-4 (WH cells), allergens
and helminths preferentially activate helper T cells that
produce IL-4, but not IFN-, (TH cells). TH cells provide
the B cells with both signals (T/B cell contact and IL-4)
required for the IgE isotype switching. Furthermore, TH
cells produce IL-5, which is a selective maturation and
activation factor for eosinophils, and therefore play a key
role in the triggering of the allergic cascade.
The mechanisms involved in the differentiation of helper
T cells specific for bacterial constituents into the TH1, and
of allergen-specific helper T cells into the TH2, phenotype
of cytokine production have also been investigated. The
.presence of high concentrations of IFN-, and the absence
of IL-4 at the recognition triad (APC-Ag-TH cell) level
favour the development ofTH cells, whereas the presence
of IL-4 with no, or low concentrations of IFNq,, favours the
TH differentiation. IL-12 and IFN-0t production by APC
and IFN-,, produced by NK cells are probably responsible
for the microenvironmental conditions favouring the TH1
response, whereas early production of IL-1 by APC and of
IL-4 by cells belonging to the mast cell/basophil lineage
may be involved in the induction of the TH response.
Thus, the cytokine profile of the ’natural’ immune response
probably determines the TH or TH profile of the subse-
quent specific immune response.
These findings may provide a means for new therapeu-
tic interventions in patients with IgE-mediated disorders
aimed to inhibit the development of allergen-specific TH
responses.
The human mast cell as a source of
proinflammatory cytokines
M. K. Church
Immunopharmacology Group, Southampton General
Hospital, Southampton S09 4XY, UK
The mast cell has long been recognized as the initiating
cell of the early allergic response, histamine, prostaglandin
D2 and leukotriene C giving rise to the symptoms charac-
teristic of the immediate phase of the response. It would
seem logical if the mast cell were also able to secrete
cytokines capable of initiating allergic inflammation.
Studies with rodent mast cells and mast cell lines have
shown messages for IL-3, IL-4, IL-5 and TNF- to increase
on cell activation. We have used immunocytochemistry,
ELISA, in situ hybridization and the polymerase chain
reaction (PCR) to explore the association of cytokines with
human mast cells. Examination of bronchial biopsies from
asthmatic and normal subjects and of nasal biopsies from
normal and rhinitic subjects have shown the presence of
immunoreactive IL-4, IL-5, IL-6 and TNF-0t in mast cells
with IL-4 and TNF-0t in particular being up-regulated in
both allergic conditions. Using immunogold, IL-4 has been
localized to the mast cell granule. Using ELISA and cell
culture assays we have preliminary evidence of cytokine
release from purified human mast cell preparations and of
IL-4 degradation, probably by chymase. In situ hybridiza-
tion has provided evidence of IL-4 message whereas PCR
has shown consistent message for IL-4 and TNF-z in
stimulated mast cells.
These studies suggest that the mast cell is a source of
proinflammatory cytokines capable of initiating allergic
inflammation.
Molecular control of human B lymphocyte
growth and differentiation
J. Banchereau, D. Blanchard, F. Bri&re, A.-C. Fluckiger,
P. Garrone, S. Lebecque and F. Rousset
Schering-Plough, Laboratory for Immunological
Research, 27 chemin des Peupliers, BP 11, 69571,
Dardilly, France
B lymphocytes express at their surface the CD40 antigen
which belongs to the NGF receptor superfamily. The
crosslinking of the CD40 antigen using a mouse
fibroblastic cell line expressing the human Fc receptor
(Fc,RII/CDw32) and anti-CD40 monoclonal antibody in-
duces resting B lymphocytes to enter a state of sustained
proliferation. Addition of IL-4 or IL-13 results in the prolif-
eration of human B cells and in the secretion of IgE
following isotype switching. Addition of IL-10 permits
limited cell proliferation but most importantly results in
very high immunoglobulin production following differen-
tiation of B cells into plasma cells. In response to IL-10,
unseparated B cells cultured in the CD40 system produce
IgG, IgG and IgG in ratio comparable to those observed
in the serum. IL-10 induces naive B cells to secrete low but
reproducible amounts of IgG and IgA. The combination of
IL-10 and TGF[3 induces naive B cells to secrete IgA and
IgA2 as a consequence of isotype switching. The
extracellular domain of CD40 binds with high affinity and
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high specificity to a ligand transiently expressed on acti-
vated T cells. This interaction of the CD40 antigen on B
cells with its counterstructure on T cells represents a key
step in T cell dependent B cell activation.
Modulation by rminterferony (rmIFNy) and
CD4 T-lymphocytes of allergic eosinophil
accumulation in the mice peritoneal cavity
C. Zuany-Amorim, D. Leduc, B. B. Vargaftig and
M. Pretolani
Unit de Pharmacologie Cellulaire/Unit Associe
Institut Pasteur-INSERM n 285, 25, rue du Dr. Roux,
75015 Paris, France
Balb/C mice immunized to ovalbumin developed a
neutrophilia and a marked eosinophilia in the peritoneal
cavity 6 and 24 h, respectively, after antigen challenge
(lg, intraperitoneally, i.p.). The subcutaneous (s.c.)
pretreatment with rmIFN (5 000-10000 U/mouse) 1 h
before and 6 h after antigen challenge inhibited the
eosinophil infiltration by 56 and 61%, respectively. Under
those conditions, the possible contamination by LPS was
ruled out, since its s.c. administration failed to affect the
intensity of antigen-induced eosinophilia. The s.c. treat-
ment of sensitized mice with a monoclonal antibody anti-
IFN (XMG 1.2, 1 mg/mouse) 1 h before and 6 h after
ovalbumin provocation potentiated the eosinophil re-
sponse. These results suggest that endogenous IFN is
involved in the down-regulation of antigen-induced
eosinophilia. Interestingly, rmlFN did not modify the
neutrophil infiltration observed 6 h after ovalbumin provo-
cation. In separate experiments, the s.c. treatment of sen-
sitized animals with the immunosuppressive agent FK-506
(1.0-2.0 mg/kg) administered h before and 6 h after
antigen challenge reduced significantly the number of
eosinophils by 54 and 60%, respectively. Finally,
pretreatment of sensitized mice with a specific antibody
directed against CD4 T-lymphocytes (GKI. 5, 500 g/mouse;
i.v., three times), which depleted by 93% the proportion of
CD4 cells without affecting that of CD8 cells, reduced by
53% the eosinophil infiltration in the mice peritoneal cavity
induced by antigen challenge. Taken together, our results
demonstrate that the eosinophil accumulation in the mice
peritoneal cavity is modulated by endogenous release of
IFN and by the production of substances (probably
cytokines) originating from CD4 T-lymphocytes.
We thank Dr G. Bordenave and Miss C. Denoyelle for
help in the fluorescent analysis of lymphocytes and CD4
cells exhaustion and CNPq for the fellowship of C. Zuany-
Amorim.
Effect of 2-adrenoceptor agonists on IgE and
cytokine production
O. Coqueret, V. Lagente, C. Petit Frbre, J. M. Mencia-
Huerta and P. Braquet
Institut Henri Beaufour, 1 avenue des Tropiques, 91952
Les Ulis, France
The present study examined the regulatory effect of
adrenoceptor agonists on IgE and cytokine production in
human and mouse. In human, salbutamol and fenoterol
potentiated the in vitro IL-4-induced IgE synthesis by
peripheral blood mononuclear cells (PBMC). These drugs
inhibited IFN-7 production by phytohaemagglutinin-acti-
vated PBMC suggesting that the blockade of the produc-
tion of this cytokine was involved in the enhancement of
IgE synthesis. Salbutamol and fenoterol potentiated the IL-
4 induced production of the soluble form of the low-
affinity receptor for IgE (sCD23) although no effect on
CD23 expression was observed.
In the mouse, salbutamol potentiated the in vitro IL-4-
induced IgE synthesis from LPS-activated murine B
lymphocytes. This effect was dose-dependent and maximal
at 10 M and no IgE synthesis was observed when this drug
was added in the absence of IL-4. When Balb/C mice are
sensitized with ovalbumin (OA) and treated with daily
injection of salbutamol (1 mg/kg), an increase of the anti-
OA IgE levels in the serum as compared to the effect ofOA
alone was observed. No effect of salbutamol on plasma IgE
was observed in non-sensitized mice. To investigate the in
vivo effect of salbutamol on the release of cytokines,
splenocytes obtained from treated and untreated mice
were incubated for 24 h with concanavalin A (Con-A, 4 g/
ml). When sensitized mice are treated with salbutamol, a
significant increase of the ex vivo production of IL-4, IL-5,
IL-6 and IL-10 was noted as compared to that obtained
with splenocytes obtained from untreated sensitized mice.
No effect on IL-2 and IFN- synthesis was observed. When
non-sensitized mice were treated with salbutamol, a sig-
nificant increase in the release of IFN-, IL-4, IL-5, IL-6 and
IL-10 was noticed as compared to control mice.
These results demonstrate that [32-adrenoceptor agonist
stimulation results in an increase in IgE production both in
human and mouse. In the latter species, this effect that was
also observed in vivo could be explained by an alteration
of the production of lymphokines from TH1 and TH2 type
lymphocytes. Further studies are required to determine
whether [32-agonists exhibit similar effects in vivo in hu-
mans.
Interleukin-4 (IL-4) is both released and
inactivated by human mast cells
J. M. Tunon de Lara, Y. Okayama, A. R. McEuen,
C. H. Heusser,
2 M. K. Church and A. F. Walls
lImmunopharmacology group, Southampton General
Hospital, S09 4XY; 2Ciba Geigy, Basel, Switzerland
It has recently been suggested that mast cells are an
important source of inflammatory cytokines in allergic
disease. Rodent mast cells have been shown to produce
and release IL-4 and it has recently been demonstrated that
human mast cells contain IL-4. On activation, mast cells
also release substantial quantities of proteases including
tryptase, chymase, cathepsin G and carboxypeptidase,
which could help to control the bioavaibility of cytokines.
We have investigated the potential of mast cells to release
IL-4 and have determined the extent to which this cytokine
may be degraded by mast cell proteases.
Mast cells were dispersed from foreskin or lung tissue,
using collagenase and hyaluronidase. Skin mast cells were
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purified using a discontinuous Percoll gradient (mast cell
purity >85%) and lung mast cells using an
immunomagnetic procedure with anti-c-kit monoclonal
antibody (YB5B8) coupled to Dynabeads (mast cell purity
>75%). Purified mast cells were challenged with anti-IgE
(10%) and IL-4 was measured in the supernatants by a
specific ELISA, and histamine using a spectrofluorometric
procedure. Lysates of purified mast cells were incubated
with human recombinant IL-4 at 37C and the IL-4 concen-
trations were measured by ELISA or by bioassay with an IL-
4-dependent cell line (C-rh4S).
After an anti-IgE activation inducing 17 + 6% of hista-
mine release, 6.4 + 3.6 ng of IL-4 were measured in the
supernatants from 106 lung mast cells, but there was no
detectable IL-4 in that from skin mast cells. A dose-depend-
ent decrease in IL-4 concentration following addition of
mast cell lysates was observed by both ELISA and bioassay.
The rate of IL-4 catalysis by the skin mast cell lysates was
significantly higher than that for the lung mast cell lysates
(20 pg and 6 pg of IL-4 degraded/min per 10 cells,
respectively) and was related to the chymotryptic activity
as measured with the chromogenic substrate Suc-Ala-Ala-
Pro-Phe-NA. The degradation of IL-4 was inhibited by the
protease inhibitors aprotonin, chymostatin and SBTI, but
not by TLCK, TPCK, or 2-macroglobulin.
These data indicate that a chymotryptic mast cell
protease can degrade IL-4 and thus, may control the
biological actions of IL-4 following its release from the
mast cell itself.
methods (i.e M.G.G. and toluidine blue staining). This
analysis revealed the growth of metachromatic cells resem-
bling, mast cells from the second week of incubation on
the MS-5 layer. The highest percentage of these cells was
observed at 8 weeks and reached at least 30% for cord
blood cells and 70% for bone marrow cells. To further
confirm the nature of these metachromatic cells,
immunohistochemical staining of tryptase was performed
on the same samples and similar percentages of tryptase+
cells were observed. In the view to determine whether the
contact between MS-5 layers and CD34+ cells was an
absolute requirement for the appearance of mast cells,
CD34+ cells were cultured in the presence of MS-5 condi-
tioned medium. This condition allowed the same develop-
ment of mast cells when compared with the coculture
experiments. Whatever the soluble factor(s) responsible
for this mast cell growth activity, our culture system allows
us to obtain significant amounts of highly enriched normal
human mast cells populations useful for further studies on
the reactivity of this cell subset.
Cytokines and airway inflammation
P. Howarth
Department of University Medicine, University of
Southampton, UK
Induction of differentiation of human mast
cells from bone marrow and cord blood
progenitor cells by factors produced by a
mouse stromal cell line
M. Arock, lF. Hervatin,2J. J. Guillosson and D. Thierry
1Laboratoire d’Hematologie, Facult de Pharmacie, 4,
Ave de l’Observatoire, 75006 Paris; 2L.I.R.B., H6pital
Saint-Louis, 1, Ave C. Vellefaux, 75475 Paris Cedex 10,
France
Human bone marrow or cord blood progenitors (i.e
CD34+ cells are now easily purified by immunological
methods involving, immunomagnetic beads. These CD34+
cells can be cultivated on normal human bone marrow
stromal cells for limited periods. In this condition, the
number of the surviving progenitors declines in a few
weeks and these cells disappear completely in less than 8
weeks, a fact suggesting that this culture system is de-
prived of growth factor(s) able to support the self-renewal
of stem cells. We have developed in our laboratory the
culture of immunomagnetically purified bone marrow or
cord blood derived CD34+ cells on a supportive mouse
stromal cell line named MS-5. The long term survival of
clonogenic cells was analysed in these cultures and com-
pared with results obtained by culture on human bone
marrow stromal cells. Results demonstrated that only
coculture of CD34+ cells on MS-5 layers allows the survival
of clonogenic progenitors for at least 12 weeks. Cytospin
smears were regularly made during, the culture period and
cell morphology was examined after classical staining,
Cytokines released from activated cells within the bron-
chial and nasal mucosa orchestrate the pattern of allergic
tissue inflammation in asthma and rhinitis. On account of
their profile of actions, emphasis has focused on the role
of IL-3, IL-4, IL-5, TNF{x and GMCSF. Between them these
cytokines promote progenitor cell development and
growth, adhesion molecule expression on the vascular
endothelium, cell chemotaxis and cell activation.
Gene expression studies, either through RNA extraction
and PCR amplification or by in situ hybridization identify
upregulation of IL-4 and IL-5 in asthma and rhinitis.
Immunohistochemical staining of tissue biopsies reveals
IL-4, IL-5, TNF0 and GMCSF product in the preformed state
IL-4, IL-5 and TNF are localized to mast cells and GMCSF
to the airway epithelium. No cytokine product can be
localized to T lymphocytes although T lymphocytes, recov-
ered by bronchoalveolar lavage have upregulated gene
expression for IL3, IL-4, ILo5 and GMCSF in asthma and
elevated levels of IL-4, IL-5 and GMCSF along with IL-1 and
IL-6 have been reported in bronchoalveolar lavage in
allergic asthma.
A model is thus developing of the mast cell as the acute
responder within the airways, having preformed cytokines
stored within its cytoplasmic granules, and following im-
munological insult initiating the inflammatory process. The
release of IL-4 from this cell population acts as a stimulator
for activation of the CD4+ T lymphocytes. This subsequent
T lymphocyte activation, with enhanced gene expression
and product production and release (but not storage),
contributes to the chronicity of the response by maintain-
ing the airway inflammation. This chronicity will also be
promoted by epithelial production of GMCSF, as this
cytokine prolongs tissue persistence of eosinophils.
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Growth- and colony-stimulating factors medi-
ate eosinophil/fibroblasts interactions in
chronic airway inflammation"
J. Gauldie, M. Jordana, I. Ohno, G. Cox and H.
Klrpalani
Departments of Pathology, Medicine and Pediatrics,
McMaster University, Hamilton, Ontario, Canada L8N
3Z5
In many states of chronic inflammation of the tissues of the
airways, such as seen in asthma, chronic rhinitis, nasal
polyposis and to some extent pulmonary fibrosis, there is
a notable accumulation of eosinophilic granulocytes which
have been implicated in the reactivity of the tissue and
which likely contribute to tissue destruction and remodel-
ling. We are now aware that the cells of the tissue,
including fibroblasts, endothelial cells, epithelial cells and
smooth muscle cells are able to release a number of
growth and differentiating factors that have a profound
influence on the accumulation and function of
granulocytes in the tissue. Thus fibroblasts are stimulated
by cytokines such as IL-1 and TNF to release the colony
stimulating factors (M-, G and GM-CSF), factors affecting
eosinophil behaviour, as well as TGF[3 and other factors
which are chemotactic for granulocytes. In turn,
eosinophils in the tissue are known to release TNF, TGF[3
and PDGF, factors which will impact on the behaviour and
differentiation of the tissue cells. We will present details of
the characterization of these cell and cytokine networks
with examples of both paracrine and autocrine ftmction in
the cellular communication between the tissue cells and
granu!ocytes. Such interactions are undoubtedly crucial in
the initiation of tissue remodelling and in the chronic
nature of the inflammatory response of the tissue.
"Supported by MRC Canada and Astra Sweden.
Rantes, a novel eosinophil chemotactic
cytokine
J.-M. Schr(Sder, Y. Kameyoshi and E. Christophers
Department of Dermatology, University of Kiel,
Schittenhelmstr. 7, 2300 Kiel, Germany
In a number of allergic diseases such as asthma eosinophils
(Eo) are known to be prominent effector cells. Reasons for
the appearance of this leukocyte type are yet speculative,
and could come from the local generation of Eo-attractants
such as PAF, LTB4, C5a or IL-5 and GMCSF.
Recently a novel family of leukocyte-selective cytokines
termed ’chemokines’ has been detected. Members of this
family are neutrophil-selective (IL-8, Gro, NAP-2) or
monocyte-selective (MCP-1) chemotaxins. We addressed
the question whether also eosinophil-chemotactic
chemokines do exist. In order to test this working hypoth-
esis we stimulated human peripheral blood leukocyte
preparations with mitogen together with bacterial
lipopolysaccharide and phorbolester and analysed
supernatants after RP-HPLC for Eo-chemotactic proteins,
which we detected. It became clear that these Eo-
chemotactic cytokines at least in part originated from
contaminating platelets. Therefore platelets were stimu-
lated with thrombin and Eo-chemotactic activity present in
supernatants was purified to homogeneiety by the use of
HPLC-techniques. NHa-terminal sequence analyses re-
vealed two polypeptides showing a sequence, which is
identical with that of the cytokine Rantes, which is a
member of the ’C-C’-branch of the chemokine family.
Rantes appeared to be a potent attractant for human
eosinophils (ED50:4 nM), which did not show any
chemotactic properties for neutrophils. Moreover cross-
desensitization studies revealed that Rantes appears to
bind to a receptor distinct from those known for other Eo-
attractants. We conclude that Rantes could be an important
cytokine in platelet-associated Eo-accumulation seen in
some inflammatory conditions.
Chronic treatment with the interleukin-1
receptor antagonist (IL-lra) inhibits pulmo-
nary hypertension in monocrotaline (MCT)
treated rats
N. F. Voelkel, J. Bridges, M. A. Voelkel, W. Franklin and
W. Arend
Pulmonary and Rheumatology Divisions, Dept of
Pathology, UCHSC, 4200 E. 9th Ave., Denver, Colorado,
80262, USA
Cytokines are released together with lipid mediators in the
lungs of rats during the inflammatory response following
the single s.c. injection of monocrotaline (an alkaloid that
produces pulmonary hypertension in rats). Lung levels of
platelet activating factor (PAF) are measurably increased
after MCT and treatment with a PAF-antagonist prevents
the MCT-induced pulmonary hypertension and lung vascu-
lar remodelling. Since PAF can lead to the formation of IL-
l, we measured IL-1 in lung tissue following MCT injection
and injected 2 mg/kg IL-lra i.p.b.i.d, into MCT-and into
sham (saline) injected Sprague-Dawley rats. We hypoth-
esized that MCT would cause an increase in lung IL-1 and
further that IL-lra treatment would inhibit the develop-
ment of MCT-induced pulmonary hypertension. MCT in-
creased lung IL-1 levels (measured by ELISA, using a rat-
specific IL-1 antibody), but less than was observed after
i.p. endotoxin priming (E). In lung homogenates from
saline injected rats IL-1 was undetectable. MCT also caused
increased gene expression of IL-1 and IL-lra when com-
pared with control animals. Using a rat-specific
monoclonal antibody against IL-1 we found that
MCT caused specific binding of the antibody to
macrophages and to lung vessels. Chronic IL-lra treatment
inhibited the MCT-induced pulmonary hypertension.
We concluded that IL-1 participates in the development
of pulmonary hypertension in this model of chronic pul-
monary inflammation.
Supported by a Grant in AID of the American Heart
Association. IL-lra was kindly provided by Synergen
Boulder, Colorado.
References
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Analysis of cytokine transcripts in the
bronchoalveolar lavage cells of patients with
asthma
S.-K. Huang, G. Krishnaswamy, S.-N. Su, H.-Q. Xiao
and M. C. Liu
Johns Hopkins University School of Medicine, Johns
Hopkins Asthma and Allergy Center, Baltimore, ND
21224, USA
Cytokines have been shown to play a critical role in the
pathogenesis of atopic asthma. We have analysed a panel
of steady-state cytokine mRNAs in the bronchoalveolar
lavage (BAL) cells from allergic asthmatic subjects or pa-
tients challenged with ragweed allergen. This was
achieved by combining both qualitative and quantitative
assays using the reverse transcription polymerase chain
reaction (RT-PCR). Analysis of BAL cells from six mild
allergic asthmatic and five non-asthmatic, non-allergic sub-
jects showed no qualitative differences in the profile of
cytokine mRNAs (including IL-5, and IFN-T), except for
TNF-Ot which was detected in three out of six asthmatic
BAL samples, but none of the controls.
A key cytokine, IL-5, has been implicated in the
pathogenesis of allergic inflammation through the recruit-
ment of eosinophils. We found a significant enhancement
of steady-state IL-5 transcripts in the BAL cells from
ragweed allergen-challenged as compared with the saline-
challenged control sites of four patients; furthermore, the
cellular source for IL-5 mRNA was identified in the
mononuclear-cell fraction, but not in the purified
eosinophils, of the allergen-challenged BALS. These results
suggest that the significant increase of IL-5 transcripts is
primarily from the infiltrating mononuclear cells.
The three dimensional structures of
interleukin-5 at 2.4 J resolution, implications
for the structures of other interleukins
M. V. Milburn, A. M. Hassel, M. H. Lambert, S. R.
Jordan, C. Y. Arod,2 A. E. I. Proudfoot,
2 P. Graber and
T. N. C. Wells
1Glaxo Research Institute, Department of Structural and
Biophysical Chemistry, 5 Moore Drive, Research Trian-
gle Park, N.C. 27709, USA; 2Glaxo Institute for Molecu-
lar Biology, 14 chemin des Aulx, 1228 Plan-les-Ouates,
Geneva, Switzerland
Interleukin-5 (IL-5) is a lineage-specific cytokine for
eosinophilpoesis and plays an important role in diseases
that involve elevated levels of eosinophils, such as asthma.
Human IL-5 is a disulphide-linked homodimer of 115
amino acid residues in each chain. The crystal structure at
2.4 resolution reveals a novel two domain structure with
each domain showing a striking similarity to the cytokine
fold exhibited by granulocyte-macrophage colony stimu-
lating factor (GM-CSF), macrophage colony stimulating
factor (M-CSF), interleukin-2 (IL-2), interleukin-4 (IL-4),
and human and porcine growth hormone (hGH and pGH).
IL-5 is unique in that each domain requires the participa-
tion of two chains. The core of the IL-5 structure consists
of two left-handed bundles of four helices laid end to end
and two short [3-sheets on opposite sides of the molecule.
Surprisingly, the C-terminal strand and helix of one chain
complete a bundle of four helices and a [3-sheet with the
N-terminal three helices and one strand of the other chain.
The structure of IL-5 provides a molecular basis for the
design of antagonists and agonists that would delineate
receptor recognition determinants critical in signal
transduction. This structure determination extends the fam-
ily of the cytokine bundle of four helices and emphasizes
its fundamental significance and versatility in recognizing
its receptor.
Identification of interleukin-4 as the major in
vivo determinant of helper T cell Ib5 produc-
tion (TH2 phenotype commitment) by direct
gene targeting in mice
G. P. Anderson, B. Hengstier, G. LeGros, M. Kopf
2 and
M. A. Bray
1Ciba-Geigy AG, Basel, Switzerland; 2Max Planck lnstitut
for Immunologie, Freiburg, Germany
Eosinophilic inflammation is driven by IL-5 produced pre-
dominantly by helper CD4+ T cells of the TH2 phenotype
(IL-4, IL-5 but little IFN7) but the determinants of CD4+
commitment to TH2 IL-5 production are unknown. IL-4 is
essential to induce T cell IL-4 synthesis in vitro suggesting
a role in TH2 commitment. To study this we have used
embryonic gene targeting to delete the genomic IL-4 gene
in mice (C57BL6 x 129cv) in vivo. IL-4 gene deleted (0/0)
and wild type control (+/+) mice were infected with 750
stage 3 larvae of the helminth Nippostrongylus brasiliensis
by s.c injection. N. brasiliensis infection causes an intense
T cell- and IL-5-dependent pulmonary and systemic
eosinophilia and IL-4-dependent elevated IgE. Differential
counts of peripheral blood made over 13 days showed
attenuated eosinophilia in gene targeted (0/0) mice (+/+,
6.0E3; 0/0, 2.3E3 eos/ml, day 13, p < 0.05, t-test). Marked
differences were observed in BAL eosinophils (+/+,1.8E6;
0/0, 4.0E5, 1.2 ml lavage, day 13, p< 0.05) and fewer
eosinophils were observed histologically in lung inflamma-
tory cell infiltrates in (0/0) mice. Serum IgE was
undetectable in (0/0) mice. Lung cytokine mRNA levels
(quantitative PCR, transcripts/g RNA) measured on day 7,
before the onset of peak eosinophilia, showed reduced IL-
5 and IL-6 in gene targeted mice. mRNA Levels of IL-2, IL-
10t, and IFN, were not changed. Cytokine protein deter-
mined in (0/0) mice by bioassay or ELISA from
supernatants of CD4 or CD8 lymphoid T cells restimulated
ex vivo with anti-CD3 showed weak CD4+ IL-5 production
and induction of CD8+ T cells weakly producing IL-5.
mouse IL-4 IL-5 IL-6 IL-2
+/+ 50 150 2 000 1.6
0/0 0 20 400 1
Neutralizing antibodies to IL-5 prevented and antibodies
to IFNT did not augment eosinophilia. These data suggest
that (a) IL-4 is a major, but replacable, determinant ofT cell
commitment to TH2 phenotype in vivo. (b) transmigration
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of eosinophils into the lung can occur in the absence of IL-
4 and IgE (c) the identification of IL-5 producing CD8+
cells indicates that eosinophilia may not be strictly gov-
erned by CD4+ TH2 cells and has implications for the
pathogenesis and therapy of eosinophil mediated diseases.
Reference
1. LeGros et al. J Exp Med 1990; 172: 921-929.
Effects of anti-adhesion antibodies in primate
models of acute and chronic lung inflamma-
tion
L. G. Letts, R. H. Gundel, L. Churchill and C. D. Wegner
Boehringer Ingelheim Pharmaceuticals Inc., 900
Ridgebury Road, Ridgefield, CT 06877 USA
We have developed several primate models of lung inflam-
mation in which cell infiltration into the airways appears
associated with the onset and progression of altered lung
function. In each of these models the role of cell migration
and their activation has been examined using specific
monoclonal antibodies to adhesion proteins. The ’acute’
model involves a single exposure to inhaled antigen
whereas the ’induced’ model involves three exposures on
alternate days. The results on several variables are shown
in the table:,
Acute Induced
mAb LPR PMN AHR Eos.
ICAM-1 +++ +++
CD1lb NT NT +++
E-Selectin +++ +++
VCAM-1 NT NT
cells, responding to exposure to a variety of inflammatory
mediators and cytokines by altering one or several of their
functions, such as mucin secretion, ion transport, or ciliary
beating. Aberrations in any of these functions can affect
local inflammatory responses and compromise pulmonary
defence. For example, oxidant stress can increase secretion
of mucin, and depress ciliary beating efficiency, thereby
affecting the ability of the mucociliary system to clear
potentially pathogenic microbial agents. Recent studies
have indicated that airway epithelial cells also can act as
’effector’ cells, synthesizing and releasing cytokines, lipid
mediators and reactive oxygen species in response to a
number of patholologically-relevant stimuli, thereby con-
tributing to inflammation. Many of these epithelial-derived
substances can act locally, affecting both neighbouring
cells and tissues, or, via autocrine or paracrine mecha-
nisms, affect structure and function of the epithelial cells
themselves. Studies in our laboratories utilized cell cultures
of both human and guinea-pig tracheobronchial and nasal
epithelial cells, and isolated human nasal epithelial cells, to
investigate activity of respiratory epithelial cells in vitro as
sources of cytokines and inflammatory mediators. Primary
cultures of guinea-pig and human tracheobronchial and
nasal epithelial cells synthesize and secrete low levels of
IL-6 and IL-8 constitutively. Production and release of these
cytokines increases substantially after exposure to specific
inflammatory stimuli, such as TNF or IL-1, and after viral
infection.
Supported in part by grant HL 36982 from NIH, a grant
from the state of North Carolina, and grants from Hoffmann
La Roche, Inc., Nutley, NJ, and Glaxo, Inc., RTP, NC. This
abstract of a proposed presentation does not necessarily
represent EPA policy.
(LPR, Late phase response; AHR, airway hyperres-
ponsiveness; NT, not tested).
In addition BAL fluid, lung tissue histology and
immunohistochemistry was used to monitor cell activation,
cytokine/mediator production and adhesion protein ex-
pression. The ’acute’ model involves an early and late
phase airway obstruction, whose intensity and time to
peak correlates with a PMN influx. The ’induced’ model
involves a predominant eosinophil influx associated with
increases in airway responsiveness. Collectively, the data
emphasize the importance of the eosinophil and its media-
tors in lung inflammation. In addition, discussion will
involve recent studies identifying T cell subsets and their
potential role in the initiation of the early events in these
models. Also, the effects of mAbs on a murine model of
RSV-induced lung inflammation will be presented.
Interactions between respiratory epithelial
cells and cytokines: relationships to lung
inflammation
K. B. Adler, L. A. Cohn and S. Becker
1North Carolina State University, Raleigh, NC; 2TRC
Environmental Corp., Chapel Hill, NC, USA
Epithelial cells lining respiratory airways can participate in
inflammation in a number of ways. They can act as target
Chemical mediators and adhesive molecules
involved in eosinophil accumulation in
allergic reactions in vivo
T.J. Williams, V. Weg, S. Nourshargh, D. A. Griffiths-
Johnson, D. T. Walsh, P. D. Collins and P. J. Jose
Department of Applied Pharmacology, National Heart
and Lung Institute, Dovehouse St, London SW3, UK
We have been investigating mechanisms underlying the
accumulation of eosinophils in allergic inflammatory reac-
tions in the guinea-pig using cells labelled with 111In.1
In passive cutaneous anaphylactic (PCA) reactions
111In-eosinophils accumulated rapidly with a peak rate over
the first 30 min, accumulation continuing for 4 h.
Plasma protein leakage, measured using 125I-albumin,
was dissociable from 111In-eosinophil accumulation;
virtually all leakage occurring from 0 to 30 min.
To investigate the mechanisms involved in selective
eosinophil, as opposed to neutrophil accumulation in vivo,
we have used an antibody to the [31 integrin VLA-4 (HP1/
2, a gift from Dr. Roy Lobb, Biogen). Pre-incubation of
lqn-eosinophils with the antibody prior to i.v. injection,
blocked their accumulation in PCA sites. Accumulation in
response to i.d. C5a, PAF and LTB, was also blocked
effectively. HP1/2 administered i.v. also blocked the accu-
66 Mediators of Inflammation. Vol 3.1994Lung inflammation
mulation of 111In-eosinophils in the skin, with no effect on
plasma leakage.
None of the antagonists to known mediators blocked
eosinophil accumulation in PCA reactions although
plasma leakage could be blocked by combinations.
We have therefore set up experiments to identify
eosinophil chemoattractants generated in vivo.
Bronchoalveolar lavage fluid from sensitized guinea-
pigs challenged with ovalbumin was injected into guinea-
pig skin and the accumulation of llln-eosinophils
was measured. Using this technique a potent,
selective eosinophil chemoattractant, ’eotaxin’, has
been purified. The source of this protein is under
investigation.
We thank the National Asthma Campaign, The
Wellcome Trust and CAPES (Brazil).
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TransendotheHal migration of eosinophils in
allergic inflammation
R. Moser and P. L. B. Bruijnzeela
Department of Internal Medicine/Hematology, Univer-
sity Hospital A-Hof 143, CH-8091 Zurich, Switzerland;
aDepartment of Pharmacology, Medical Biological
Laboratory, TNO, Rijswijk, The Netherlands
Beside lymphocytes, eosinophils are the most prominent
cell type in allergic inflammation. Why particularly
eosinophils transmigrate the endothelial barrier is still
unclear. Our investigations in this phenomenon led
to the following data. (A) ’Priming’ of circulating human
eosinophils from non-allergic donors by pM concentrations
of IL-3, IL-5 and GM-CSF renders eosinophils the capacity
to transmigrate IL-l-activated human umbilical vein
endothelial cell (HUVEC) monolayers, whereas non-
primed eosinophils do not. In contrast, eosinophils from
allergic individuals (already ’primed’ in vivo) spontane-
ously transmigrated the IL-l-activated endothelial barrier.
Using HUVEC monolayers on microporous filters, this
transmigration was severely impaired by anti-CD18 mAbs,
but not by the mAb BP2/1 against VLA4. (B) Using bilayer
vascular constructs (BVC), activation with IL-4 led to selec-
tive transmigration of eosinophils. Again, this transmigra-
tion was restricted to in vitro or in vivo ’primed’
eosinophils and was partially blocked by mAbs against
CDll/CD18 and VLA-4. IL-l-induced transmigration of
eosinophils was partially the result of enhanced ICAM-1
expression. The lack of inhibition by mAb HP2/1 points
against the involvement of VCAM-1, despite VCAM-1 and
ELAM-1 were both presented by IL-l-activated HUVE. It
remains a role for ELAM-1. In contrast, IL-4 activation was
followed by selective expression of VCAM-1. No induction
of ELAM-1 was detectable. Together with constitutive
ICAM-1, VCAM-1 is thought to be the basis of the selective
eosinophil transmigration. (C) The monolayer-on-filter
system allowed non-selective passage of neutrophils
and eosinophils in response to IL-1 and TNF. Whereas in
the BVC IL-1 and TNF only provoked transmigration of
neutrophils and not of eosinophils. These findings allow
the important question: why do eosinophils fail to transmi-
grate IL-l-activated BVC in the presence of elevated ICAM-
1 and VCAM-1 levels?
Expression of ELAM-1, ICAM-1 and VCAM-1 on
bronchial biopsies from allergic asthmatic
subjects
P. Gosset, I. Tillie-Leblond, A. Janin, C. H. Marquette, M.
C. Copin, B. Wallaert and A. B. Tonnel
CJF 90-06, Institut Pasteur and CHR, Lille, France
Eosinophil and lymphocyte infiltration has been demon-
strated in the lung of asthmatic patients. The involvement
of adhesion molecules in the leucocyte migration has
been shown by in vitro experiments and in an animal
model of allergic asthma. Moreover, supernatants of
alveolar macrophages from allergic subjects developing a
LAR amplified the in vitro endothelial expression of
ICAM-1 and ELAM-1 by a TNF-dependent mechanism.
The aim of this study was to evaluate in patients with
allergic asthma, the ELAM-1, ICAM-1 and VCAM-1
expression on pulmonary endothelium and bronchial
epithelium. Thirteen patients with allergic asthma and ten
control subjects were biopsied under fibreoptic
bronchoscopy. After paraffin embedding, cellular infiltrate
was evaluated by May-Griinwald-Giemsa staining and
adhesion molecule expression by immune-histochemistry
study using mouse monoclonal antibodies (British
Biotechnology, Oxford, UK). The results were expressed
as the percentage of positive cells. Before the
bronchoscopy, we evaluated each patient for asthma
severity by the score of Aas, lung function and treatment.
Local accumulation of eosinophils and lymphocytes was
detected in eleven asthmatic subjects whereas none was
observed in control subjects. Using immunohistochemistry,
a low expression of ICAM-1 was revealed on biopsies from
control subjects. ICAM-1 expression on epithelial and
endothelial cells and ELAM-1 expression on endothelial
cells were significantly increased compared with the con-
trol subjects (p < 0.05 in all cases). A significant correlation
was obtained between the mucosal eosinophilia and
ICAM-1 (r 0.66, p < 0.01) and ELAM-1 expression on
endothelium (r= 0.71, p < 0.02) whereas no relation was
shown between the adhesion molecule expression and the
score of Aas. No change in cellular infiltration or in adhe-
sion molecule expression was observed in patients treated
by inhaled corticotherapy compared to untreated patients.
In conclusion, an increase of adhesion molecule expres-
sion on epithelial and endothelial cells was observed in
allergic asthmatics compared to control subjects.
The possible involvement of TNF in this process is under
investigation.
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Endotoxin-induced neutrophil adherence to
endotheHum: relationship to CD11b/CD18 and
L-selectin expression and matrix disruption
A. Finn, S. Strobel, M. Levin and N. Klein
Division of Cell and Molecular Biology, Institute of
Child Health, 30 Guilford St., London WCLN 1EH and
Department of Paediatrics, St. Mary’s Hospital Medical
School, South Wharf Rd., London, W2 1NY, UK
Vascular endothelial injury observed in severe bacterial
infection may be caused by neutrophil-derived enzymes.
Adherence to the endothelium, a prerequisite for this
process, is mediated sequentially by the neutrophil
adhesion molecules t-selectin and the 2 integrins includ-
ing CD11b/CD18. We have explored the relationship
between expression of these molecules, neutrophil
adherence, endothelial activation and consequent
endothelial injury, as assessed in vitro by changes to
heparan sulphate and fibronectin matrices which
colocalize. Endothelial prestimulation with lipo-
polysaccharide (endotoxin) caused an increase in
adherence and a generalized reduction in heparan
sulphate; disruption of the fibronectin matrix only oc-
curred on the further addition of fMet-Leu-Phe. Although
maximal disruption of these matrices was associated with
elevation, of neutrophil CD11b/CD18 and reduction in
t-selectin expression, these changes did not determine
either the nature or extent of endothelial damage. CD11b/
CD18 expression was similar in both adherent and
non-adherent neutrophils, while L-selectin was shed in
association with adherence in the absence of other stimuli.
These changes in expression were thus independently
regulated. This model may provide further insights into the
interrelationship between neutrophil adhesion and
activation and endothelial damage in infection with Gram-
negative bacteria.
LFA-1 is a key mediator of eosinophil migra-
tion to the airways in a murine model of
allergic airways inflammation
C. A. Hbert, p. Jardieu, T. Terrell, B. Lyon, R.J.
Holmes, G. Hatami, G. Brusselle
2 and R. Pauwels
2
Genentech, SO San Francisco CA 94080, USA; 2Roche
Research/University of Gent, 9000 Gent, Belgium
Balb/c mice were sensitized i.p. with ovalbumin/alum.
Fourteen days after sensitization the mice were subjected
to daily aerosolizations of 0.1% ovalbumin in PBS for 7
days. Twenty-four hours after the last aerosolization, the
lungs were lavaged. Differential counts of the cells in the
lavage fluid indicate that mice that were sensitized and
aerosolized (group +) developed a profound eosinophilia
(50-75% of lavage cells were eosinophils). In contrast, no
eosinophils were present in total lung lavages from naive
mice or from mice which received aerosol challenge
without antigen sensitization or aerosol challenge only.
Histological examination indicates that the eosinophil
infiltration occurs at the level of the major airways and is
accompanied by changes in the morphology of the
bronchial epithelium which becomes hypertrophied.
Alcian blue/PAS staining suggests that the airways
epithelial cells of group + mice are actively secreting
mucus and glycoproteins. Furthermore, mucus plugs can
be seen in the airways of non-lavaged animals from
group +. Additional characteristics of this model include a
profound mucosal infiltrate of macrophages, lymphocytes
and plasma cells and the development of an ovalbumin-
specific IgE titre. Two separate experiments (six animals
per group) indicate that treatment of the mice with M17,
a monoclonal antibody against CD11a, (100 btg i.v. on
the day of the first aerosol challenge) causes a 91% and a
92% decrease, respectively, in the number of eosinophils
found in the total lung lavages. The number of eosinophils
found in the lavages of mice treated with an isotype
control antibody was equal to the number of eosinophils
found in the mice which did not receive antibody
treatment (group +). These results indicate that LFA-1 is a
key component in the cascade of events which lead to the
migration of eosinophils to the airways.
Role of macrophages in pulmonary diseases
A. B. Tonnel, P. Gosset, D. Vanhee and B. Wallaert
CJF INSERM 90.06, lnstitut Pasteur de Lille, 59019 Lille
cddex, France
The alveolar macrophage (AM) is a critically important cell
playing a prominent role in lung inflammation by
producing oxygen radicals, enzymes, arachidonic acid
metabolites but also a large panel of cytokines. Among
interstitial lung disorders, our interest was recently
focused on Coal Worker’s Pneumoconiosis (CWP),
which is one of the most widespread fibrotic lung
diseases. Although its physiopathology remains incom-
pletely understood several lines of evidence suggest the
participation of AMs at least in the initiation of the
alveolitis.
In coal miners, bronchoalveolar lavage showed a large
influx of mononuclear phagocytes with a sponta-
neous increased production of oxidants, fibronectin,
neutrophil chemotactic factor, but also of interleukin-1
(IL-1), and tumour necrosis factor x (TNFz). This sponta-
neous cytokine release was higher in patients with
progressive massive fibrosis (PMF) than in simple
pneumoconiosis (SP). However, we also observed a
spontaneous high cytokine release by AMs from coal
miners still working and exposed to coal mine dust,
indicating that TNFz may participate in the early phase of
lung inflammation.
In vitro exposure of AMs (obtained from healthy
subjects) to coal dust particles triggered a significant
release of TNFx and interleukin-6, by comparison with
titanium oxide used as a biologically inert control dust.
Moreover, it appeared that coal mine dust (i.e. a mixture
of silica and coal particles) was more aggressive than
similar concentrations of pure silica, suggesting that
cytokine secretion induced by coal mine dust was not excl-
usively related to the presence of silica but resulted from
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a complex interaction between the different components.
In the last part of this study we concomittently evaluated
in AM supernatants from pneumoconiotic patients, two
pro-fibrotic factors (PDGF and IGF-1) and the production
of transforming growth factor (TGF[3): interestingly, while
PDGF and IGF-1 levels were largely secreted in patients
with PMF, TGF[3 production was predominant in AMs obta-
ined from patients with SP, suggesting a potential protec-
tive effect of TGF[3 on the development of pulmonary
fibrosis.
The role of macrophage-derived PDGF in lung
fibroblast proliferation
A. R. Brody, 1,2J. C. Bonner and L. Blalock
1Laboratory of Pulmonary Pathobiology, National
Institute of Environmental Health Science, N.C. 27709;
2Department of Pathology, Tulane University Medical
Centre, 1740 Tulane Ave., New Orleans, La. 70112, USA
Lung interstitial and alveolar macrophages have been
shown to synthesize and secrete a wide array of cytokines
and growth factors which could mediate pulmonary in-
flammation and fibrosis. The most potent known inducer
of mesenchymal cell proliferation is platelet-derived
growth factor (PDGF). Thus, we have been studying the
biology, biochemistry and molecular characteristics of
macrophage-derived (MD)-PDGF in vitro and in vivo in
our model of asbestos-induced lung fibrosis. Initially, we
showed that macrophages from rats secrete increased
amounts of PDGF in vitro after asbestos treatment in a
concentration-dependent fashion. This dimeric protein
(-30 kDa)was predominantly the BB isoform of PDGF,
although all three isoforms (AA, AB, BB) were synthesized
by macrophages. This was determined by an ELISA using
several monoclonal antibodies against PDGF and by
in situ hybridization of the mRNAs for both PDGF A- and
B-chains in macrophages in vitro. The MD-PDGF proved to
be an excellent mitogen for early passage rat lung
fibroblasts, and cell proliferation was blocked by a
polyclonal antibody to PDGF. Since we showed that brief
asbestos, inhalation by rats and mice caused up to 30-fold
increases in epithelial, mesenchymal and vascular cell
proliferation, we asked if the PDGF A- and B-chain mRNAs
were expressed in the lungs of exposed animals. In situ
hybridization revealed that both mRNAs were up-regulated
in lung macrophages, epithelial and interstitial cells by 2
weeks after asbestos exposure. Unexposed animals, exhib-
ited few labelled cells while tissues hybridized with a
’randomer’ probe were completely negative. In summary,
we have shown that lung macrophages synthesize and
secrete all three PDGF dimers, and the BB isoform is a
potent mitogen for lung fibroblasts. After asbestos
inhalation, the mRNAs which code for the PDGF A- and
B-chains are up-regulated in the lung at sites associated
with initial fibre deposition and macrophage accumulation.
Our ongoing studies are focused on the potential of PDGF
as a primary mediator of mesenchymal cell proliferation in
lung fibrogenesis.
The role of alveolar macrophages in
the regulation of lung inflammation
T. Thepen, G. Kraal
2 and P. G. Holt3
1Department of Dermatology, AZU, Utrecht,
Heidelberglaan, 100 3584 CX Utrecht, The Netherlands;
2Department of Histology, Vrije Universiteit, 1081 BT,
Amsterdam, The Netherlands and 3WARICH Princess
Margaret Hospital Perth, Western Australia
Because of their strategic positioning in the lung, alveolar
macrophages (AM) have been assigned an important role
in lung inflammation. Their active participation in the
effecter arm of pulmonary immunoinflammatory re-
sponses, via such functions as receptor-mediated
phagocytosis and secretion of pro-inflammatory mediators
has been recognized for many years. However, recent
studies performed in our laboratories show that, after in
vivo depletion of AM via intratracheal administration of
a liposome encapsulated drug dichloromethylene
diphosphanate (DMDP) experimental animals become
hyper-responsive to inhaled allergens. The animals show
both an increased primary as well as secondary pulmonary
immune response. In the latter, the IgE response increases
dramatically with the numbers of plasma cells, including
IgE producing plasma cells, and T cells entering the lung.
The experiments indicate that this control is excerted at the
T cell level. In addition to this, we show that the regulatory
function of AM is not limited to this level. The antigen
presenting cell function of pulmonary dedritic cells is also
down-regulated by AM thus preventing the presentation of
allergen to T cells in the lung after allergen inhalation.
Next to their role in preventing inflammation in lung tissue
as described above, we present evidence that AM might be
involved in the regulation of pulmonary immune re-
sponses in the draining lymph nodes. We show that AM
are able to migrate from the alveolar space into the drain-
ing lymph nodes and in particular to the paracortical T cell
area. This migration pattern is aberrant from that of other
types of macrophages that migrate to subcapsuler sinus
and medulla of the lymph nodes and suggests an addi-
tional immunoregulatory function of AM in the draining
nodes, stressing the importance of AM in the control of
pulmonary immune responses.
Role of nitric oxide radicals in
asbestos-induced lung inflammation
G. Thomas, T. Ando, K. Verma and E. Kagan
Departments of Pathology and Physiology and Biophys-
ics, Georgetown University School of Medicine, Wash-
ington, D.C. 20007, USA
It has been shown recently that alveolar macrophages
(AM) can synthesize nitric oxide (NO*), an effect which is
inducible by interferon-T. Because asbestos workers have
elevated levels of intrapulmonary interferon-z, asbestos
exposure conceivably may stimulate the production of
NO* by AM. To test this postulate, pooled AM were
obtained by bronchoalveolar lavage from Sprague-Dawley
rats. Thereafter, 5 x 105 AM, suspended in RPMI 1640
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medium containing 10% fetal bovine serum, were added to
24-well tissue culture plates. After allowing the AM to
attach for 2 h at 37C, the AM were incubated in 5% CO,
at 37C for 4-48 h in the presence (10 g/ml) or absence of
either crocidolite (amphibole) or chrysotile (serpentine)
asbestos fibres. Nitrite (NO,.-) production, a measure of
NO* formation, was assayed in conditioned medium by the
Griess reaction. Confirmation of NO* production was
shown by relaxation of rat aortic smooth muscle. Both
types of asbestos exposure induced significantly greater
NO; production than was produced by untreated cultures
(p<0.001). The presence of 250 or 500 IU/ml of
recombinant rat interferon-7 markedly increased the syn-
thesis of NO* by AM. However, the effects of asbestos and
interferon-7 were synergistic, were statistically significant
after crocidolite exposure (p<0.001) and were seen
maximally in 48 h cultures. The addition of the NO*
synthetase inhibitor, N-monomethyl-L-arginine (500 btg/
ml), significantly reduced NO production by AM. Asbestos
exposure is known to induce the formation of superoxide
anion (O-), but the addition of superoxide dismutase (150
units/ml) to asbestos-containing cultures markedly stimu-
lated the production of NO* by AM. Since O-can react
with NO* to form peroxynitrite anion (ONOO), the induc-
tion of NO* formation may represent a novel mechanism
of asbestos-related injury.
Platelet-activating factor-induced interleukin-6
production by alveolar macrophages involved
both cyclooxygenase and 5-1ipoxygenase
pathways
M. Thivierge and M. Rola-Pleszczynski
Immunology Division, Department of Pediatrics, Faculty
of Medicine, Universit de Sherbrooke, Sherbrooke QC
Canada J1H 5N4
We have recently shown that platelet-activating factor
(PAF) could stimulate interleukin-6 (IL-6) production by rat
alveolar macrophages (AM) and that its effect was depend-
ent on 5-1ipoxygenase (5-LOX) activity. Because indome-
thacin was also capable of inhibiting PAF-induced stimu-
lation of IL-6 production we investigated the potential
involvement of both cyclooxygenase (COX) and 5-LOX
pathways in these events and compared them with modu-
lation of tumour necrosis factor (TNF) production by PAF.
Treatment of AM with PAF concomitantly enhanced their
IL-6, TNF, prostaglandin (PG) E and leukotriene (LT) B
production two- to five-fold with peak effects at I x 10-1M.
Inhibition of COX with indomethacin, aspirin or ibuprofen
(1 x 10-6M) abrogated the PAF-induced augmentation of
both IL-6 and PGE2 production, but further enhanced PAF-
stimulated TNF production. In parallel, exogenous addi-
tion of PGE (3 x 10-6M) or dibutyryl-cAMP (1 x 10-3M) to
AM resulted in enhanced (five- to ten-fold) IL-6 production
and a concomitant suppression ofTNF production. On the
other hand, PAF induced augmentation of IL-6 production
was abrogated by the 5-LOX inhibitors AA 861 (1 x 10-5M)
and MK 886 (2 x 10-6M), while TNF production was
affected marginally. Exogenous LTB markedly enhanced
IL-6 (three- to five-fold) and PGE (two-fold) production
with a peak effect at x 10q2M, but stimulated TNF
production to a lesser degree. In contrast, indomethacin
abrogated the LTB effect on IL-6 production, while further
enhancing its effect on TNF production. PAF was also
found to stimulate inducible COXmRNA accumulation, but
had no effect on mRNA levels of either 5-LOX or 5-LOX-
activating protein (FLAP). Taken together, our data indi-
cate a differential regulation of cytokine production by
COX and 5-LOX metabolites in response to PAF and
suggest that PAF induces both positive and negative feed-
back mechanisms in its interactions with macrophages and
their cytokine networks. These findings may have rel-
evance in PAF-mediated events in the lung, such as the
cellular components of late-phase asthma.
Supported by the Medical Research Council of Canada
and the Fonds de Recherche en Sant du Quebec.
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Compartmentalized response of alveolar
macrophages in unilateral community
acquired pneumonia
M. Dehoux, A. Boutten, J. Ostinelli, N. Seta, B. Crestani,
M. C. Dombret, C. Rolland and M. Aubier
H6pital Bichat, Inserm U226, 46 rue Henri Huchard
75877 Paris Cedex 18, France
TNFx, IL-l[3 and IL-6 which can be released by peripheral
blood monocytes (PBM) and alveolar macrophages (AM)
are the main cytokines found during an inflammatory
process. Many of their activities indicate a local rather than
a systemic production. The aim of this study was to assess
the response ofAM and PBM to a local infection in patients
with non-treated unilateral community acquired pneumo-
nia (CAP). Nine patients suffering from a CAP with a
unilateral consolidation or an infiltrate on chest X ray and
without bilateral purulent bronchial secretion, were stud-
ied before antibiotherapy. During a bronchofibreoscopy,
two small bronchoalveolar lavages (BAL) were performed:
one in the non-infected side and then one in the territory
of the pneumonia. A blood sample was simultaneously
collected. BAL and blood from eight healthy volunteers
served as control. The in vitro spontaneous and LPS-
induced secretion of IL-I[3, IL-6, and TNFx ofAM from the
infected lung and from the non-infected lung and of PBM
were studied (ELISA Medgenix). AM or PBM (106 cells/rnl)
were incubated for 18 h in the presence or absence of LPS
(E. coli 10 btg/mD. When AM from infected lung were
cultured in the absence of LPS, spontaneous release of
TNFz, IL-I[3 and IL-6 were higher than in the non-infected
lung and than in healthy controls. No significant difference
were found beetwen the spontaneous cytokine secretion
of AM from the non-infected lung and from the healthy
controls. After LPS-induced activation, cytokine secretion
of AM was not significantly different beetwen the non-
infected and the infected lung. Interestingly, a profound
decrease of LPS-induced TNFx, and IL-6 production ofAM
was observed in CAP (non-infected p<0.05; infected
p< 0.05) as compared to healthy subjects. Cytokine
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secretion of unstimulated PBM from CAP were higher than
healthy control (p < 0.05). After LPS activation cytokine
secretion by PBM from CAP was higher than control but
the difference between the two groups did not reach
statistical significance. Our data indicate a
compartmentalized response of AM within the lung and
indicate an in vivo activation of both AM and PBM during
CAP. Furthermore, the different responses ofAM and PBM
to an in vitro activation suggests that local cytokine pro-
duction by AM during CAP are regulated differently than
the systemic production by PBM.
hybridization. These studies have suggested that CD3 cells
were the principal source of IL-5 in nasal allergen-induced
late-phase reactions, while mast cells and eosinophils, a
small percentage of which expressed mRNA for IL-5, were
less prominant. Thus, cytokines which are active on
eosinophils, derived from T lymphocytes, eosinophils or
mast cells, may play an important role in the orchestration,
control and augmentation of the inflammatory reaction
known to be associated with allergic responses.
Eosinophils, cytokines and allergic
inflammation
R. Moqbel
National Heart and Lung Institute, London SW3, UK
Eosinophils are prominent cells in the blood, sputum and
bronchoalveolar lavage (BAL) of asthmatic subjects and
eosinophil numbers have been shown to correlate with
disease severity and the degree of bronchial
hyperreactivity. The presence of eosinophils in the airways
and their subsequent activation and exocytosis are thought
to be important elements in the damage to the airways and
the subsequent development of airway irritability.
Eosinophils secrete a number of basic (cationic) granule
proteins, following activation, which been shown to be
cytotoxic to lung tissue. Activated eosinophils (i.e. under-
going exocytosis) are increased in numbers in association
with asthma and bronchial hyperreactivity. Furthermore,
stimulated eosinophils express and translate mRNA for a
number of these inflammatory cytokines, including
granulocyte/macrophage colony-stimulating factor GM-
CSF, IL-3, IL-5 and IL-6. Human eosinophils can be specifi-
cally identified by immunostaining with mAb BMK-13,
which binds to eosinophil granule major basic protein,
thus providing total eosinophil counts at the site of inflam-
mation and EG2, which recognizes the secretory form of
eosinophil cationic protein (activated eosinophils). There
is now evidence to support the hypothesis that T cells,
especially those of the helper phenotype, are involved in
the immunological and inflammatory reactions associated
with eosinophil-mediated allergic inflammation. T cells can
influence the inflammatory process through the release of
cytokines including interleukins-3, 4, 5 and the
granulocyte/macrophage colony-stimulating factor (GM-
CSF). IL-4 is an important cofactor required for the induc-
tion of IgE synthesis from B cells while IL-3, IL-5 and GM-
CSF are important cytokines in the growth, maturation and
terminal differentiation (IL-5) of eosinophils. They are also
known to prime, activate and prolong the survival of
eosinophils. Recent studies on bronchial biopsies and BAL
of mild asthmatic subjects, using the technique of in situ
hybridization, have demonstrated increase in the expres-
sion of mRNA IL-4 and IL-5, as well as IL-3 and GMoCSF,
suggesting a pattern associated with TH,.-type
lymphocytes. The precise source of IL-5 mRNA in sites of
allergic inflammation has also been studied using a simul-
taneous combination of immunocytochemistry and in situ
IgE-dependent activation of human
granulocytes
M. Capron, M.-J. Truong and A. Capron
C.I.B.P., Unite Mixte INSERM U167 CNRS 624, Institut
Pasteur, 1, rue du Prof. Calmette, 59019 Lille, Cedex,
France
Eosinophils represent one of the major cell populations
involved in IgE-dependent diseases such as asthma. Not
only mast cells and basophils but also eosinophils and
more recently neutrophils, can be activated by IgE antibod-
ies in the presence of the specific allergen. Eosinophils
express different types of functional IgE receptors, among
which CD23 and the S-type lectin Mac2/BP. They are
involved in IgE binding and in IgE-mediated release of
cytotoxic granule proteins. Recently, it has been shown
that IgE-dependent activation of eosinophils could iduce
the release of IL-5, the main factor for terminal differentia-
tion of eosinophils, suggesting a local autocrine pathway
of activation. More recently, we could show that
neutrophils, the only leukocyte population with no detect-
able Fc receptor could express Mac2 and be activated by
IgE antibodies and the specific antigen. The nature of
mediators released by neutrophils upon IgE-dependent
activation is presently under investigation. However, these
results suggest that all granulocytes might participate di-
rectly to IgE-mediated mechanisms during inflammation.
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Chemotaxis of eosinophilic granulocytes to
cytokines in allergic disorders
P. L. B. Bruijnzeel, G. R. Dubois and L. Koenderman
1Department of Pharmacology, Medical Biological
Laboratory, Rijswijk, Norway; aDepartments of Dermatol-
ogy and 3Pulmonary Diseases, University Hospital
Utrecht, Utrecht, The Netherlands
Eosinophils are important effector cells in allergic inflam-
mation. Increased numbers of activated eosinophils are
found in allergic inflamed lesions. Cytokines a.o. IL-3, IL-
5 and GM-CSF have been identified as important modula-
tors and inducers of eosinophil chemotaxis. In this study
we have investigated the chemotactic potency of these
cytokines for eosinophils from the peripheral blood of
normal individuals (N), allergic asthmatics (AA) and
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allergic atopic dermatitis (AD) patients using a
microchemotaxis Boyden chamber assay. Optimal
chemotaxis was reached for most cytokines at a concentra-
tion of 10 nM in all investigated groups with one excep-
tion; in AD patients the optimal chemotactic concentration
for GM-CSF was already reached at 1 nM. Dose ranges of
these chemoattractants demonstrated that eosinophils from
AA generally showed a decreased response to these
cytokines compared to eosinophils from N. In contrast
eosinophils from AD patients showed an increased
response. This phenomenon was most pronounced in
case of GM-CSF. These findings indicate that different
signalling pathways are initiated during priming of
eosinophils in vivo in allergic inflammation, resulting in a
different modulation of eosinophil responses towards
cytokines.
IL-4 induced mobilization of eosinophils in
allergic inflammation
G. R. Dubois and P. L. B. Bruijnzeel
Department of Dermatology, University Hospital
Utrecht, Heidelbergln 100, 3584 CX Utrecht, The
Netherlands
Eosinophils are considered important effector cells in both
asthma and eczema. They are abundantly present in e.g.,
lung tissue and show signs of activation. T lymphocytes
present in allergically inflamed tissue synthesize and se-
crete the cytokines IL-3, IL-4, IL-5 and GM-CSF. IL-3, IL-5
and GM-CSF act as chemotaxins on eosinophils. However,
IL-4 also may act as a chemotaxin on eosinophils. In
contrast to the former cytokines IL-4 is only chemotactic for
eosinophils from peripheral blood of patients with allergic
disorders and not for eosinophils from normal individuals.
IL-4 has the same chemotactic potency as the other
cytokines. The optimal chemotactic potency is reached at
a concentration of 10 nM. In contrast, neutrophils do not
respond chemotactically to IL-4. Checkerboard analysis,
inhibition studies with monoclonal anti-IL-4 Abs and de-
sensitization experiments indicated specific interaction of
IL-4 with eosinophils. In eosinophils from normal individu-
als IL-4 responsiveness could be induced by pretreatment
of the cells with GM-CSF. Since IL-4 may be responsible for
selective eosinophil trans-migration across the endoth-
elium, ILo4 may further direct eosinophil migration and
function within allergically inflamed tissue.
Modulation of the enhanced migration of
eosinophils from the airways of sensitized
guinea-pigs: role of IL-5
E. Coffier, D. Joseph and B. B. Vargafiig
Unite de Pharmacologie Cellulaire, Unit Associe
Institut Pasteur-INSERM n 285, 25, Rue du Dr. Roux,
75015, Paris, France
PAF, LTB and interleukin (IL)-5 are potent
chemoattractants for guinea-pig eosinophils,
1,2 which may
be involved in eosinophil recruitment and upregulation
in allergic diseases. Eosinophils from the bronchoalveolar
lavage fluid (BALF) of guinea-pigs sensitized to ovalbumin
(OA) were collected 24 h after antigen provocation,
isolated on a metrizamide gradient and were studied
with respect to migration by PAF, LTB and rhlL-5.
Total BALF content and distribution of eosinophils were
greater (p<0.05, n= 35) in sensitized, OA-challenged
guinea-pigs (5.0 + 0.8 x 106/guinea-pig; 12 + 1%) than in
sensitized saline-challenged animals (3.0 + 0.7 x 106/
guinea-pig; 7 + 1%). Spontaneous, PAF and LTB4-induced
migration of eosinophils from sensitized and OA-
challenged guinea-pigs were significantly enhanced, as
compared to sensitized and saline-challenged animals (170
+ 36 vs 35 + 9 migrating eosinophils for 10 nM PAF-acether;
271 + 60 vs 110 + 19 for 1 nM LTB4). TRFK-5, an antibody
to IL-5, reduced eosinophil recruitment in BALF of antigen-
challenged sensitized animals as well as the enhanced
responsiveness of eosinophils from the challenged ani-
mals, suggesting a role for IL-5 in the priming of
eosinophils in vivo. Nedocromil sodium reduced to a
similar extent eosinophil, macrophage and lymphocyte
recruitment in the BALF of antigen-challenged and of
saline-challenged sensitized animals, but failed to down-
regulate the enhanced responsiveness of eosinophils from
the challenged animals. Our results support the concept IL-
5 is essential for recruitment and priming of eosinophils
from the guinea-pig BALF.
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Effects of interleukin-5 inhibition on antigen-
induced airway hyperresponsiveness and cell
accumulation in guinea-pigs
A. A. Y. Milne and P. J. Piper
Department of Pharmacology, The Royal College of
Surgeons, London WC2A 3PN, UK
Asthma is characterized by bronchial hyperresponsiveness
(BHR) which is correlated with increased numbers of
eosinophils in bronchoalveolar lavage fluid (BALF).
Interleukin-5 (IL-5) has many actions specific for
eosinophils, and is present in increased levels in BALF
from asthmatics. Blockade of IL-5 in vivo using the anti-
body TRFK5 results in a reduction of airway eosinophilia
in guinea-pig models of airway inflammation2,3 but the
effect on BHR was not studied. We have used TRFK-5 to
evaluate the importance of IL-5 and eosinophils in medi-
ating BHR in antigen-induced airway inflammation in the
guinea-pig. Animals were sensitized and challenged with
ovalbumin, resulting in BHR to acetylcholine (Ach) (three-
fold change in EC50) and an increase in total cells (three-
fold) and eosinophils (16-fold) in BALF 24 h post chal-
lenge. TRFK-5, or control antibody (rat IgG) were given
h before challenge (1 mg/kg i. v. n 5). Control antibody
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had no effect on cell numbers in BALF, or on BHR com-
pared to untreated animals. TRFK-5 reduced eosinophilia
(11.4 + 2.6 to 2.8 + 0.9 x 106/ml (mean + S.E.M.)) in BALF,
and reduced BHR (airway resistance to 10 g/kg Ach, 1 141
+ 93 to 494 + 96 cm H,.O/1 per s) These results confirm
that IL-5 mediates the eosinophilia and show further that
this cytokine is also involved in the development of BHR
in this model.
were more likely due to the local effect of inhaled steroids
on the bronchial mucosa than to a systemic effect.
Supported by TAssociation pulmonaire du Quebec’ and
Glaxo Canada Inc, ’Bureau d’affaires du Quebec’.
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A role for cytokines in resolution and repair
of pulmonary inflammation
P. Henson
National Jewish Center for Immunology and Respiratory
Medicine, 1400 Jackson Street, Denver, Colorado 80206,
USA
Effects of inhaled steroids on blood
eosinophils in moderate asthma
M. Laviolette, C. Ferland, L. Trpanier, H. Rocheleau, A.
Dakhama and L.-P. Boulet
Unit de recherche Centre de Pneumologie
(Universite Laval). H6pital Laval, 2725 Chemin
Sainte-Foy, Sainte-Fay, Quebec, Canada GIV 4G5
Inhaled steroids could improve asthma by decreasing the
bronchial release of chemotactic factors and cytokines and
consequently inhibiting eosinophil activation and
recruitment. We studied the effect of a low dose of
beclomethasone on asthma symptoms, peak expiratory
flow rates (PEFR), methacholine response (PC20), blood
eosinophil counts and eosinophil leukotriene C (LTC4)
production. Twelve asthmatics, using ]32 agonists on de-
mand, were randomized in a double-blind cross-over study
to take 400 l-tg Beclodisk(R) or a placebo twice daily for 6
weeks. Blood eosinophils were purified with a 1.078/1.100
g/ml Percoll gradient after a 10 min incubation with FMLP
10 nM. Mean (S.E.M.) eosinophil recovery and purity were
77 + 4% and 97 + 2%. Eosinophils were incubated + GM-
CSF (100 U) for 30 min and then + 2 btM calcium ionophore
A23187 for 15 min. LTC was measured in the cell
supernatants by EIA. Compared to placebo, inhaled ster-
oids increased morning PEFR from 391 + 30 to 472 + 41 1/
min (p 0.007). decreased asthma symptoms and the 2
agonist use from 3.1 + 0.9 to 0.72 + 0.5 daily inhalations
(p 0.007), increased PC20 methacholine from 0.38 to 1.9
mg/ml (geometric mean) (p 0.02) and decreased blood
eosinophil counts from 0.35 + 0.06 to 0.26 + 0.04 cells x
109/1 (p= 0.084). In the absence of A23187, eosinophils
released no detectable LTC4. However stimulation with
ionophore provoked the release of large amounts of LTC
by eosinophils, and GM-CSF further enhanced the
ionophore-induced LTC production. Inhaled steroids de-
creased the eosinophil A23187-induced LTC release from
5 571 + 899 to 3 129 + 462 pg/250 000 eosinophils
(p= 0.04) and the GM-CSF-enhanced LTC production,
from 11 177 + 1597 to 5950 + 531 pg/250 000 eosinophils
(p 0.003). These results show that clinical asthma im-
provement is associated with a reduction in eosinophil
LTC production. Since the effects on blood eosinophils
were obtained with a low dose of inhaled steroids, they
The inflammatory process is incomplete without the
resolution and consequent repair of the tissue, optimally
by an restoration of normal structure and function, but all
too often by fibrosis. Since inflammation is characterized
by influx of migratory cells, alterations in vascular
permeability and usually by local tissue damage, the first
step in resolution has to involve removal of fluid proteins,
cells and cell debrismnot to mention any microorganisms
or exogenous material that might have initiated the re-
sponse. It is suggested that incoming monocytes mature
along a number of different and mutually exclusive path-
ways to orchestrate these processes. (1) Phagocytosis of
digestible particulate matter leads to expression of new
surface receptors for phosphatidylserine as well as to
increased synthesis of TGF-[3 and PDGF by mechanisms
that involve autocrine action of lipid mediators, TGF-[3,
PKC and perhaps engagement of surface integrins.
The PS receptors are suggested to participate in removal of
debris and cells that have undergone apoptosis
a process that is accompanied by surface expression
of phosphatidylserine. This could account for the removal
of inflammatory cells from the lesion preparatory to the
repair process. (2) Exposure of maturing macrophages to
connective tissue elements such as hyaluronic acid induces
on the other hand a pathway that leads to increased
expression and release of IGF-1. Acting through CD44, this
stimulus initiates its own cytokine-driven sequence
involving the autocrine action of TNFz. (3) Stimulation
with polyribonucleotides (or LPS) induces yet another
pathway of maturation that results via mechanisms that in-
volve calcium and tyrosine and serine/threonine
phosphorylation in a cytocidal cell. Here too a req-
uirement for autocrine TNF0t action has been demon-
strated, and yet the pathway is quite exclusive of that
induced by hyaluronidate depending whether or not
the cells synthesize interferon. In its presence the cyto-
cidal pathway is induced by TNF, in its absence, cells that
synthesize IGF-1. These various pathways can pro-
ceed independent of external cytokines because of
the extensive autocrine feedback processes. How-
ever, they are also modulated by cytokines derived
from other cells in the environment. Equally imp-
ortantly, the cytokines and growth factors produced
by the macrophages during the maturation diffuse
into the inflamed lung to help orchestrate the processes of
resolution and repair.
Mediators of Inflammation. Vol 3.1994 73Cells and Cytokines in Lung Inflammation
Modulation of IL-lra and TNF soluble
receptors produced by alveolar macrophages
and blood monocytes
L. P. Nicod, B. Salve de Rochemonteix andJ.-M. Dayer
Division of Respiratory Diseases and Division of Immu-
nology and Allergy, University Hospital, Geneva,
Switzerland
Alveolar macrophages (AM) are not only able to produce
several inflammatory substances such as IL-lz and [3 or
TNF0t, but also inhibitors of these same cytokines which
are the IL-1 receptor antagonist (IL-lra) and soluble
receptors of TNF. Comparison of in vitro kinetics of IL-lra,
IL-Rx and IL-1[3 in the presence of phorbol myristate acetate
revealed that their mRNA expression was assynchronous.
IL-lz and IL-l[3 mRNA were expressed after as little as 15
min, whereas IL-lra mRNA was detectable after 3 h in
culture. Twenty-four hours later, the amount of
extracellular IL-lra was equal to that of intracellular IL-lra
and was 30 and 100 times higher than IL-10t or [, res-
pectively. In the presence of IL-4 or GMCSF IL-lra was
markedly increased whereas that of IL-I or [3 was
decreased or unchanged with the former and slightly
enhanced with the latter.
AM were then tested for their ability to release the
inhibitors of TNFx, the soluble receptors of 55 and 75 kDa.
Although unstimulated AM express low levels of TNF-R55
and TNF-R75; they shed more TNF-sR75 as measured by
ELISA. PMA stimulation increased mostly the expression
and the release of TNFsR75 and had little effect on
TNFsR55. Amon.g the cytokines analysed IFN increased by
three-fold the shedding of TNFsR75. This suggests that the
expression of the two TNFsR are ruled by separate mecha-
nisms and differ in shedding sensitivity.
Supported by the FNRS N 31-31019.91 (LN) and 31-
33786.92 (JMD)
Cells and cytokines in chronic bronchial
infection
age can result from direct effects of toxins released by
luminal bacteria and subversion of the normally protective
host inflammatory response to a damaging one. The host
response is characterized by intense neutrophil traffic
through the bronchial wall to luminal bacteria-laden mucus
and by a cellular immune response within the affected
bronchial wall. This cellular infiltrate is mainly composed
of macrophages and activated T-lymphocytes, mostly
CD8+ cells, some of them presenting cytolytic potential. In
follicular bronchiectasis, CD4+ cells are found predomi-
nantly within the bronchial lymphoid aggregates. Produc-
tion of cytokines by these cells is a likely possibility in this
situation, some of which could have chemotactic activity
for neutrophils and other inflammatory cells. We
quantitated the cytokine profile in luminal secretions.
Twelve consecutive bronchiectasis patients with acute in-
fective exacerbations were treated with antibiotics. IL-1,
TNF-0t and IL-8 were measured by ELISA in plasma and
sputum pre- and post-therapy. IL-8 was also determined 2
weeks after treatment. All patients showed a marked re-
duction in sputum volume, purulence and cell counts at
the end of treatment. Cytokine levels in plasma were
below the limit of detection. All three cytokines were
found in bronchial secretions before treatment: IL-1 and
TNF levels decreased after therapy but IL-8 levels remained
raised, even 2 weeks into remission. We conclude that a
major chemoattractant signal for neutrophil traffic in
bronchiectasis remains raised, despite clinically effective
antimicrobial therapy. The stimulus for IL-8 production and
its source(s) in this condition remain to be determined.
Cytokine gene and peptide regulation in lung
microvascular injury: new insights on the
development of adult respiratory distress
syndrome (ARDS)
R. Rabinovici, L. Neville and G. Feuerstein
Department of Surgery, Jefferson Medical College,
Philadelphia, PA 19107 and SmithKline Beecham, King
of Prussia, PA 19406, USA
J. Eller, J. R. Lapa e Silva, H. Lode and P. J. Cole
Host Defence Unit, Royal Brompton National Heart &
Lung Institute, London, UK; Section of Infection &
Immunology, Department of Pulmonology I,
Krankenhaus Zehlendorf, Berlin, Germany; Servigo de
Pneumologia, Hospital Universitario Clementino Fraga F
UFRJ, Rio de Janeiro, Brazil
Bronchiectasis is a well defined model of chonic bronchial
sepsis. It is regarded as the inflammatory final common
pathway from several causes. Over 60% of all cases
are idiopathic and less than 5% result from
immunodeficiencies. The bronchial secretions are usually
infected with non-virulent bacteria. The damage to the
bronchi seen in the condition is stimulated by the coloniz-
ing bacteria but it is induced by a host-mediated ’vicious
circle’ of inflammatory events. Progressive bronchial dam-
We have recently shown that the combined administration
of non-injurious doses of LPS and PAF in the rat produce
ARDS-like lung injury characterized by neutrophil
adhesion to lung capillary venules, neutrophil accum-
ulation in lung parenchyma, pulmonary oedema, and
increased protein in BAL fluid. This new paradigm of lung
injury was associated with elevated serum TNFz and
pretreatment with anti-TNFcz mAb dose-dependently
prevented these responses. Also, the combined admini-
stration of LPS and PAF induced lung mRNA levels ofTNF
(five-fold vs. LPS or PAF alone), IL-1[3 (80-fold), KC
(60-fold) and IL-6. Taken together, these data suggest that
this new paradigm of lung injury is cytokine-mediated and
that LPS/PAF in vivo can functionally couple to the
activation of gene expression of a multi-cytokine network
system, all of which may be involved in the pathogenesis
of ARDS.
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Relations between neutrophils and cytokines
in patients with adult respiratory distress
syndrome (ARDS)
S. Chollet-Martin, P. Montravers, C. Gibert, C. Elbim, J.
M. Desmonts and M. A. Gougerot-Pocidalo
Laboratoire d’Immunologie et d’Hmatologie et INSERM
U 294, Services de ranimation, CHU X. Bichat, 75877
Paris Cedex 18, France
To gain further insight into the pathogenesis of ARDS, we
studied possible relationships among the activation status
of circulating neutrophils, cytokine levels and the severity
of lung injury in 31 patients: 15 with ARDS, nine with
severe pneumonia and seven mechanically ventilated with
neither ARDS nor pneumonia. Using flow cytometry, we
identified a subpopulation of neutrophils with an increased
capacity to generate hydrogen peroxide after stimulation
ex vivo in all patient groups; significantly higher values
were found in those with ARDS. This was correlated
with elevated TNF0t levels in plasma and produced by cul-
tured monocytes, and with elevated IL-8 levels in
bronchoalveolar lavage fluid (BAD. The neutrophil activa-
tion status and TNFz parameters correlated with indices of
the severity of lung injury, as IL-8 levels were related to a
fatal outcome and the presence of shock. The BAL fluid to
plasma ratio of IL-8 was significantly greater than that of
TNF, indicating higher local production of IL8. Thus,
TNFz and IL-8-primed neutrophils may play a major role
in the pathogenesis of ARDS-associated lung injury.
The effect of airborne particulates on in vitro
interactions of human basophils and
neutrophils
H. Behrendt, B. Hitzfeld and K. H. Friedrichs
Medical Institute of Environmental Hygiene at the
Heinrich-Heine-University, PO Box 103751, D-4000
Dtisseldorf, Germany
The effects of extracts of airborne particulate matter (APM)
on the morphology of and the mediator release from
enriched basophils (HBC) and from purified neutrophils
(PMN) of pollen allergic and non-allergic individuals were
investigated. For this purpose APM was collected on glass
fibre filter sheets using high volume samplers HVS150.
After preparing an aqueous extract, in which allergens are
absent, followed by extraction of organic substances, the
mediator releasing activity of the APM extracts was studied
under defined and physiological in vitro conditions.
The results indicate that APM potentiates anti-IgE in-
duced histamine release (HR) and that this enhancement is
significantly higher in HBC samples from pollen allergic
donors than from non-allergic individuals. This is a non-
cytotoxic event, it does not depend on extracellular cal-
cium and does not affect the calcium dependency of HR
induced subsequently by anti-IgE. Electronmicroscopy of
APM exposed HBC reveals basophil degranulation in ad-
dition to strong activation of platelets and neutrophils, the
latter sticking on to the surface ofHBC and forming clusters
with them. We therefore also investigated the effects of
APM on mediator release of purified PMN. The results
show that organic APM extracts preferentially induce LTC
and IL-8 release. Incubation of purified PMN with APM
prior to zymosan stimulation showed that these substances
also enhance the release of LTB4, LTC4, PGE and IL-8.
This indicates that substances adsorbed to APM interfere
with mediator cells of the allergic inflammation and exhibit
’priming’ effects on them. Therefore, exposure of individu-
als to high concentrations of APM can provoke enhance-
ment of symptoms of allergy and continuation of allergic
inflammation.
New therapeutical approaches in the treat-
ment of asthma
Ph. Godard
Hopital Arnaud de Villeneuve, Montpellier, France
Bronchial asthma is a chronic inflammatory disorder of the
airways. It’s a disabling condition and all the epidemiologi-
cal data indicate an increase of prevalence, morbidity and
mortality. Despite the high efficiency of inhaled
corticosteroids (ICS), there is a need for new therapeutical
approaches. We need to increase our knowledge of the
pathophysiology. During a long period of time, allergen
challenge was the gold standard to test the efficacy of a
new drug. However, it is clearly established now that
chronic asthma is quite different and some drugs which
can prevent or reverse allergic reactions are not very active
on a chronic basis. Chronic asthma is an inflammatory
disorder of the airways; the cellular influx is related to the
severity of the disease; the vascular component of the
disease could be linked to the activity, in other words to
variability or instability of airway obstruction.
The inflammatory cascade is not well known. However,
it can be hypothetized that resident cells are able to initiate
it, either spontaneously or after specific or non-specific
targeting. In that context alveolar macrophages could be
good target cells for drug: their suppressive activity on
lymphocytes is decreased; they express high quantities of
HLA-DR and ICAM-1; specific antagonists could be tried;
they appear to be in a high activation state (high
releasibility); this could be the consequence of a priming
effect or of an intrinsic defect (low intracellular cAMP, high
turnover of phosphoinositides, translocation of the PKC
could be good candidates). Mast cells are present in nor-
mal airways and it has been suggested that they could
participate in the defence mechanisms. It could be pro-
posed to act specifically at this level, for example by
targeting aspecific drug. Epithelial cells are present all
along the bronchial tree; it is clear that they do not act only
as a passive barrier. They express abnormally high levels
of 1CAM-1. In animals, it has been shown that anti-ICAM
was able to prevent eosinophil recruitment.
Corticosteroids are able to reverse airway obstruction, to
clear inflammatory cells and to restore a nominal epithelial
line. However, the repair is not totally satisfactory: the
pseudo thickening of the basement membrane appears not
to be modified; can it be suggested that inflammatory
process has not to be totally abolished? their efficacy is not
identical in all patients; the heterogeneity of airway inflam-
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mation has been suggested, but not fully investigated and
not well understood. However, it can be thought that the
importance of lymphocytes has to be taken into account;
the results which have been obtained with cyclosporine
sustain this hypothesis; there are some corticoresistant
asthmatic patients; some authors suggested the role of
specific cytokine; but additional data are required.
In the near future, the therapeutical approaches of bron-
chial asthma could be as follows: 1. better use of the drugs
which are currently available; this means that we have to
educate the patients and their doctor(s); 2. prevent the
onset or worsening of asthma. Indeed environmental fac-
tors are critical and several possibilities of action exist at an
individual and general level; 3. develop more effective ICS;
this could be done by developing new ICS with more
topical activity or which could be targeted to specific
cell(s); 4. discover new drugs which could act at a specific
cellular level in order to down-regulate its high
releasibility; 5. introduce adjuvant drugs which could
’prime’ the effect of corticosteroids at the receptor level.
Perspectives and diagnostic potential for
cytokines and adhesion proteins
J. L. Gordon and A. J. H. Gearing
British Biotechnology, Oxford, OX4 5LY, UK
The co-ordinated expression of cytokines and adhesion
molecules (CAMs) is essential for the development of
immune and inflammatory responses. There is consider-
able interdependence in the functions of cytokines and
CAMs for example, the expression of adhesion molecules
E-selectin, VCAM-I and ICAM-I is regulated by the pro-
inflammatory cytokines IL-1 and TNF, and the affinity of [32
and [31 integrins is increased following stimulation of
leucocytes with chemotactic cytokines such as MIP-I[3 and
GMCSF. Recent experiments also show that MIP-I[3 bound
to the adhesion molecule CD44 on endothelial cells can
stimulate lymphocytes to upregulate the affinity of their 14
integrin for its endothelial ligand VCAM-1.1
The potential diagnostic or prognostic value of measur-
ing blood levels of cytokines has been explored in a
number of pathological states but the significance of these
measurements can be limited because cytokines are usu-
ally produced (and act) locally, and are cleared rapidly
from the circulation. Specific inhibitors of cytokines can
also be measured in the blood (e.g., soluble receptors for
TNF and IL-1, which can be shed from the surface of cells),
and measuring the balance between cytokines and their
inhibitors may be more meaningful than measuring
cytokine concentrations alone.
We speculated that soluble CAMs might also be released
from cell surfaces, and by using specific ELISAs and
immunoprecipitation analysis we have demonstrated that
endothelial cells can be stimulated to release soluble
ICAM, VCAM and E-selectin. These soluble CAMs are all
found in the serum or plasma of healthy individuals, and
levels of some or all of them can be elevated in renal,
vasculitic, diabetic, transplant and septic shock patients,
and during cytomegalovirus infection. The cellular sources
of these molecules, and the mechanism(s) by which they
are released, have not yet been determined, but in some
instances the levels measured apparently reflect the clinical
prognosis.
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Correlation between membrane marker
CD23- soluble CD23 and cytokines in
atopic patients
A. Sabbah and C. Buchman
Laboratoire d’Immuno-Allergologie, CHU 49033 ANGERS
Cedex 01, France
IgE has two types of receptors: high affinity RFcI and low
affinity RFcZII. The latter may be studied by flow
cytometry by the membrane marker CD23 (mCD23), ex-
pressed on B and T cells monocytes, macrophages,
Langerhans cells, eosinophils and platelets. Soluble CD23
(sCD23) corresponds with the extracellular C-terminal
domain of mCD23.
The aim of the study was to search for a correlation
between the levels of mCD23 and sCD23, comparatively
with IgE, eosinophils, eosinophil cationic protein (ECP)
and to the cytokines IL-2, IL-4 and IL-6. Seventy-eight
patients took part in the study, divided into two groups:
group 1: atopics (n 61)
group 2: controls (n 17)
The majority presented with rhinitis, asthma, atopic
dermatitis isolated or associated. The results showed a
highly significant correlation between CD23 and sCD23
compared with the control group. There was also a statis-
tically significant increase for mCD23, sCD23, cytokines IL-
2, IL-4 and IL-6, mediator ECP in parallel with eosinophils
and total IgE.
The study confirms amongst other things the rise in IL-
4 in atopy and the correlation between the level of ECP
and that of eosinophils, and that there is an overall corre-
lation between mCD23 and sCD23
Inhibition of GM-CSF gene transcription by
glucocorticoids in the Jurkat T cell line:
selection of resistant clones from Jurkat
cells treated with methylprednisolone
M. BossY, M. Laviolette and M. Audette*,
Unit de recherche, Centre de pneumologie de I’H6pital
Laval, Rseau de Centres d’excellence en Sante
Respiratoire/Laboratoire d’Endocrinologie MoMculaire*,
Centre de Recherche du CHUL, Ste-Foy, Quebec,
Canada
In asthma, T cells modulate the inflammatory response by
producing haematopoietic cytokines like IL-3, IL-5 and
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GM-CSF. Glucocorticoids are potent anti-inflammatory
drugs, they inhibit the transcription of various cytokine
genes including IL-2, IL-5, IL-6. However, the
dexamethasone inhibition of the synthesis of IL-2 by
mitogen-stimulated T lymphocytes was significantly de-
creased in asthmatic subjects resistant to glucocorticoid
treatment. First, we verified the transcriptional inhibition of
GM-CSF by methylprednisolone (MP) with RT-PCK in the
Jurkat T cell line. T cells were incubated 20 h with
mitogens (PHA 10 g/ml, PMA 5 ng/ml) in RPMS 10% at 106
cells/ml with concentrations of MP ranging from 10.5 to 10
9M. Total RNA was immediately extracted by the guan-
idium chloride method. One }.tg of total RNA was used for
reverse transcription (5 units r Tth, 200 mM NTPs, 1 mM
MnCl2, 100 pmol of the reverse primer 5’GCACAGGA-
AGTTCCGGGGT3’, 1 min 95C; 2 min 50C; 15 min 72C).
PCR reaction was performed using the forward primer
5’GCTGCTGAGATGAATGAAAC3’ (100 pmol) in the fol-
lowing conditions: 10 mM MgCl2, 30 s 95C, 30 s 55C, 1
min 72C, 30 cycles, 10 min 72C. The amount of PCR
product evaluated by ethidium bromide staining showed a
dose dependent inhibition and was barely detected at
10-5M of MP. Second, in attempt to establish an in vitro
model of steroid resistance, Jurkat T cells were incubated
at 105 cells/ml with 10-3M ofMP sodium hemisuccinate and
grown up to 106 cells/ml. MP-treated Jurkat cells were
maintained for up to 15 passages. The inhibition of
mitogen-induced proliferation of the MP-treated cells was
compared to untreated Jurkat cells. The MP-treated cells
were less inhibited by steroids. The transcription of GM-
CSF evaluated by RT-PCR was not inhibited up to 10-4 M
of MP. The transcription of GM-CSF was inhibited by MP
in the Jurkat T cells. The pool of MP-treated T cells was
resistant to the glucocorticoid, according to mitogen-in-
duced proliferation and GM-CSF transcription activity,
fourteen clones were obtained from this MP resistant pool.
In conclusion, glucocorticoids inhibit gene transcription of
GM-CSF and we obtained resistant clones to study the
molecular mechanisms of the resistance to glucocorticoids.
Azelastine modulates T cell function
N. Chand and R. D. Sofia.
Wallace Laboratories, Cranbury, NJ 08512 USA
T cell recruitment, proliferation and activation in the lungs
play a critical role in the pathogenesis of chronic asthma.
Drugs which interfere with the proliferation, blastogenesis
and/or activation ofT cells may be effective in the manage-
ment and treatment of chronic asthma. Azelastine (40 ng/
ml, 12 h preincubation with dendritic cells) inhibited an-
tigen (Dermatophagoidesfarinae, 10 g/ml) induced IL-2
responsiveness (proliferation response) in T lymphocytes
obtained from asthmatic children. Azelastine (40 ng/ml)
also inhibited purified protein derivative-induced IL-2 re-
sponsiveness in normal human peripheral blood
lymphocytes but did not influence Con-A-induced expres-
sion of IL-2 responsiveness. These data demonstrate that
azelastine exerts a specific T cell, suppressive effect. It
appears to act on an antigen-presenting pathway. It, also
inhibited LPS-stimulated IL-1 generation in human
monocytes. Azelastine (1-100 laM, 3-5 day incubation)
inhibited food allergen (ovalbumin)-induced blastogenesis
of lymphocytes obtained from bronchial asthmatics com-
plicated with atopic dermatitis (IC50<5 laM). Azelastine
(5-500 t.tM, 24 h preincubation) also inhibited IL-2-induced
T cell blastogenesis in IL-2-dependent NKC-3 cells (IC50<5
M). However, it did not influence antigen-induced IL-2
generation in the peripheral blood monocytes. The
chemotactic activity of calcium pyrophosphate-induced
pleural exudate on rat T cells was also inhibited by
azelastine and dexamethasone. Both the drugs also inhib-
ited IL-1 release in pleural exudate and leukocyte
chemotactic activity in mice. Furthermore, azelastine in-
hibited aeroallergen induced (T cell-dependent, IL-5-medi-
ated) bronchial eosinophilia in guinea pigs. Therefore,
these activities of azelastine would suggest a steroid-spa>
ing effect in asthmatics.
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Effect of cyclosporin A on the infiltration of T
lymphocytes and eosinophils in lungs of
sensitized rats
F. Kyriacopoulos, C. Carr6 V. Lagente,
J-M. Mencia-Huerta and P. Braquet
Institut Henri Beaufour, 1 avenue des Tropiques, 91952
Les Ulis, France
The immunosuppressive compound cyclosporin A has
been demonstrated to inhibit lung eosinophil infiltration
induced by antigen challenge in sensitized guinea-pigs
(Lagente et al., submitted), suggesting a link between
activation ofT lymphocytes and the recruitment of this cell
type. The effect of treatment of the animals with
cyclosporin on the eosinophil and T lymphocyte accumu-
lation and activation induced by antigen challenge in the
lung of sensitized rats, was investigated. Brown Norway
rats were sensitized by i.p. and s.c. injections of ovalbumin
(OA) in AI(OH), at a 15-day interval. Seven days after the
last injection, aerosol challenge was performed. Histologi-
cal preparations of lung specimens using Luna staining
showed a marked and significant increase of eosinophils in
lung tissue 24-96 h following OA challenge. Pretreatment
of the rats with cyclosporin (10 mg/kg twice a day for 2
days and 10 mg/kg orally, 1 h before OA challenge totally
inhibited the accumulation of eosinophils observed in the
lungs of sensitized rats at 48 h. Cyclosporin also reduced
the increase in eosinophil number in the bronchoalveolar
lavage fluid after OA challenge (54% inhibition). In order
to characterize the T lymphocyte subsets possibly involved
in this process, cryostat sections of lung tissue were stained
by various mouse monoclonal antibodies. Antigen chal-
lenge of sensitized rats provoked a significant accumula-
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tion of CD3+, CD4+ and CD25+ T lymphocytes in lung
tissue that was inhibited when the animals are treated with
cyclosporin. These results demonstrate that cyclosporin
treatment reduces the antigen-induced accumulation of
eosinophils and T lymphocytes in sensitized rats and fur-
ther strengthen the fact that T lymphocyte activation and
eosinophil recruitment are related events.
Effects of FK-506 and nedocromil sodium on
the bronchial inflammatory inf’tltrate of
actively sensitized guinea-pigs
J. R. Lapa e Silva, D. Baker, R.J. Scheper, B.B. Vargaftig,
M. Pretolani
University Hospital, Federal University of Rio de Janeiro,
Brazil; Unit de Pharmacologie Cellulaire, Institut
Pasteur, Paris, France; Royal College of Surgeons of
England; Free University, Amsterdam.
The bronchial wall from guinea-pigs sensitized by 2 s.c.
injections of ovalbumin at a 2 week interval exhibit
marked infiltration by CD4+ T-lymphocytes/eosinophils.
We have now investigated the effects of nedocromil so-
dium and of FK-506, a novel immunosupressive agent, on
the bronchial inflammation in sensitized guinea-pigs. Four
groups of six Hartley guinea pigs received s.c.injections of
10 g ovalbumin in 1 ml AI(OH) at day 0 and 14, and were
killed at day 21: two groups received from day 14 s.c.
injections of FK-506 (1 mg/kg) or nedocromil sodium (30
mg/kg) daily. The other two groups received daily injec-
tions of the diluent (ethanol+Tween 80 or saline, respec-
tively). The animals were killed, the lungs frozen and
cfyostat sections stained with immunohistochemical meth-
ods using monoclonal antibodies: CT5 T cells,
macrophages; H159=T cells; H155=CD4; CT6=CD8. Cya-
nide-resistent eosinophil peroxidase activity (EPO) was
used to stain eosinophils. Sections were coded, and posi-
tive cells were enumerated in the lamina propria:
CT5 H159 HI55 CT6 EPO
FK-506 10.9(1.8) 8.0(0.9) 6.7(1.1) 7.1(0.6) 14.8(0.8)
DIL 42.1(5.8) 42.7(1.3) 43.3(4.9) 22.8(3.1) 29.2(4.8)
p value <0.05 <0.01 <0.01 <0.01 <0.05
NEDO 37.5(8.7) 41.3(1.3) 40.7(6.3) 26.7(6.1) 24.5(3.5)
DIL 39.7(6.3) 52.2(4.4) 47.1(5.8) 20.7(3.1) 51.3(7.3)
p value NS NS NS NS <0.05
Evidence of ytotoxic activity of CD8+ T
lymphocytes in the chronic inflammatory
infiltrates of bronchiectasis
J. R. Lapa e Silva, L. W. Poulter, P.J. Cole
University Hospital, Federal University of Rio de Janeiro;
Royal Free Hospital School of Medicine, London, UK;
Host Defence Unit, Royal Brompton National Heart &
Lung Institute, London, UK.
The chronic bronchial inflammatory response in bronchie-
ctasis (Bx) includes a large number of T-lymphocytes,
many CD8+ cells with evidence of activation and im-
munological commitment (Lapa e Silva et al. Am.Rev.Res-
pir.Dis.1992; 145: A335). The question as to whether these
CD8+ T cells possess cytolytic potential and damage the
bronchial mucosa or possess suppressor function and con-
trol the T cell response in the mucosa, has not been
clarified. We have investigated the expression of a protein,
recognized by a novel monoclonal antibody (TIA-1),
which may distinguish cells exhibiting cytolytic activity
(Anderson et al., Immunol.1990; 144: 574) in the cellular
infiltrate of Bx. Bronchial biopsies were obtained from 12
Bx patients and six controls (C), snap frozen in isopentane
cooled by liquid nitrogen, and cryostat sectioned for con-
ventional histology and immunohistochemistry. Consecu-
tive sections were stained with CD8 or TIA-1 using
immunoperoxidase. Double immunofluorescence was
employed to study co-expression of both antigens, using
fluorescein and rhodamine as fluorochromes. The positive
cells were counted in the bronchial lamina propria:
CD8 T\IA-1 CDS/TIA-I*
Bx 7.9 (0.8) 1.9 (0.3) 16.0 (1.7)
c 1.2 (0.3) 0.03 (0.01) 0.9 (0.2)
p <0.0001 < 0.001 < 0.001
mean (S.E.M.) positive cells per unit area; *mean (S.E.M.)
% double-positive cells; p values= Student’s t-test
A significant increase in the co-expression of CD8 and
TIA-1 was seen in Bx. However, expression of TIA-1 was
not restricted to the CD8+ cells, but was also found in
putative CD4+ cells. These findings are compatible with a
proportion of CD8+ T ceils having cytolytic potential in Bx
and could account for some of the damage seen in this
disease.
Reference
1. Lapa e Silva et al. Am Rev Respir Dis 1992; 145: A335.
mean (SEM) of positive cells per unit area Student’s t-test.
FK-506 abolished the T-cell/eosinophil invasion in
the bronchial wall, whereas nedocromil sodium was
ineffective in protecting the lungs from T-cell infiltration,
although it reduced the eosinophil influx. These findings
suggest that independent mechanisms may be involved in
the recruitment of eosinophils to the bronchi in this model.
Reference
1. Lapa e Silva et al. Am Rev Respir Dis 1992; 145: A39.
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The immunosuppressive activity of
rimtnophenazines is mediated by
lysophospholipids
R. Anderson
Department of Immunology, University of Pretoria,
South Africa.
The relationship between the
ulating and immunosuppressive
phospholipase-stim-
properties of theLung inflammation
riminophenazine antimycobacterial agent clofazimine and
its experimental analogue, B669, has been investigated in
vitro. At concentrations of 0.6 t-tM and upwards, both
agents caused dose-related inhibition of mitogen- and
alloantigen-stimulated uptake of tritiated thymidine by
human mononuclear leukocytes (MNL), while in short-
term assays both agents, particularly B669, caused dose-
related enhancement of the release of lysophos-
phatidylcholine (LPC) and arachidonic acid from these
cells. Arachidonate per se at concentrations of 20M did
not affect mitogen-activated lymphocyte proliferation,
while cyclooxygenase and 5’-lipoxygenase inhibitors as
well as water- and lipid-soluble oxidant scavengers and
anti-oxidant enzymes failed to protect the cells against the
anti-proliferative effects of clofazimine and B669. How-
ever, LPC caused dose-related inhibition of lymphocyte
proliferation. Moreover, co-incubation of MNL with alpha-
tocopherol (Vitamin E), a lysophospholipid-complexing
agent, or with lysophospholipase, protected the cells
against clofazimine and B669, as well as against LPC. Na
K ATPase was identified as the primary target of
riminophenazine/LPC-mediated inhibition of lymphocyte
proliferation. Excessive release of anti-proliferative
lysophospholipids during clofazimine or B669 treatment of
mitogen- or antigen-activated lymphocytes, leading to in-
hibition of Na/, K+-ATPase activity, is the probable
biochemical mechanism of the immunosuppressive activity
of these agents.
Ribomunyl modulates the expression
of DR and IL-2R antigens on blood
cells in patients with severe immune
disorders
L Khomenko and V. Chukanov
Central TB Research Institute, Yauzskaya alley, 2,
Moscow, 107564 Russia.
The aim of the investigation was to assess Ribomunyl’s
(Pierre Fabre) influence on the expression of ’activation’
antigens (DR+and IL-2R+) on blood cells of patients with
severe immune disorders (secondary). Thirty-two adult
patients with active, sputum-positive lung tuberculosis
were under observation. Immunological blood testing in
the method of indirect immunofluorescence revealed se-
vere secondary immune disorders: decreased CD3 content
(42.3 + 1.4), CD4+/CD8 ratio (1.2 + 0.06) and increase in
DR* and IL-2 cells (36.8 + 2.1 and 14.2 + 1.7 respectively).
In the treatment of 20 patients in addition to
antituberculosis chemotherapy Ribomunyl was applied
(group 1), while other 12 patients received only chemo-
therapy. The effect of Ribomunyl application on immune
indices was confirmed by repeated blood testing. In group
1 the level of CD3 lymphocytes was normalized, CD4//
CD8 ratio considerably improved, the levels of ’activated’
lymphocytes decreased (DR cells from 36.8-+ 1.3 to
21.0 + 1.4; p < 0.05; IL-2R cells from 14.2 + 1.1 to 7.3 + 1.0;
p < 0.05) in comparison with that in the group receiving
only chemotherapy. The data given above approve
Ribomunyl application in patients with severe secondary
immune disorders.
Interleukin-2 therapy in the treatment of
malignant lymphoma
A. A. Umnyashkina, F. M. Abdullayev and
R. F. Umnyashkina
Institute of Phtisiology and Pulmonology, Quarter 2514,
Zardabi Street, Baku 370IIS, Azerbaijan Republic.
Interleukin-2 (IL-2), produced by stimulated lymphocytes,
is thought to hold promise in the treatment of malignant
lymphoma. Twenty-eight patients with mean age 19.5
years affected by malignant lymphoma were studied. All
received intravenous IL-2 (30 000 to 70 000 U/kg) every
8 h for 9-12 days. All patients had major adverse reac-
tions to IL-2, but only one had to withdraw from the trial.
In addition to multiple laboratory abnormalities, at least
80% had fever, chills, cough, anorexia, malaise, hypoten-
sion, or skin rash. Overall clinical improvement was mod-
est. The 15 patients improved dramatically during therapy
but relapsed within 8 weeks. Seven patients had a 4-month
remission, the increase of a number of CD1, CD21
lymphocytes, phytohaemagglutinin-induced blastogenesis
and normalization of CD4/CD8 indices was detected.
These outcomes, especially the side effects, are disap-
pointing for a therapy that once held high hope. On the
basis of these results, it is possible to conclude that
perhaps long-term therapy with lower doses of IL-2 in
patients with malignant lymphoma will prove more
valuable.
Mast cell heterogeneity and hyperplasia in
crocidolite-induced pulmonary and pleura1
fibrosis of rats
M. Respondek, B. VOSS,
2 T. Kereyni, Th. Wiethege,
2 and
K.-M. Maller.
1Institute of Pathology, Bergmannsheil Hospital, Ruhr
University Bochum and "Professional Associations’
Research Institute for Occupational Medicine at the Ruhr
University Bochum.
The presence of mast cells in lung is of considerable
interest because these cells contain a wide variety of
chemical mediators of importance in health and disease.
Although pulmonary mast cell hyperplasia has been iden-
tified in lung fibrosis, the histochemical and functional
characteristics of these mast cells have not been analysed.
By means of different experimental animal studies we tried
to investigate the formal and causal pathogenesis of
crocidolite fibres-related pulmonary and pleural tissue re-
action pattern. Groups of eight animals received a single
intratracheal instillation of saline buffered crocidolite (2 mg
crocidolite) or physiological saline as control. Animals
were sacrified 1, 3, 7, 14, 38, 64, 119, 169, 206, 364, 400
and 540 days after instillation of crocidolite. Lungs were
proceeded for light and electron microscopical examina-
tions. The mast cell density was significantly increased in
the rat alveolar wall, the subpleural parenchyma and in the
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diffuse sclerosing pleura. The mast cell hyperplasia occurs
on day 38 after the single intratracheal instillation of
crocidolite until at least day 540. In the lung parenchyma
of crocidolite treated rats we found between 20 and 125
mast cells per middle power field (obj. x 20), in contrast
to less than five mast cells in the control group. The lung
parenchymal and pleural mast cells were histochemically
of the connective tissue type (CTMC). Interestingly, CTMC
showed a chronic process of partial degranulation which
differs from that found in anaphylaxis. In summary, thus
pronounced mast cell hyperplasia occurs during the evo-
lution of experimental pulmonary fibrosis. This model
provides a powerful tool to study pulmonary mast cells
and to identify their role in fibrotic disease.
Dexamethasone diminishes stem cell
factor-induced serotonin release by rat
peritoneal mast cells
A.M. Taylor, S.J. Galli*, and J. W. Coleman,
Department of Pharmacology, University of Liverpool,
P.O. Box 147, Liverpool L69 3BX, UK and *The Depart-
ments of Pathology, Beth Israel Hospital and Harvard
Medical School, Boston, MA 02215, USA
Stem cell factor (SCF), the ligand of the c-kit receptor, is
an important mast cell growth and differentiation factor
that has recently also been shown to exert direct or
synergistic mediator releasing effects on tissue mast cells in
vivo or in vitro. Accordingly, SCF may modulate mast cell
function during tissue hypersensitivity reactions. We have
investigated the effects of culture in vitro with or without
a corticosteroid on the responsiveness of mast cells to
stimulation by SCF.
Rat peritoneal mast cells were purified to >95% through
72.5% Percoll and cultured at 1-5 x 105/ml in complete
DMEM (containing 5% FCS) at 37C in 5% CO for 1 or
24 h, before challenge for 30 min at 37C with recombinant
rat SCF (4-500 ng/ml). The cans released a substantially
greater proportion of granule-associated [3H]serotonin (5-
HT) after 24 h compared to 1 h of culture in drug-free
medium (100 ng/ml SCF gave 28.1 + 9.8% 5-HT release
after 24 h of culture compared with 0.6 + 0.2% release after
1 h of culture; p < 0.05). The development of responsive-
ness to SCF was virtually abolished by the presence of 10-
7M dexamethasone during the 24 h culture period. The
drug caused 85% inhibition of 5-HT release induced by 100
ng/ml SCF compared to 50% inhibition of release induced
by either 48/80 (2.5 g/ml) or anti-IgE (1/100). Our obser-
vation that the acquisition by mast cells of responsiveness
to SCF during culture is reversed by dexamethasone sug-
gests that in vivo corticosteriods may down-regulate in-
flammator responses induced by this cytokine.
Mechanism of mast cell TNFtz-dependent
cytotoxicity and its modulation by
sulfasalazine
E. Y. Bissonnette, J. A. Enciso, and A. D. Befus.
Department of Medicine, University of Alberta, Edmon-
ton, AB, Canada T6G 2S2.
Mast cells (MC) are an important source of the multipotent
cytokine tumour necrosis factors (TNFz). We investigated
the mechanism of action of MC derived TNFz-dependent
cytotoxicity (WEHI-164 target) and its modulation by anti-
TNFz and sulfasalazine. Rat peritoneal MC (PMC) were
pretreated for 4 h with and without anti-TNFz and/or
sulfasalazine, washed to eliminate free anti-TNF{z or
sulfasalazine and tested for their cytotoxic activity.
Sulfasalazine pretreatment inhibited by 49% PMC
cytotoxicity and anti-TNF0t pretreatment reduced PMC
cytotoxicity by 64%, raising the possibility of active TNF
on the membrane of PMC as demonstrated on
macrophages. To further investigate this hypothesis, PMC
were fixed with 1% paraformaidehyde. Fixed PMC exhib-
ited TNF{z-dependent cytotoxicity (48.6 + 6.3 LU20/106
compared to 136.2 + 8.2 LU20/106 for control) without
releasing TNFz, but which could be eliminated by anti-
TNF{z in the assay. Interestingly, the binding of anti-TNF
to membrane TNF increased the levels ofmRNA for TNFz,
suggesting that the binding of membrane TNF to its
receptor on the target cell stimulates TNF mRNA in PMC.
By contrast, sulfasalazine treatment inhibited by 77% the
levels of mRNA for TNF. Thus, PMC cytotoxicity is medi-
ated by an increase in the levels of mRNA for TNF0t and
by soluble and membrane TNFx. Sulfasalazine treatment
reduces TNFz-dependent cytotoxicity by depressing the
levels of mRNA for TNF{z as well as the release of TNF0t.
Supported by Alberta Heritage Foundation for Medical
Research and Medical Research Council, Canada.
TNF0 release during systemic reaction in cold
urticaria
I. Tillie-Leblond, P. Gosset, A. Janin, B. Wallaert and
A. B. Tonnel
Institut Pasteur Lille, France.
Primary cold urticaria (PCU) characterized by urticaria, and
sometimes a shock-like reaction after cold exposure, is
usually considered to be linked with histamine and PGD2
release by mast cells. To determine the involvement of
mast cell cytokines, we studied the release of Tumor
necrosis factor alpha (TNF) in the blood after immersion of
the hand in chilled water. Five patients with PCU were
compared to a control population. Among patients with
PCU, submitted to the cold immersion test, two exhibited
a shock-like reaction with a large urticarial plaque, one
only a mild cutaneous reaction and two did not have any
reaction. Patient 1 was reevaluated after treatment by
antihistamine; he did not respond to this challenge. All
controls were strictly negative. Histamine was released
within the first minute following the challenge in the three
patients with urticaria. TNF was undetectable in the blood
of the patient with only a mild cutaneous reaction, whereas
a TNF release was observed in the blood of two patients
with a systemic reaction, 2 and 6 min after the challenge,
suggesting that the secreted TNF was a preformed protein.
The two other patients, the patient 1 under treatment and
the control subjects released neither histamine nor TNF.
Pathological and immunohistochemical (with a rabbit anti-
TNF antibody) studies were performed on skin biopsies
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collected 10 min after ice-cube test (ICT). Four patients
with PCU presenting a positive ICT were studied as well
as the patient after treatment with antihistamine which did
not respond to the ICT. Sections stained with MGG re-
vealed that mast cells were the only cells infiltrating the
dermis. Ultrastructural studies demonstrated that most
mast cells were degranulated in the four patients with
positive ICT, whereas they were still quiescent in
patient 1 with a negative ICT. Quantitative studies showed
that 90.2 + 5% mast cells were stained with anti-TNF
antibody using cryocut sections of the four patients and
patient 1 under treatment. No other cells were positive for
TNF. Moreover, the detection of TNF in the blood seems
to be related to the urticarial plaque area, since similar
numbers of degranulated TNF positive mast cells per field
were found in all four patients although two of them did
not develop a shock-like reaction. This study demonstrates
a release of TNF by mast cells in a clinical situation, as
already observed in experimental data. Since hypotension
has been demonstrated after TNF infusion, this cytokine
might be implicated in the shock-like reaction in addition
to histamine in cold urticaria.
Production of cytokines in a human mast cell
line
M. Buckley 1, j. Thompson 2, j. Coleman 1, Ko Ray e j. H.
Butterfield
3
1Department of Pharmacology, University of Liverpool,
P.O. Box 147, Liverpool L69 3BX, England, 2Depart-
ment of Cellular Science, Glaxo Group Research,
Greenford Rd, Greenford, Middlesex, UB6 OHE, Eng-
land; 3Department of Allergic Diseases and Internal
Medicine, Mayo Clinic, Rochester, Minnesota, 55905,
USA.
Activation of mast cells leads to the release of a number
mediators such as histamine, tryptase, prostaglandin D
(PGD2) leukotriene C (LTC4) and platelet activating factor
(PAF). These can produce many of the phenomena seen in
the acute asthmatic response such as bronchoconstriction,
oedema, and excessive mucus production. Studies with
mouse mast cells have shown that these cells produce
multiple cytokines, and these have been implicated in the
late phase of allergic responses. Using the techniques of
reverse transcription and the polymerase chain reaction
(PCR) we have detected the mRNA for interleukins-3, 4,
and 6 (IL-3, 4, and 6) granulocyte-macrophage colony
stimulating factor (GM-CSF) and tumour necrosis factor
alpha (TNFz) in an unstimulated human mast cell line,
RMC-1. This cell line does not appear to express a func-
tional high affinity IgE receptor as demonstrated by lack of
IgE binding and response to IgE priming followed by
triggering with anti-human IgE. However, the production
of IL-3, IL-4, IL-6 and GM-CSF mRNA appeared to be
increased when the cells were activated with the calcium
ionophore ionomycin. The time course for this induction
spanned several hours but appeared to peak by 4 h in the
case of IL-3, IL-6, and TNF. The HMC-1 cells also express
mRNA encoding cytokine receptors for IL-4, interferon
gamma (IFN-T), and stem cell factor (SCF). Overnight
treatment of these cells with IL-4 resulted in an enhance-
ment of their constitutive and ionophore-induced produc-
tion of mRNA for IL-3, IL-4, IL-6, and GM-CSF.
The potential of human mast cells to produce cytokines
supports the concept that these cells may be able to
promote the late phase reaction of asthma, which is char-
acterized by inflammation, infiltration by eosinophils, and
airway hyperresponsiveness. In summary, these results
suggest that human mast cells can act as a source of, and
target for, cytokine action.
Neuropeptides and cytokines in magnesium
deficiency
W.B. Weglicki, I. T. Mak, R. E. Stafford, B. F. Dickens,
M.M. Cassidy and T. M. Phillips,
Departments of Physiology and Medicine, The George
Washington University Medical Center Washington, DC
20037, USA
Significant lesions develop in the heart and other tissues of
young animals fed a diet deficient in magnesium (Mg). We
have identified a role for oxygen derived free radicals in
the pathobiology for this disorder. 1,2 Diminished RBC
glutathione levels, increased serum lipid peroxidation and
tissue protein oxidation occur. More recently we have
discovered that the inflammatory cytokines (ILl, IL6,
TNF{z) are elevated significantly during the third week of
Mg-deficiency, when cardiovascular lesions are prominent.
During the first week of Mg-deficiency we found signifi-
cant serum elevations of the neuropeptides, substance P
and calcitonin gene-related peptide. Microdissection re-
vealed significant elevations of substance P in cardiac
lesions suggesting an association of this neuropeptide with
local inflammatory changes. We have used several inter-
ventions to retard lesion formation: antioxidants, e.g. Vita-
min E diminishes lesion formation without affecting circu-
lating cytokines or Mg; substance P-receptor inhibition
results in the inhibition of lesion formation as well as a
significant decrease in TNF0t levels. Our present hypoth-
esis involves a role for neuropeptides, cytokines and oxy-
gen-derived free radicals in the pathobiology of Mg-
deficiency.
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Changes in mast cell number and phenotype
after syngeneic lung transplantation in the rat
N. Frossard, A. Buvry,
2 M. Garbarg, V. Dimitriadou,
A. Rouleau, G. F.J. Newlands, R. Tavakoli, V. Poaty,
A. Lockhart, lj.C. Schwartz
1UFR Cochin Port-Royal, 2UFR Bobigny and INSERM
U109, Paris, France and 4Moredun Research Institute,
Edinburgh, UK
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Transplantation causes the total section of vascularization
and innervation followed by repairing processes. An in-
crease in mast cell number is generally associated with
tissue repair. We have studied the number, phenotype and
distribution of mast cells 1 month after syngeneic unilateral
left lung transplantation in the Lewis rat, without interfer-
ence of inflammation, graft rejection or of any treatment
(Tavakoli et al. AmJPhysiol 1992, 242: L322-6). Connec-
tive and mucosal mast cell phenotypes were characterized
using antibodies directed against their specific rat mast cell
proteases, RMCPI and RMCP2, respectively. Tissue levels
of proteases were determined by ELISA. Localization of
mast cell phenotypes was studied by immunofluorescence
after double immunostaining on two sections and three
levels per lung. Results obtained in left lungs from five
transplant recipients and five control animals were com-
pared. RMCPI and RMCP2 levels (13.1 + 1.2 and 5.6 + 1.0
lag/g in controls, respectively) increased by 172% and
239% after transplantation. The number of mast cells (cells/
length unit) increased from 1.3 in controls to 6.3 after
transplantation for RMCPI-immunoreactive (IR) cells and
from 5.7 to 17.7 for RMCP2-IR cells. The increase was
significant a) around bronchioles and arterioles for both
subtypes, b) around large vessels and in the pleura for
RMCPI-IR cells and c) in smooth muscle layer of large
airways for RMCP2-IR cells. Some mast cells expressed
both enzymes. Their number increased from 1.4 in control
lung to 7.1 after transplantation: the increase was signifi-
cant around bronchioles and arterioles and in the pleura.
No significant increase of intraepithelial mast cells was
observed. In conclusion, an increase in the number of both
connective and mucosal mast cell phenotypes occurs in the
lung after transplantation. Mast cells expressing both
intragranular proteases also increased after lung transplan-
tation, indicating the possibility of an intermediary state
between connective and mucosal mast cells. This suggests
a local differentiation/maturation of mast cells in the lung
after transplantation. The function of mast cell phenotypes
during the repairing processes after transplantation re-
mains to be clarified.
This work was supported by INSERM (90-0503).
Interleukin 8 mRNA expression in sheep
alveolar macrophages experimentally infected
with ovine lentivirus
G. Cordier, I. Legastelois, T. Greenland, P. Arnaud and
J.F. Mornex
Laboratoire d’Immunologie et de Biologie Pulmonaire
(H6pital Louis Pradel), et INSERM U80, Lyon-France and
1Department of Microbiology and Immunology, Medical
University of South Carolina, Charleston, SC, USA
Interstitial lung disease can be observed after infection by
most lentiviruses including HIV-1 in human and visna-
maedi virus (VMV) in sheep. The VMV-induced disease is
a model to decipher the mechanisms of lung tissue dam-
age. Both naturally and experimentally infected animals
develop lung pathology showing peribronchovascular
lymphoid nodules, lung parenchymal damage and
alveolitis. In previous studies we demonstrated the
alveolitis to be lymphocytic and neutrophilic and that
alveolar macrophages release a neutrophil chemotactic
activity. Interleukin 8 (IL-8) belongs to the chemokine
superfamily and has been shown to be chemotactic for
neutrophils and lymphocytes. In order to analyse the
expression of IL-8 by sheep alveolar macrophages follow-
ing natural and experimental in vivo and in vitro infection,
we cloned and sequenced an ovine IL-8 cDNA probe after
retrotranscription of LPS-activated macrophages mRNA
and amplification of a fragment using primers established
from consensus regions in the human and rabbit se-
quences. This probe showed strong positive hybridization
signal on Northern blots prepared with RNA from LPS-
activated macrophages, in vitro virus-infected cells and
cells from naturally infected animals but less for untreated
cells. IL-8 could account for at least a part of the
neutrophilic and lymphocytic alveolitis observed early af-
ter infection.
Modulation of interleukin 8 gene expression
and protein production in human monocytes:
effect of silica and lipid mediators
M.-J. April, S. Denault andJ. Stankova
Immunology Division, Dept. of Pediatrics,, Faculty of
Medicine, University of Sherbrooke, Sherbrooke, QC,
J1H 5N4, Canada.
Silica is an inorganic dust well-known to cause inflamma-
tion and fibrosis of lung tissues. The phagocytosis of silica
particles by pulmonary macrophages leads to the release
of various substances which can affect other immune cells.
IL-8 is a potent chemotactic factor for neutrophils and T-
lymphocytes, produced by a variety of blood and tissue
cells. This cytokine is believed to play an important role in
the development of inflammation by its property of cell
recruitment. In this report, we have examined the modu-
lation of IL-8 mRNA expression and protein production in
human monocytes stimulated with silica. Northern blot
analysis demonstrated a concentration-dependent increase
of IL-8 mRNA accumulation and protein production after in
vitro stimulation with silica. This increase was partially
dependent on endogenous prostaglandin (PG) production
since the inclusion of indomethacin caused a noticeable
reduction of IL-8 mRNA accumulation induced by silica.
Morover, exogenously added PGE induced an increase in
IL-8 mRNA accumulation. Inhibition of 5-1ipoxygenase
activation did not change silica-induced IL-8 mRNA expres-
sion and exogenous LTB did not modulate IL-8 mRNA
accumulation. Another lipid mediator, platelet-activating
factor (PAF), whose production can be induced by silica,
augmented IL-8 mRNA expression in a time and con-
centration-dependent manner. PAF upregulated IL-8
mRNA with a peak at 5 h after stimulation, with 100 pM
PAF showing a maximal increase. PAF-induced IL-8 mRNA
accumulation was prevented with WEB 2170, a PAF
receptor antagonist. Nuclear run-on experiments showed
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that PAF increased IL-8 gene transcription within 30 min.
Experiments using actinomycin D suggested that PAF also
slightly augmented (10-20%) IL-8 mRNA half-life. These
studies indicate that silica and PAF modulate IL-8 gene
expression and thus may contribute to IL-8 production at
sites of pulmonary inflammation.
Supported by MRC and FRSQ.
The effect of st andardized D. farinae
immunotherapy on cytokine production in
asthmatics
C. Jones, E. Milgrom, Z. Haddad.
Los Angeles, California, USA.
The purpose of this study was to evaluate the effects of
allergen desensitization on cytokine production by periph-
eral blood mononuclear cells (PBMC) in vitro. Initially in
vitro cytokine production in response to D. farinae (df)
antigen was evaluated comparing allergic asthmatic pa-
tients (n=9) and non-allergic non-asthmatic control sub-
jects (n=6). Peripheral blood mononuclear cells (PBMC)
were cultured with and without df antigen, recovered, and
stained by immunochemical techniques for the presence of
ILIB, IL6, GMCSF, and IFNG. Lymphocytes and monocytes
were counted independently to obtain a percentage of
each cell type staining positive for the presence of cytokine
above baseline levels. The allergic asthmatic patients were
randomly assigned into two groups in a double blinded
fashion. One group underwent a course of allergen desen-
sitization with D. farinae antigen (n=5), and the other
group received equal volume of placebo (n=4). After
completion of the injection schedule culture experments
were repeated, and cytokine production was reevaluated
in response to the same specific df antigen. Allergic asth-
matic patients demonstrated significantly higher baseline
presence of ILIB, IL6, and GMCSF in response to co-
culture with the df antigen as compared to non-allergic
non-asthmatic controls. No difference was observed in
IFNG levels. Following the course of desensitization injec-
tions, antigen stimulated cytokine production changed in
the following ways: 1. Antigen treated patients showed a
significant decrease in the production of IL6 and GMCSF by
both lymphocytes and monocytes when compared to
pretreatment levels. 2. With the exception of ILIB, no
significant change in cytokine presence was seen in the
placebo treated group. 3. Antigen treated patients showed
significantly less monocyte IL6 and GMCSF production
after treatment than the placebo group. 4. Antigen treated
patients showed a trend toward suppression of IL6 and
GMCSF production; there was a higher level of spontane-
ous cytokine present in the absence of antigen than when
antigen was added in vitro. This pilot study supports the
concept that specific allergen desensitization may affect the
inflammatory process of allergic disease by decreasing and
possibly suppressing immunoregulatory cytokine produc-
tion as suggested by the cytokine data obtained using
(specific) antigen stimulated PBMC.
Interleukin-6 production by a pulmonary
epithelial cell fine (A549 cell).
B. Crestani; P. Cornillet;
2 M. Dehouxo;
C. Rolland, M. Guenounou,
2 M. Aubier.
IlNSERM U226, Faculte X. Bichat, Paris, 2Lab.
d’Hmatologie, H6pital R. Debr, Reims, France.
Regulation of type II pneumocytes proliferation after injury
is unknown. IL6 is a broad spectrum cytokine with growth-
promoting effects. An autocrine effect of IL6 has been
shown in myeloma cell lines. The aim of this study was 1)
to characterize the regulation of the gene and protein
expression of IL6 in A549 cells and 2) to detect any growth-
promoting effect of IL6 on A549 cells. A549 cells grown to
confluence were stimulated with LPS, recombinant human
(rh) ILl[3, TNF0t, or interferon , (IFN-T). Supernatants were
assayed for immunoreactive IL6 (ELISA) and biologically
active IL6 (B9 cellproliferation assay). Total RNA was
extracted, Northern-blots were performed and hybridized
with 32P-IL6 cDNA. [3HJ-thymidine incorporation measured
A549 cell proliferation. Unstimulated A549 cells did not
express IL6-gene nor secrete IL6. ILlJ3 strongly induced IL6-
gene expression. The effect was maximal 2 h after stimu-
lation and at 2 ng/ml ILl[3 concentration. Immunoreactive
IL6 was maximal 4 h after stimulation and at 2 ng/ml ILl
concentration. Time course for biologically active IL6 was
similar. TNF0t was a much less potent inducer of IL6 gene
expression and IL6 secretion (10 fold smaller than ILI[-
induced).
LPS-stimulated human alveolar macrophage-conditioned
media (AM-CM) strongly induced IL6-gene expression and
IL6 secretion. This effect was mediated by IL-113 andTNF
since IL-6 mRNA expression was abolished when A549
cells were incubated with AMCM + anti-ILl[3 and anti-TNFz
antibody. In some experiments, A549 monolayers were
stimulated for 24 h with LPS (0.1-100 lu.g/ml) or IFNT
(0.02-20 ng/ml) or a combination of IFNT (20 ng/ml) and
LPS (0.1-100 g/ml). LPS alone did not induce the expres-
sion of IL-6 mRNA, whereas IFN induced a small expres-
sion of IL-6 mRNA. However, the combination of IFN and
LPS induced a dose-dependent expression of IL-6 mRNA
by A549 cells, rhlL6 (up to 20 ng/ml) did not induce IL6-
gene expression, rhIL6 (0, 0.01, 0.1, 0.5 ng/ml) did not
modify [3H]-thymidine incorporation (192 + 12, 207 + 23,
196 + 10, 202 + 16 x 103 dpm/dish respectively; mean +
SEM, n=4).
We conclude that IL6 gene expression and protein
secretion by A549 cells is signal specific and that IL6 has
no growth-promoting effect on A549 cells.
Interleukin-5 production by pulmonary
T-cell clones: inhibition by
immunosuppressive drugs cannot be
assessed with the B13 bioassay
F. H. Krouwels, R. Lutter, H. M. Jansen and T. A. Out
Clinical Immunology Laboratory and Department of
Pulmonology, Academic Medical Centre, Meibergdreef 9,
1105 AZ, Amsterdam, The Netherlands.
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lnterleukin-5 (IL-5) is presumed to be an important
cytokine in the regulation of the pulmonary inflammation
in patients with allergic asthma (AA). We have studied the
production of IL-5 by airway and peripheral blood derived
T-lymphocyte clones (TLC) of AA patients and controls
including the effects of the immunosuppressive drugs
dexamethasone (DEX) and cyclosporin A (CyA). TLC were
simulated with mAb zCD3 or {zCD2+zCD28+PMA. IL-5
was measured both with a sandwich ELISA and with the
B13 bioassay. In particular the application of the ELISA
enabled us to study the effects of DEX and CyA. Results:
1) TLC (1 x 106/ml) produced IL-5 ranging from 1.26 to 73.5
ng/ml (as measured in the ELISA). As soon as 16 h after
stimulation IL-5 production up to 42 ng/ml was found. 2)
IL-5 activity in TLC supernatants measured with the ELISA
correlated closely with IL-5 activity in the B13 assay
(Spearman rank test: rho 0.86, p < 0.001). 3) The
proliferation of B13 cells, induced by rhIL-5, was inhibited
both by DEX and CyA. The drugs did not influence the
ELISA, which means that only the ELISA can be used in
evaluating modulation of IL-5 production by DEX and CyA.
4) DEX (375-1500 ng/ml) and CyA (10-7M) inhibited It-5
production by TLC up to 82% as measured in the ELISA.
We conclude that lung TLC are able to produce IL-5. The
inhibition of IL-5 production by DEX and CyA may contrib-
ute to the overall effects of these drugs on pulmonary
inflammation in patients with asthma.
Simple method for measuring ex-vivo
cytokine production by alveolar
macrophages
R. M. Perenboom, P. Beckers, R. W. Sauerwein, A. van
Schijndel, M. F. van de Broek, J. w.M. van der Meer
Departments of General Internal Medicine and Medical
Microbiology, University Hospital Nijmegen, Geert
Grooteplein zuid 8, 6525 GA Nijmegen, The Nether-
lands.
To study cytokine production by alveolar macrophages in
HIV seropositive patients, we developed a system for ex-
vivo production, with minimal manipulation of the HIV
positive specimen, thus minimizing accidental contact with
HIV contaminated material and minimizing potential con-
tamination (and subsequent unwanted stimulation) of the
specimen. An additional advantage is that this simple,
practical method can also be applied in developing coun-
tries where advanced laboratory technology is not readily
available and HIV-related pulmonary problems pose im-
mense problems. Broncho-alveolar lavage material, col-
lected via a closed system is transported to the laboratory
on ice. There the bottle is opened, 30 t.tl is taken for cell
count and the remaining fluid is centrifuged at 1 200 g for
10 min. The supernatant is removed and frozen at -20C
until assay; the pellet is resuspended in Dulbecco’s modi-
fied Eagle’s medium at a concentration of 0.5 x 10
macrophages per ml; the tube is closed again and incu-
bated with and without stimulant at 37C for 24 h Follow-
ing incubation the tubes are centrifuged at 1200 g for 10
min and the supernatant and cell pellets separately
frozen until cytokine analysis can be performed. Data will
be presented on cytokine production in whole blood
cultures and these alveolar lavage cultures from healthy
volunteers and patients with Pneumocystis carinii infec-
tion.
Dehydroepiandrosterone and
androstenediol: potential use in
lung diseases
R. M. Loria and D. A. Padgett.
Virginia Commonwealth University, Medical College of
Virginia Department of Microbiology and Immunology,
Richmond, Va 23298, USA.
The levels of the steroid hormone dehydroe-
piandrosterone (DHEA) decline with ageing in humans
and mammals, and has been associated with deterioration
of the immune condition. Previous reports have shown
that DHEA (5-androsten-3[3-17-one) may function in vivo
to regulating host immune resistance to protect mice from
a variety of lethal infections. This includes, but is not
limited to, infection with viruses (herpesvirus type
2, coxsackievirus B4-CB4). bacteria (Enterococcus
faecalis, Pseudomonas aeruginosa), and parasites
(Cryptosporidium parvum). We reported that
androstenediol (5 androsten -3[3-17[3-diol, AED), derived
from DHEA, in the skin and the brain, is strikingly more
effective in up-regulating systemic resistance against CB4
infection than DHEA. Compared to DHEA, treatment with
AFD was markedly superior in protecting mice against
virus-induced myocardiopathy, pancreopathy, and mortal-
ity. In particular, AED prevented virus-infected target tis-
sues from destruction by cellular infiltrates. Neither steroid,
has any significant direct antiviral effects. The effects of
DHEA’s function in vitro, specifically on mitogen-induced
spleen cell proliferation, were examined. The data illus-
trated that DHEA significantly decreased 3H-thymidine in-
corporation by ConA-stimulated spleen cells in a dose-
dependent manner. However, the inhibition associated
with DHEA was not as potent as that observed with
hydrocortisone. Inhibition of spleen cells proliferation cul-
tured with both DHEA and hydrocortisone was not addi-
tive and did not exceed the inhibition achieved with
hydrocortisone alone. The in vitro results indicate that
DHEA retains significant ’glucocorticoid’ properties. Based
on the data showing that AED is significantly more effec-
tive in regulating the in vivo immune response, it is likely
that DHEA is converted to a more active metabolite(s) for
its function as an immune up-regulator. In conclusions,
these steroids may have significant potential for use in the
treatment of lung diseases.
The estimation of specific immunotherapy in
asthmatic children
L. S. Namazova and V. G. Ivanov
Institut of Pediatrics RAMS/109172, Gontcharnaya nab.,
3, 8, Russia.
The specific immunotherapy (SIT) is the most specific and
pathogenetic treatment of bronchial asthma in children.
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But due its long duration it’s possible to estimate its
efficacy only in course of time. We supposed that it was
necessary to find some indexes which, were capable of
showing the SIT efficacy in different stages of this treat-
ment. So we examined in dynamics 27 treated asthmatic
children: 12 by mite allergens (Dermatophagoides
pteronyssinus) by parenteral way, eight by bacterial aller-
gens (Streptococcus pyogenus, Staphylococcus aureus) by
endonasal way, seven by corticosteroids as other
immunotherapy group and 20 healthy children as controls.
Treatment efficacy was estimate after its end. We investi-
gated blood levels of IL-1, IL-2, 2-microglobulin (2-MG),
LTB4, IgE, PgE, PgF2, C3a-C4a-C5a-des-Arg (by RIA Kits,
’Amersham’, UK and ot.), IgA, IgM, IgG, ClC, E-ROC, EA-
ROC (by classical studies) and IL-1, production by
monocytes (in biological test). We found that IL-2 was a
very informative index; its blood level in asthmatic
children was in 2.5-3 times more than in controls. After
corticosteroid therapy IL-2 level decreased (and was not
different from controls). SIT caused IL-2 level increasing
after the first dilution (1:1 000 000), but its dynamics was
different in groups of effective (1) and low-effective (2) SIT
(in first group IL-2 level slowly decreased, in second group
increased). Good efficacy of therapy we observed if we
began SIT in the moment of high blood level of IL-2. Other,
immunological figures had different dynamics in these two
groups too. There was the extension of the correlations
number between all these figures after the SIT. We
suppose it shows the inclusion of some compensative
immune mechanisms during immunotherapy in children.
Upregulation of lung fibroblast-derived PDGF
A-chain and its alpha receptor by asbestos
fibres
J. A. Lasky, J. C. Bonner, A. L. Goodell and A. R. Brody
National Institute of Environmental Health Sciences,
Research Triangle Park, N.C., 27709, U.S.A.
We are investigating the role of platelet-derived growth
factor (PDGF) in a model of asbestos-induced fibrosis in
rats and mice. PDGF, a potent mitogen for mesenchymal
cells, is a 30-40 kDa glycoprotein dimer composed of A
and/or B chains. Mesenchymal cells possess alpha and/or
beta PDGF receptors which dimerize and differentially
recognize the three PDGF dimer isoforms. Mesenchymal
cells and tumour cells have been shown to secrete PDGF
in vitro and an autocrine growth response has been pro-
posed for this mitogen. Because asbestos fibres interact
with mesenchymal cells at the site of the fibrotic lesion in
vivo, we investigated whether chrysotile asbestos alters
PDGF secretion or PDGF receptor expression in rat lung
myofibroblasts in vitro. An in vitro autocrine role for PDGF
in rat lung fibroblasts (RLFS) exposed to asbestos was
demonstrated. Medium and cell lysates from RLFs exposed
to asbestos contained more PDGF than unexposed RLFs as
detected by Western blot. We believe that the 36 kDa
protein band is PDGF-AA since we could not detect any
PDGF in a sensitive ELISA which recognizes only PDGF BB
or AB isoforms, and because we could detect PDGF A-
chain mRNA, but not PDGF B-chain mRNA on Northern
blots. We are currently searching for PDGF B-chain mRNA
in our RLFs by combining reverse transcription, PCR am-
plification and Southern blotting. In addition to detection
of A-chain PDGF mRNA we also found on Northern blot
an upregulation of the mRNA which codes for the PDGF
alpha receptor, i.e., the only receptor type to which A-
chain PDGF binds. Concordantly, there was an increase in
the normally low PDGF alpha receptor protein according
to a radioreceptor assay. A significant dose-dependent
mitogenic effect was found when our RLFs were exposed
to chrysotile asbestos under serum free conditions in vitro,
and this effect was significantly blocked with an anti-PDGF
antibody. Whether PDGF A-chain and its alpha receptor
are upregulated in lung mesenchymal cells in vivo follow-
ing asbestos inhalation is currently under investigation.
Resistance to recombinant interferon
alpha-2A in patients with pulmonary
tuberculosis
R. F. Umnyashkina, F. M. Abdullayev, A. A.
Umnyashkina
Institute of Phtisiology and Pulmonology, Quarter 2514,
Zardabi Street, Baku 370II8, Azerbaijan Republic.
To explain the haematologic deterioration occasionally
observed during interferon therapy, we assayed serum
specimens from 81 patients with pulmonary tuberculosis
receiving treatment with recombinant interferon alpha-2a
for the presence of anti-interferon antibodies. After a me-
dian of 6 months of therapy, anti-interferon antibodies
were found in 33 patients. Seventeen of these patients had
only non-neutralizing antibodies, but antibody from the
other I6 neutralized the antibacterial effects of recombinant
interferon alpha-2a in vitro. In no case, however, did
neutralizing antibody inhibit the antibacterial effects of
purified natural interferon alpha. Clinical resistance to
interferon of various degrees was present in seven of 16
patients with neutralizing antibodies; the remaining nine
patients and all 19 patients without antibody continue to
respond after a minimum of 1 year of therapy. In all the
patients with interferon resistance, antibody was present
when it developed. These data suggest that the develop-
ment of clinical resistance to interferon alpha-2a in pulmo-
nary tuberculosis is not necessarily related to an altered
cellular response to interferon. Treatment with other
interferons, such as purified natural interferon alpha, may
be useful in patients with clinically important neutralizing
antibodies against interferon alpha-2a.
The endotoxin bronchial challenge:
an ethically acceptable model of
acute lung inflammation in human
subjects?
O. Michel and R. Sergysels
Clinic of Pneumology, Saint-Pierre Hospital (ULB), rue
Haute 322, 1000 Brussels, Belgium.
An inflammatory response is associated with several lung
diseases; its modulation is the main goal of related therapy.
Endotoxins are potent pro-inflammatory substances
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present in domestic house dust and responsible for several
occupational lung diseases. In asthmatics, 20 g inhaled
endotoxin induces a significant bronchial obstruction with
an increase in nonspecific bronchial hyperreactivity, in
absence of any clinical response. This lung function re-
sponse is associated with a blood inflammatory response
(neutrophilia and rise in CRP) (146: 352-357) and is
inhibited after pretreatment with an anti-inflammatory
agent, sodium cromoglycate (submitted). The lung func-
tion response to endotoxin is independent of the atopic
status but is associated with the degree of non specific
bronchial responsiveness. Nevertheless, in normal sub-
jects (n 8) inhaled endotoxin induces a blood inflamma-
tory response (activation with increase in neutrophils and
rise in CRP and ACTH (as marker of IL-1) submitted) in
absence of any lung function response.
Thus, 20 g inhaled endotoxin induces a blood inflam-
matory response without clinical effect in both asthmatics
and normal subjects and, or the other hand, a lung function
response (blocked with cromoglycate) in asthmatics. To
confirm the validity of this model, the blocking effects of
anti-inflammatory agents on the LPS-induced blood inflam-
mation could be evaluated.
References
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Intrapulmonary immune activation during
CMV pneumonitis complicating lung
transplantation
M. Humbert, J. Cerrina, G. Simonneau, P. Galanaud
and D. Emilie
INSERM-UI31, 32, rue des Carnets, 92140 Clamart,
France.
Methods. The immune status of lung recipients displaying
cytomegalovirus (CMV) pneumonitis or allograft rejection
was analysed in 44 lung recipients after the third post-
operative week. The parameters studied included (i) se-
rum markers of immune activation [neopterin/creatinine
ratio (Neo/Creat), soluble interleukin-2 receptor (slL-2R),
and IL-6]; (ii) IL-6 concentration in the epithelial lining fluid
(ELF); (iii) gene expression of monokines (IL-I[, and IL-
6), and cytotoxic mediators (granzyme B, and perforin)
analysed by in situ hybridization (ISH) in alveolar cells
collected by bronchoalveolar lavage (BAL).
Results. (i) serum Neo/Creat ratio, slL-2R levels, and IL-
6 levels were increased during CMV pneumonitis [818 + 78
(mean + S.E.M.) mol/mol, 451 + 85 pmol/1, and 61.2 + 11.5
U/ml, respectively], as compared to rejection events (190
+ 27 mol/mol, p<0.001, 179 + 27 pmol/1, p<0.02, and 59.3
+ 20.5 U/ml, NS, respectively), and controls (158 + 47
btmol/mol, p<0.001,159 + 32 pmol/1, p<0.01, and 24.2 + 3.3
U/ml, p<0.01, respectively); (ii) IL-6 concentration in ELF
was increased during CMV pneumonitis (1 022.3 + 467.5
U/ml ELF), as compared to rejection events (508.9 + 111.3
U/ml ELF, p<0.05), and controls (241.6 + 63.5 U/ml ELF,
p<0.02); (iii) The IL-lJ3, the IL-6, the granzyme B, and the
perforin genes were expressed in most samples from
patients with CMV pneumonitis (898 + 449, 92 + 74, 37 +
19, and 19 + 4 gene-expressing cells per 10 000 cells,
respectively). This gene expression was always signifi-
cantly higher than that observed during rejection or in
controls.
Conclusion. CMV pneumonitis is associated with a
significant systemic and intrapulmonary activation of both
cytotoxic cells (presumably, NMC-restricted cytotoxic T
lymphocytes, and non-MHC restricted natural killer cells)
and monokine-producing cells (presumably macro-
phages). Although contributing to the limitation of viral
spreading, these activated cells may also be involved in
acute and chronic post-transplantation lung damage.
Bradykinin-induced increase in cytosolic free
calcium in tracheal smooth muscle cells via B2
receptors: effects of pertussis toxin and
various cytokines
Y. Amrani, M. Mousli, Y.Landry and C. Bronner
Laboratoire de Neuroimmunopharmacologie, INSERM
CJF 9105, Faculte de pharmacie, BP 24, 6 7401 Illkirch
Cedex, Strasbourg.
Bradykinin is an inflammatory peptide which induced
bronchoconstriction only in asthmatic patients but the
reason for this as well as the precise mechanism of action
of bradykinin are still unclear. It has been reported that
cytokines, such as tumour necrosis factor, can modulate
calcium signal induced by bradykinin in various cell sys-
tems. Moreover it is well known that smooth muscle
contraction depends essentially on the concentration of
cytosolic calcium. Therefore, we have examined the pos-
sibility that cytokines generated by inflammatory cells can
modulate bradykinin induced rise in cytosolic free calcium
at the smooth muscle level and by this way contribute to
explain the sensitivity of asthmatic patients to bradykinin.
For this purpose, we have developed tracheal smooth
muscle culture which provides a novel preparation in
studying the molecular mechanism underlying bradykinin-
induced bronchoconstriction. In Fura-2 loaded guinea-pig
tracheal smooth muscle cells, bradykinin (10-8) induced
an increase of cytosolic free calcium which is either
completely inhibited by the B2 antagonist Hoel40
(10*M) or treatment with Pertussis toxin (500 ng/ml) for
6 h. In contrast, a 24-h pretreatment with interferon ,
(1 000 U/ml), or interleukin-6 (1 000 U/ml) and tumour
necrosis factor (20 ng/ml) did not inhibit or enhance
calcium signal.
These results show that bradykinin induced calcium
mobilization via B2 receptors coupled to a G-protein sen-
sitive to Pertussis toxin and that this rise is not affected bv
a pretreatment with the different tested cytokines. Further
investigations are undertaken on the effects of cytokines
on bradykinin-induced calcium mobilization in tracheal
smooth muscle cells, including combination of different
cytokines.
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In vivo role of adenylate cyclase-haemolysin
and pertussis toxin during Bordetella
pertussis infection
N. Khelef, C. M. Bachelet,
2 B. Vargafiig
2 and N. Guiso
1Unit de Bact4riologie Mol4culaire et M4dicale et 2Unit6
de Pharmacologie Cellulaire. Institut Pasteur. 28 rue du
Dr. Roux, 75724 Paris Cedex 15. France.
Bordetella pertussis, the agent of whooping cough, synthe-
sizes and secretes factors thought to play a role in the
adhesion of the bacteria on to the respiratory epithelium,
such as the filamentous haemagglutinin (FHA), pertactin,
agglutinogens. Other factors such as PTX, an
ADP-ribosylating toxin, dermonecrotic toxin, tracheal
cytotoxin, or adenylate cyclase-haemolysin (AC-Hly) are
involved with toxicity. PTX induces in vivo many biological
effects, such as lymphocytosis, but the in vivo activity of
AC-Hly is not well defined. Using a murine respiratory
model, we have shown that AC-Hly is absolutely required
by the bacteria to initiate infection whereas PTX is required
for colonization.
After infection with virilent B. pertussis strains or
adhesin- mutants, infected mice (like infected children)
have a pronounced lymphocytosis. This lymphocytosis is
due to PTX since it is not observed after infection with
PTX- mutants and followed injection of purified PTX.
However, we observed an increase in total cell number in
bronchoalveolar lavage fluids of infected mice with an
increase in macrophage number and an influx of
polynuclear neutrophils and lymphocytes. This effect was
not observed after infection with PTX- mutants but surpris-
ingly, also not after infection with AC-Hly- mutants, which
express PTX. This result confirms the role of AC-Hly in the
initiation of infection and demonstrates that PTX is respon-
sible for lymphocytosis, but is not the only factor involved
in the influx of polynuclear neutrophils and lymphocytes
in bronchoalveolar lavage fluids.
Adhesion molecules in AIDS. Increased
expression of ICAM-1, decreased expression
of HLA-DR on AM
K. Dalhoff, S. Bohnet, H. Kothe, J. Braun and
K. J. WieJgann
Department of Internal Medicine, Medical University,
Lobeck, Germany.
AM are the primary cell targets chronically harbouring HIV-
1 in the lung. The mechanisms leading to the enhanced
ability of macrophages to serve as AC in AIDS-patients are
still incompletely understood. In addition to soluble me-
diators like IL-1 and IL-6 molecules of the MHC class II
complex and adhesion molecules like ICAM-1 play a major
role in the regulation of these cellular interactions. We
investigated ICAM-1 and HLA-DR expression on AM from
13 AIDS patients in context with other parameters of
macrophage activation comparing the results to a group of
healthy volunteers.
ICAM-1 expression was quantified using a sandwich
ELISA technique. HLA-DR+ macrophages were identified
by immunocytochemical staining. The spontaneous and
NAF-triggered release of ROS was determined by a
superoxide anion microassay, TNF-0t secretion of AM in a
standard bioassay using L929 mouse fibroblasts.
In AIDS-patients ICAM-1 levels were elevated (0.84 EU
+ 0.25 vs 0.42 EU + 0.12, p<0.05), while the number of
HLADR+ AM was slightly decreased (80% + 5 vs 89% + 3,
p<0.05). ICAM-1 levels in the patients group correlated
strongly to the NAF-triggered release of ROS (r 0.7,
p<0.05) but not to TNF- secretion. No relation to the
absolute numbers of CD4+ lymphocytes and serum levels
of p24 could be established.
Highly elevated ICAM-1 levels on AM in AIDS patients
lead to increased adhesiveness of those cells, thus enhanc-
ing the interaction between AM and lymphocytes and
ultimately resulting in a depletion of CD4+ cells in
the pulmonary compartment. Although TNF- is a potent
inducer of ICAM-1 in AIDS different mechanisms
are likely to contribute to the increased expression
of ICAM-1 on AM.
IL-4 and IL-13 exhibit comparative abilities
to reduce pyrogen-induced expression of
procoagulant activity in endothelial cells
and monocytes
P. Savi, M. C1 Laplace, A. Lal4, F. Dol, A. Dumas,
A. Minty, D. Caput, p. Ferrara and J. M. Herbert
Sanofi Recherche, 195 Route d’Espagne, 31036 Toulouse
and lSanofi Elf-Bio recherches, 31676 Lab4ge, France.
Tissue factor (TF) is an ubiquitous membrane-anchored
glycoprotein that initiates blood coagulation by forming a
complex with circulating factors VII and VIIa. Under
normal circumstances, endothelial cells do not express
TF activity while they constitutively express thrombomo-
dulin (TM) which accelerates thrombin-catalysed activation
of protein C thus contributing to the anticoagulant proper-
ties of the endothelium. In some pathological situations,
when the endothelium or the monocytes are exposed to
inflammatory mediators, they can acquire procoagulant
properties.
Endotoxin (LPS), IL-1]3 and TNFt increased the expres-
sion of TF on the surface of cultured bovine aortic (ABAE)
or human umbilical vein endothelial cells (HUVEC) and
human monocytes while they simultaneously reduced the
amount of TM on the endothelial cell surface.
On endothelial cells and monocytes, interleukin-4 (IL-4)
and interleukin-13 (IL-13), a newly described cytokine
(Nature, 362: 248-50, 1993 ) both strongly inhibited LPS-
induced TF expression, a similar activity being also ob-
tained with regard to the effects of ILl or TNF. Simultane-
ously, IL-4 and IL-13 counteracted TM down-regulation
consecutive to an incubation of endothelial cells with LPS,
ILl or TNF.
These results therefore show that IL-4 and IL-13 both
protect the endothelial cell and the monocyte surface
against inflammatory mediators-induced procoagulant
changes.
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Soluble intercellular adhesion molecule
1 (sICAM-1) in bronchial lavage fluid (BALF)
and serum in asthmatics and patients with
chronic obstructive bronchitis, smokers, and
non-smokers
1G. Rauls, 1K.-CH Bergmann and 2go Rabe
1Allergy and Asthma Clinic Bad Lippspringe, FRG and
2Lungenklinik Beelitz, FRG
ICAM-1 may play a central role in airway infiamation. We
compared two ELISAs produced by Boehringer Ingelheim
Pharmaceuticals (A) and British Bio-Technology Products
Ltd (B) in patients with COLD to quantitate the soluble
form of ICAM-1. slCAM-1 was detectable by both assays in
sera, BALF and saliva and the values of standard curves and
samples were closely related. Handling and costs are
similar.
Assay A was used to determine sICAM-1 in serum and
BALF in patients with bronchial asthma (BA) and chronic
obstructive bronchitis (COB), smokers (S) and non-smok-
ers (NS). Values are given in ng/ml.
Patients Serum BALF
n x Median Range n x Median Range
BA, S 4 237 223 152-350 4 13 20 4-51
BA, NS 14 200 206 112-276 14 39 30 0-141
COB, S 9 278 213 146-534 4 13 9 0-34
COB, NS 8 182 178 140-248 3 10 10 1-21
Values given as mean value of double determinations.
Summary: Two assays are commercially available for
quantitation of sICAM-1.
Non-smoking asthmatics have similar sICAM values in
serum as patients with COB but smoking leads to higher
values in both groups. BALF concentrations are higher in
asthmatics. Comparison of slCAM-1 values in serum and
BALF (n 14) showed no correlation (p>0.5).
Contrasting effects of endothelins 1, 2 and 3
on vascular permeability in the rat lung.
S. Lehoux, P. D’Orlans-Juste, P. Sirois and G. E. Plante
The endothelins are a family of closely related vasoactive
peptides. Endothelin (ET)-I is formed from its precursor
via the endothelin converting enzyme (ECE), a
phosphoramidon (PA) sensitive metalloprotease. This
study was undertaken to verify the effects of ET-1, 2, and
3 and their precursors, big-ET-1,2 and 3, on vascular
permeability in the rat lung.
Male Wistar rats received an injection of Evans blue dye
(EB), which binds to albumin, in the caudal vein 10 min
before being killed. Big-ET-1, ET-1 (400 pmol/kg), big-ET-
2 and 3, and ET-2 and 3 (1 nmol/kg) were administered
with EB, while PA was injected 5 min earlier. The rats were
decapitated and the lungs perfused with 15 ml of Krebs’
solution via the pulmonary artery. The trachea (T), upper
(UB) and lower bronchi (LB), and parenchyma (P) were
removed and tissue content of EB (g/g dry weight) after
treatment was compared to control (*p<0.05)
Big-ET-2 and ET-2 did not modify vascular permeability
significantly from control values. We conclude that big-ET-
1 increases vascular permeability in the lung after its
conversion to ET-1 via a PA-sensitive ECE, whereas the
decreased EB extravasation by big-ET-3 is unaffected by
PA. This suggests that big-ET-1 and big-T-3 are converted
to their active moieties through two distinct ECEs. In-
creased vascular permeability in the lung induced by ET-
1 could be involved in the pathophysiology of asthma.
Endothelin-1 and-3 increase albumin
permeability in monolayers of bovine:
aortic endothelial cells
P. Farmer, T. Kawaguchi, M. G. Sirois,
P. D’OrlOans-Juste and P. Sirois
Department of Pharmacology, Faculty of Medicine,
University of Sherbrooke, Sherbrooke, PQ, Canada, JIH
5N4.
As previous reports have demonstrated that endothelin-1
(ET-1) increases vascular permeability in conscious rats,
the present study investigated the direct effects of
endothelins on monolayers of bovine aortic endothelial
cells (EC). The cells were cultured in medium M199 in the
presence of 10% fetal bovine serum (FBS) and antibiotics,
seeded on polycarbonate filters fixed in a modified Boyden
chamber. Five days after seeding, the medium of the
Boyden chamber was replaced with 700 btl of solution
which included M199, 0.5% BSA and 3 x 106 cpm of
125I-albumin. The chambers were placed in a beaker
containing 25 ml of M199 and 0.5% BSA. Albumin transfer
rate (ATR) through the monolayer was evaluated by the
following equation: ATR= C x V0/CiAt where Co= lower
chamber concentration, V lower chamber volume and Ci
initial Boyden chamber concentration. C was evaluated
by withdrawing 75 ILtl aliquots of medium every 90 s for a
total period of 90 min. Endothelins were added to the
Boyden chamber after 30 or 45 min. The variation of the
permeability was evaluated by linear regression of the
control and experimental slopes. ET-1 (107,10-6M) in-
creased the slope value from 0.400 + 0.017 to 0.900 + 0.142
EB Bit-ET-1 Big-ET-I+PA ET-I+PA Big-ET-3 Big-ET-3+PA ET-3+PA
T 119+19
BE 61+8
BI 54+5
P 61+3
196+16" 145+20 175+12 124+21 112+3 131+11
94+13* 60+4 97+9* 73+13 43+4 39+2*
84+4* 54+6 117+11" 32+5* 40+2* 45+6
103+7" 69+2 84+5* 41+6" 33+3* 36+4*
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lal/min (n=4 p<0.05) and 0.280 + 0.003 to 0.804 + 0.128 btl/
min (n=5, p<0.05) respectively. This represents an increase
in permeability of 125 and 187%. ET-3 (10-6M) increased
the EC permeability in a similar manner: from 0.418 + 0.013
to 1.13 + 0.075 l/min, (n=6, p<0.001; 170%). These
results show that ET-I and ET-3 have direct effects on in
vitro EC permeability and suggest that these phenomena
are either mediated by a non-selective receptors for
endothelins, or alternatively ET-1 and ET-3 stimulate
different receptor types to increase EC permeability.
(Supported by the MRC)
LTB increases the permeability of guinea-pig
lung epithelial cells to albumin
T. Kawaguchi, P. Farmer, S. Prie and P. Sirois,
Department of Pharmacology, Faculty of Medicine,
University of Sherbrooke, Sherbrooke, PQ, Canada JIH
5N4.
The effect of LTB4, a potent inflammatory mediator, was
studied on the permeability of monolayers of guinea-pig
lung epithelial cells to lz5I-labelled albumin. The epithelial
cells were collected in Krebs’ buffer with protease type
XXIV. The isolated cells were suspended in DMEM/FI2
medium containing 10% FBS and seeded (3.0-6.0 x 105
cells/cm’) on fibronectin-treated polycarbonate filters
glued at the bottom of modified Boyden chambers. The
medium was removed 24 h after seeding and the cells were
then maintained in medium without FBS. Thereafter the
medium was changed every 48 h. At confluency, 700 lal of
medium containing 0.5% bovine serum albumin (BSA)
with v5I-labelled albumin was added to the chambers
which were immersed in a beaker containing 25 ml of the
same medium without labelled albumin. Aliquots were
withdrawn from the beaker at 90 s intervals for 120 min.
Albumin permeability was defined as the albumin
transfer index: TIAI (Ct_6t lZ5I-Alb.beaker.Vt+6t C az5I-
Alb.beaker.V)/C lZ5I-Alb.Boydon/At. Four groups of cells
were studied: 1) a control group (120 min), 2) a group
treated with LTB (10-6M) for 60 min after a control incu-
bation of 60 min, 3) a group that was treated with LTB
(10-6M) after a 10 min preincubation with receptor antago-
nists, 4) a group treated with LTB antagonists only. The
TIb before and after treatment was compared. The perme-
ability of epithelial cells did not change in the control
group. However, the permeability of the cells to albumin
was enhanced by 16% (p<0.005) following treated with
LTB4. Our results suggest that LTB could play a role in the
airway oedema associated with lung inflammatory and
hypersensitivity reaction. (Supported by MRC.)
Differential muscarinic liberation of
3H-arachidonic acid metabolites from
epithelium-containing and epithelium-
denuded isolated rat tracheae
G. Brunn, I. Wessler and K. Racke,
Department of Pharmacology, J.W. Goethe-University of
Frankfurt, W-6000 Frankfurt and 1Department of Phar-
macology, University of Mainz, W-6500 Mainz, F.R.G.
Recent experiments from our laboratories showed that
prostanoids can modulate neurotransmitter release from
isolated rat tracheas. Additional experiments indicated
that muscarinic modulation of neurotransmitter release
involves indirect, indomethacin-sensitive mechanisms.
Therefore, a possible muscarinic liberation of arachidonic
acid (AA) metabolites within the airways was tested.
Isolated rat tracheas were labelled with 3H-AA and the
outflow of tritium was determined. Radioactive com-
pounds in the incubation media were separated by gradi-
ent reverse phase HPLC. The spontaneous tritium outflow
was 0.13 %/min of the tissue radioactivity. Acetylcholine
(ACh) and the muscarinic agonist carbachol concentration-
dependently increased tritium outflow maximally by about
30% at 300 and 30 laM, respectively. HPLC separation of the
radioactivity showed that ACh and carbachol enhanced
several fractions, but the most pronounced effect (three-to
four-fold increase) was observed in the fractions represent-
ing 3H-PGEz and H-PGDz. For comparison, the ionophore
A 23187 (10 btM) increased the outflow of total tritium by
about 100%, but the 3H-PGEz/H-PGDz fractions about
10-fold. The effect of ACh was antagonized by the M3
selective muscarine receptor antagonist p-fluoro-
hexahydrosiladiphenidol (1-10 laM), but not affected by
the M2 selective muscarine receptor antagonist
methoctramine (up to 10 l.tM). Removal of the epithelium
either before or after the labelling period resulted in a large
attenuation of ACh evoked release of total tritium and 3H-
PGE,/3H-PGDz. In conclusion, activation of muscarine
receptors, most likely of the M3 subtype, can cause libera-
tion of AA in the airway epithelium, resulting in an en-
hanced formation of prostanoids.
References
1. Rack6 et al. Am Rev Respir Dis 1992; 146: 1182.
2. Brunn et al. Naunyn Schmiedeberg’s Arch Pharmacol
1991; 344: R74.
Granulocyte macrophage-colony stimulating
factor (GM-CSF), interleukin 8 (IL-8) and 15
hydroxyeicosatetraenoic acid (HETE)
production by human bronchial epithelial
cells in asthmatic and control subjec,ts
F. Gormand, R. Hosni, S. Cheria, B. Chabannes,
M. Lagarde, M. Perrin-Fayolle and Y. Pacheco.
INSERM U 352, Service de Pneumologie, Centre
Hospitalier Lyon-Sud, France.
Human bronchial epithelial cells (HBEC) are involved in
bronchial inflammatory processes by secreting cytokines
(EL6, IL-8, GM-CSF) and lipidic mediators
(Prostaglandins,15 HETE). Biological and cytological ab-
normalities of bronchial epithelium have been described in
asthmatic patients Thus GM-CSF production is increased
by HBEC of asthmatic patients.
The aim of this study was to determine the production
of GMCSF, IL-8, and 15 HETE by HBEC in control subjects
(n=6) and asthmatic patients (n=3). Human bronchial tis-
sues were obtained from either surgery or biopsy sources.
HBEC were isolated from the tissue samples by protease
treatment for 24 h at 4C. Dissociated cells were
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resuspended in DMEM/HAMFI2 supplemented with
growth factors, antibiotics, fetal calf serum (2%) and were
plated on to collagen coated dishes at a density of 5 x 103
cells/cm". HBEC were stimulated by TNF (100 u/ml) for 0,
3, 12, 24 h and supernatants were collected for analysis.
Immunoreactive GM-CSF, IL-8, 15 HETE were quantified
by RIA or EIA.
In control subjects, GM-CSF, IL-8, 15 HETE were de-
tected in basal conditions and the levels of cytokines
increased with time. Upon TNF stimulation GM-CSF and
IL-8 levels increased significantly at 3, 12, 24 h and 12, 24
h respectively. No difference was observed with 15 HETE.
In asthmatic patients GM-CSF levels were significantly
greater than controls at 24 h. For asthmatic patients TNF
did not increase GM-CSF basal levels. In conclusion TNF
increased the basal secretion of GM-CSF and IL-8 in control
subjects The greater and spontaneous production of GM-
CSF in asthmatic patients could be involved in the follow-
up of bronchial inflammation in asthma.
Endothelin and airway cells in asthma
1A. M. Vignola., P. Chanez, 2D. R. Springall, A. Campbell,
M. Farce, 2j. Polak. F. B. Michel, J. Bousquet and P. Godard
Montpellier France, 1CNR Palermo Italy and 2London UK.
Background: Endothelins represent a family of peptides
which might be implicated in asthma because of their
potent bronchoconstrictive and proliferative effects. On
bronchial epithelial cells endothelin immunoreactivity was
upregulated in asthmatics as compared with normal sub-
jects. We studied in asthmatics and normal subjects
endothelin immunoreactivity in alveolar macrophages
(AM) and bronchial epithelial cells (EC), and, the capability
of these cells to release endothelin.
Methods: AM were obtainedby BAL from 17 asthmatics
and nine normal subjects. EC were recovered by brushing
(>90% epithelial cells) from nine asthmatics and six normal
subjects. Cytospin preparations of AM or EC were stained
using a polyclonal antibody against endothelin using
the APAAP technique. AM were stimulated with 10/.tg/ml
of LPS during 24 h in plastic dishes (n=26). EC were
stimulated for 90 min by A23187 (0.5 /.tM) for 90 min.
The release of endothelin was measured by RIA
(Amersham).
Results:
asthma controls p value
immunoreactivity (% positive cells)
AM 8.7 + 6.5 3.2 + 4.2 p<0.03
EC 9.5 + 5.8 1.5 + 2.3 p<0.02
endothelin release (pg/ml)
AM resting 1.3 + 3.6 0.3 + 0.8 NS
AM + LPS 5.4 + 9.6 1.8 + 2.9 NS
EC resting 1.2 + 0.3 7.4 + 1.4 p<0.001
EC + A23187 8.6 + 1.4 8.0 + 2.3 NS
Heat stable products from alveolar
macrophages of ovalbumin immune and
non-immune guinea-pigs that stimulate
eosinophils and early progenitors
P. Elsas, M. I. Elsas, L. A. Silva, D. Joseph, N. Havet,
B. Saliou and B. B. Vargafiig,
Microbiologia UFRJ and FIOCRUZ, Rio de Janeiro,
Brazil, Unit de Pharmacologie Cellulaire (U285 I.
Pasteur-INSERM), 25 rue du Dr. Roux, 75015, Paris,
France.
To define whether products from alveolar macrophages
(AM) add to the eosinophilia of asthmatic lung, liquid and
semisolid cultures of guinea-pig bone marrow (BM) were
seeded in the presence of LPS-stimulated culture
supernatants (SN) of 95% pure AM (1% or less T ceils). The
SN increase eosinophil (EOS) production in liquid culture
and support formation of myeloid colonies containing
EOS, but not of pure EOS colonies, by acting on purified
progenitors devoid of mature EOS. This effect is not dupli-
cated by natural or recombinant sources of GM-CSF which
stimulate guinea-pig GM colony formation, and could not
be attributed to residual LPS, even though LPS is required
for induction of the activity (detectable at 30 min of
culture, plateau levels reached at 6 h). The activity is heat
resistant (30% residual activity after 30 min heating at
100C, detected in colony formation assays), with an ap-
parent m.w. of 43 kDa by FPLC on a Superose 8 column,
one peak being active on both liquid and semisolid cul-
ture. AM SN are active across species barriers, promoting
EOS production in liquid culture of human BM and increas-
ing human EOS helminthotoxicity. Comparable levels of
activity in liquid BM culture were found in LPS-stimulated
AM SN from guinea pigs immunized twice (OVO-OVO) or
once (OVO-ALUM) with ovalbumin in alum or from
ALUM-ALUM control animals, cultured 48 h after the
challenge injection, suggesting that LPS induces maximal
secretion irrespective of immunity. Significant activity was
found in one out of seven SN from OVO-OVO animals, but
in none of 8 OVOALUM and 7 ALUM-ALUM AM SN. While
ovalbumin (100 g/ml) induced low levels of activity, these
were comparable in AM SN of immune and non-immune
animals. The data suggest that a heat stable product ofAM
contributes to eosinopoiesis and ovalbumin immunization
promotes its secretion in the absence of LPS, at least in
some animals.
Supported by INSERM-I. Pasteur, CNPq/RHAE, FAPERJ,
FINEP and WHO/TDR.
Phospholipase C and D activation in rabbit
alveolar macrophage stimulated by cotton dust
tannin or zymozan
D. Lauque, R. Aslane, M. C. Prevost, H. Chap
INSERM U326, CHU Purpan, 31059 Toulouse Cedex.
Statistical analysis by Mann-Whitney U-test
Conclusion: Endothelin is over-expressed on airway
cells in asthma. However, its in vitro release, spontane-
ously or after non-specific stimulation, is not significantly
increased in asthmatics.
Alveolar macrophages (AM) play a main role in the devel-
opment of the acute lung inflammation observed after
cotton dust inhalation. Tannin, present in large amounts in
this respirable dust, promotes arachidonic acid and
neutrophil chemotactor factors release by AM. We investi-
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gated the role of phospholipase C (PLC) and D (PLD) in
the signal-transducting mechanisms of rabbit AM isolated
by lung lavage, then stimulated by cotton dust tannin or
zymozan. [3H]Lyso-PAF was used to label the
phosphatidylcholine (PC) pool of AM. Tannin or zymozan
promoted PC hydrolysis, phosphatidic acid (PA) and
diglycerides release after several minutes of stimulation.
Since these metabolites may come from PC hydrolysis by
a PLC or PLD, the exclusive property of PLD of
transphosphatidylation in presence of ethanol was used in
order to discriminate between these two routes. In pres-
ence of tannin and ethanol, phosphatidylethanol (Pet)
formation and decrease of PA synthesis were seen.
Preinhibition of proteine-kinase C (PKC) by GF 109203X
suppressed tannin-induced Pet formation. No Pet syn-
thesis was observed when AM were stimulated by
zymozan in the presence of ethanol. We conclude that
tannin-induced, but not zymozan-induced, PC, hydrolysis
in rabbit AM is, at least partially, mediated through PKC
and PLD activation.
Cytochemical examination of acid
phosphatase activity in alveolar macrophages
obtained by BAL from patients with pulmo-
nary sarcoidosis
S. Zunic-Minic, P. Cvetkovic, V. Cemerikic, O. Duric,
G. Dordevic-Denic, S. Zunic and D. Mandaric
University Clinical Center, Clinic for Allergy and Immu-
nology, Belgrade, Yugoslavia
This study was carried out to quantify and compare the
presence of acid phosphatase (E.C. 3.1.3.2.) activity in
alveolar macrophages (AM) obtained by bronchoalveolar
lavage (BAL) from patients with pulmonary sarcoidosis and
bronchitis. Thirty-four persons: 15 healthy subjects nine
non-smokers and six smokers), nine patients with pulmo-
nary sarcoidosis, (clinical grade I), and 10 patients with
different inflamative pulmonary disorders, pathohistologi-
cally confirmed as bronchitis and peribronchitis chronic,
were lavaged. Activity of alveolitis in sarcoid patients was
estimated clinically and supported with the evidence of
lymphocytosis and increase of CD4+/CD8+ ratio in BAL.
Diagnosis of sarcoidosis was pathohistologically con-
firmed. The AM from smokers showed slight, but not
significant increase of acid phosphatase activity in com-
parison with healthy non-smokers. Activity of acid
phosphatase from sarcoid patients revealed decrease in
comparison with the healthy subjects, as well as bronchitis.
This finding supports an idea about the use of acid
phosphatase activity as a possible non-specific prognostic
indicator for the alveolitis in pulmonary sarcoidosis.
Expression of surface markers on alveolar
macrophages (AM) from patients with HIV-
infection or sarcoidosis as detected by flow
cytometry
K. Wasser,nann, M. Subklewe and E. Schell-Frederick
Med. Dept. I/III, University of Cologne, Joseph
Stelzmann Str. 9, D-5000 Cologne 41, Germany.
The goal of this study was to quantify surface antigens on
human AM by flow cytometry as an indirect indication of
cell function. The primary antibodies were selected to
measure monocyte-like cells (Leu M3, Leu M5, My 7, My
9), antigen presenting capacity (HLA-DP, DQ, DR) and the
state of cell activation (Transferrin-R, Leu 15, 27E10, RM
3/1, IL-2R, ICAM-1). FITC-labelled F(ab’)2 anti-Ig served as
a second antibody. A CD2, 3, 19 cocktail was used to gate
out lymphocytes. The results are expressed as the median
linear fluorescent intensity of the test antibody divided by
that of the non-reactive isotype control. This quotient
indicates the intensity of specific antigen expression and
corrects for differences in autofluorescence between pa-
tients. We have analysed cells from 32 HIV-infected pa-
tients, ten patients with newly diagnosed sarcoidosis and
13 normal controls. The results show significantly in-
creased intensity of Leu M3, Leu M5, Leu 15, My 9 and
HLA-DP expression in both patient groups. There is signifi-
cantly higher expression of Transferrin-R in AM from pa-
tients with sarcoidosis as compared to controls but no
increase in AM from HIV-patients. A comparison of the
results in HIV patients with or without Pentamidine
aerosol prophylaxis suggests that Pentamidine decreases
AM surface marker expression.
Phagocytosis of viable Candida albicans by
alveolar macrophages: flow cytometric
quantification
S. Rosseau, W. Seeger, H. Pralle andJ. Lohmeyer
Dept. of Internal Medicine, JLU, Klinikstrasse 36, 6300
Giessen, FRG.
Granulocyte, monocyte and macrophage phagocytic ca-
pacity has been assessed by flow cytometric techniques
using FITC-labelled heat-killed yeasts and bacteria or
BCECF/AM-labelled viable Staphylococcus aureus or
Candida albicans. Application of this approach to AM is
hampered or even rendered impossible by the strong
autofluorescence of this cell type. This approximates or
even surpasses the fluorescence intensity of the labeled
bacteria or fungi. Furthermore, heat-killing of’microorgan-
isms may result in some overestimation of phagocytosis
due to destruction of putative phagocytosis inhibitory fac-
tors by this technique. We loaded viable C. albicans with
the membrane-permeable pH indicator carboxy-SNARF 2/
AM, which is cleaved intracellularly to generate the mem-
brane-impermeable derivative carboxy-SNARF 2. Fluores-
cence was excited with the 488 nm line of an argon-ion
laser, with two emission peaks arising at 583 nm and 633
nm. Rabbit alveolar macrophages were labelled using a
monoclonal mouse antibody and a secondary FITC-cou-
pied anti-mouse antibody. After coincubation of
macrophages and yeasts, paraformaldehyde (PFA, 4%) and
0.5% EDTA in PBS was used to stop the phagocytic process
and to detach adherent yeasts from the macrophage sur-
face. This procedure was shown to reduce the adherence-
associated background staining to <5%. FITC-labelled al-
veolar macro-phages were gated for right angle light scat-
ter and green fluorescence, and red fluorescent yeasts
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were detected with a 630/26 nm bandpass filter.
Macrophage-associated yeasts induced a shift from mono-
chromatic (green) to dual (green and red) fluorescence.
The percentage of yeast-positive macrophages and the red
fluorescence intensity per macrophage were quantified. 85
+ 5% of rabbit alveolar macrophages displayed phagocytic
activity within a 60 min incubation period at an 8:1 yeast
to macrophage ratio. Yeast opsonization with rabbit serum
or rabbit anti-Candida IgG was a prerequisite for
phagocytosis. Yeast engulfment was completely inhibited
in the presence of 0.1 mM n-ethyl-maleimide and 10 mM
Iodoacetic acid during the incubation period. Conclusion:
Phagocytosis of viable Candida albicans can be feasibly
quantified in alveolar macrophages by flow cytometric
techniques designed to circumvene the autofluorescence
of this cell population.
Airway macrophage releasibility during differ-
ent oestrogenic impregnation
P. Mourlanette, R. Escamilla, M. C. Prevost, C. Cariven,
H. Chap
Service de Pneumologie et Allergologie, INSERM U 326,
H6pital de Purpan, 31059 Toulouse Cedex.
The sudden appearance or worsening of asthma symptoms
in women during menstrual cycles, pregnancy or meno-
pause is widely reported. Moreover, it is suggested that
alveolar macrophages (AM) play an important role in
physiopathology of human bronchial asthma. The aim
of our study is to correlate AM activity in female rats
with different oestrogenic blood levels. We investigated
four groups of female rats: a control group, three
ovariectomized groups, one with 1 oestrogen implant (1I)
(corresponding to physiological blood oestrogen level in
oestrus), the other with three implants (3I) and the last
with an empty oestrogen implant (EI) during 20 days
(about duration of four rat menstrual cycles).
We investigated in each group the AM releasability after
non-specific stimulation by platelet activating factor (PAF).
Under stimulation, [14C]arachidonic acid labelled AM
showed a decreased release of 20% in 1I group (no
progesterone) and of 40% in 3I group (hyperoestrogen and
no progesterone) compared to control group (p<0.05) and
EI groups (no oestrogen and no progesterone) (p<0.001).
We suggest an oestrogen and progesterone scale dose
dependant activation of AM which may play a role in
women respiratory failures.
Allergen-induced skin eosinophilia is inhibited
in vivo by interferon (IFN) alpha
E. Hnocq, M. Raffard, M. Biderman-Fabas and B.
Bizzini
H6pital des Diaconesses, 18 Rue du Sergent Bauchat,
75012, Paris, France
Striking eosinophilic responses, revealed by the Rebuck
skin window test, have been observed in patients sensitive
to common allergens. The accumulation of eosinophils
reaches a peak 18-24 h after the application of the aller-
gen to the denuded skin surface. Recently, it has been
demonstrated that IL-4 enhances spontaneous IgE synthe-
sis by peripheral blood mononuclear cells of atopic
patients. This IgE synthesis was suppressed dose-depend-
ently by IFNT or IFN0t. Furthermore, a highly significant
decrease in the levels of IgE was observed in ragweed
sensitive individuals, as compared to controls. In order to
determine whether IFNz regulates allergen-induced
eosinophil recruitment into the tissues, we studied the
effects of human recombinant IFN{z on eosinophil infiltra-
tion by means of the Rebuck skin window. In ten atopic
patients, windows were performed with allergen alone
and with allergen admixed with IFNz (50 000 I.U./0.5 ml,
intra-dermal). Six patients were allergic to grass pollens,
three to D. Pt. and one to candidin. With allergen alone,
eosinophil recruitment was of 26.6% of the total cells,
versus 4.6% when IFNz was admixed (p 0.0009). Imme-
diate type wheal and flare reactions were uninfluenced by
IFN (W=8.2, F=27 versus W=9.3 and F=28.5). Total IgE
were high (800 I.U.) and specific IgE (3.5-41.9 PRU). In
three patients (grass pollen allergy), IFNz was injected at
three decreasing concentrations, showing a dose-depend-
ent blocking effect at only 50 000 I.U.. One patient with
atopic dermatitis had a polysensitivity (grass, cat and food
allergy to wheat) and a high IgE level (>6 000 1.U.).
Eosinophils represented 40% of the total cell number with
grass, versus 5% only with Grass + IFN0t respectively and
18% versus 1% with Cat Feld and Cat Feld + IFNz
respectively. However, the effect of wheat was not inhib-
ited by IFN0t suggesting different environmental conditions
of allergen exposure and/or insufficient doses of IFNz in
those specific conditions. In summary, the skin window
assays can be used to study comprehensively the
immunoregulatory capacities of cytokines in vivo.
Interaction of PAF with the plasma membrane
of eosinophils obtained from allergic asth-
matic children
A. Kantar, N. Oggiano, P. L. Giorgi and R. Fiorini
Departments of Pediatrics and 1Biochemistry, University
of Ancona, Ancona, Italy.
Platelet activating factor (PAF) is a potent phospholipid
mediator involved in a variety of pathophysiological
events, including inflammation and asthma. It exhibits a
wide range of biological activities on different types of
cells including eosinophils. The effect of PAF on the
plasma membrane of human eosinophils was investigated
by measuring the steady-state fluorescence anisotropy (rs)
and fluorescence decay of 1-(4-trimethylammonium-
phenyl)6-phenyl-l,3,5-hexatriene (TMA-DPH) incorpor-
ated in eosinophils plasma membrane. TMA-DPH r value
reflects the packing of membrane lipid fatty acid chains,
whereas fluorescence decay of TMA-DPH offers a good
description of membrane heterogeneity. Eosinophils ob-
tained from seven children with allergic asthma were
labelled with TMA-DPH and r was measured before and
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after PAF addition at a final concentration of 10-7M. The
effect of PAF on TMA-DPH fluorescence decay was deter-
mined using multifrequency phase fluorometry and data
were analysed by a model that assumes a continuous
distribution of lifetime values characterized by a Lorentzian
shape centred at time C and having a width C. Our results
demonstrate that PAF induces a time-limited and signifi-
cant increase in r value, indicating an increase in lipid
packing of the membrane. Fluorescence decay measure-
ments show a narrowing in the distribution width of the
long component, reflecting a decrease in membrane het-
erogeneity after the addition of PAF. These changes were
blocked in the presence of the PAF antagonist, L-659,989.
arachidonic acid (10 btM); the synthesis of PGE was
decreased whereas the synthesis of TxB was not
affected. These results suggest that eosinophils may
release MBP which decreases the synthesis of PGE
by tracheocytes, without affecting synthesis of TxB2. (Sup-
ported by the MRC.)
Bronchial hyperreactivity and pulmonary
eosinophilia in guinea-pigs
P. Sirois and K. Maghni
Dpartement de pharmacologie, Facult de mdecine,
Universite de Sherbrooke, Sherbrooke P.Q., Canada.
The metabolism of arachidonic acid by the
guinea-pig tracheal epithelial cells is
selectively modulated by eosinophils
P. Sirois and S. Pri
Department of Pharmacology, Faculty of Medecine,
University of Sherbrooke, Sherbrooke, P.Q., Canada, J1H
5N4.
Airway epithelial cells are not only responsible for the
mucociliary clearance of the airways but are also involved
in the control of airway reactivity and tone by the release
of a number of myotropic factors. Experimental evidence
suggests that selected functions of these cells are modu-
lated by inflammatory cells such as eosinophils,
lymphocytes and neutrophils. The aim of the present study
was to evaluate the influence of eosinophils on
prostaglandin E (PGE2) and thromboxane B (TxB) syn-
thesis by the guinea-pig tracheal epithelial cells
(tracheocytes). Guinea-pig tracheocytes were isolated by
enzymatic treatment with 0.1% protease XXlV at 37C for
I h. Freshly isolated tracheocytes were cultured in a serum-
free medium (DMEM/F12). Eosinophils were isolated by
bronchoalveolar lavage, 24 h after i.v. Sephadex bead
injection (G50, 24 mg/kg). The purification of eosinophils
was performed on a continuous Percoll gradient (65%).
Our results showed that unstimulated tracheocytes pro-
duced eight times more PGE2 (176 + 62 pg/ml ) than TxB
(21 + 5 pg/ml). In contrast, eosinophils synthesized
mostly TxB (9300 + 1850 pg/ml) and 26-fold less PGE2
(360 + 97 pg/ml) over a period of 2 h. In the presence of
arachidonic acid (0.1-10 M), the synthesis of PGE and
TxB by tracheocytes increased up to 450-fold and 28-fold
respectively. Eosinophils incubated in the presence of
arachidonic acid released 22 and two times more PGE2 and
TxB2 respectively. In coculture, the basal release of PGE,.
and TxB was 163 + 12 pg/ml and 430 + 96 pg/ml
respectively. In presence of arachidonic acid, the synthesis
of PGE,. and TxB2 by tracheocytes cocultured with
eosinophils increased up to 17- and 28-fold respectively. In
brief, the presence of eosinophils strongly reduced the
formation of PGE2 but not that of TxB2 from tracheocytes
incubated with exogenous arachidonic acid. Similar results
were obtained when tracheocytes were incubated with
major basic protein (MBP; 100 g/ml ) in presence of
The characteristic features of bronchial asthma are the
bronchoconstriction, airway inflammation characterized by
oedema, leukocyte migration and epithelial desquamation,
and bronchial hyperreactivity. We have recently developed
a model to study bronchial hyperreactivity and pulmonary
eosinophilia by the intravenous injection of Sephadex
beads (24 mg/kg) to conscious guinea-pigs. Significant cell
migration was noted in the airways 24 h after the injection
of Sephadex beads. Cell counts in bronchoalveolar lavage
increased from 20 x 106 to 85 x 106. Guinea-pig bronchi of
Sephadex treated guinea-pigs were hyperreactive to ace-
tylcholine and histamine as evaluated in vitro.
Pretreatment of the animals with aspirin (30 mg/kg) re-
duced by 43% the eosinophil infiltration but increased by
10-19% the bronchial hyperreactivity to histamine and
acetylcholine. Compound MK866 (5 mg/kg) reduced the
eosinophil infiltration by 49% and the hyperreactivity by 5-
22%. Compound BW755c (15 mg/kg) reduced the
eosinophil infiltration by 56% and the hyperreactivity by
8%. The PAF antagonist BN52021 (20 mg/kg) decreased
the eosinophil infiltration by 41% and the hyperreactivity
by 16-28%. Dexamethasone (5 mg/kg) decreased the
eosinophil infiltration by 43% and increased the hyperac-
tivity by 12-16%. Ketotifen (15 mg/kg) reduced the
eosinophil infiltration by 66%, but increased the hyperac-
tivity to acetylcholine by 68%. From these results, it does
not appear that eosinophil infiltration is always correlated
with bronchial hyperactivity. It is suggested that other cell
types could also play a major role in this complex interac-
tion. (Supported by the MRC.)
New model of bronchial hyperreactivity and
airway eosinophilia in guinea-pigs
K. Maghni, C. Lanoue, S. Cloutier, J-P. Cristol,
F. Blanchette, A. Cadieux and P. Sirois
Department of Pharmacology/Faculty of Medicine,
University of Sherbrooke, Sherbrooke P.Q., JIH 5N4
Canada.
Bronchial asthma is mainly characterized by airway inflam-
mation and bronchial hyperreactivity (BHR). Experimental
evidence suggests that eosinophils (EO) are involved in"
the pathogenesis of asthma. However, in some experimen-
tal models of asthma the BHR did not seem related to EO
infiltration in alveolar walls and in some lung diseases,
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pulmonary eosinophilia was observed whereas some sub-
jects do not present BHR to methacholine. Recently, we
developed a new model of airway eosinophilia (AE) in
guinea-pigs following intravenous injection of G-50
Sephadex beads (24 mg/kg). The AE was assessed by
bronchoalveolar lavage (BAL). The BHR to histamine (His)
and acetylcholine (Ac) was measured in vitro (bioassays)
on airway tissue preparations. Histological studies were
also performed. The injection of Sephadex beads induced
a marked AE (around 36 x 106 EO recovered in BAL fluid)
in guinea-pigs 1 day post-injection (p.i.). The number of
EO decreased to 22% and 41% 7 and 14 days p.i.. The
lower bronchi of Sephadex-treated animals presented a
BHR to His with an increase of the maximal tension
(Emax) of 4.6-, 2.6- and 3.2-fold at 1, 7 and 14 days
respectively. BHR to Ac was also observed with a 4.8-, 2.3-
and 2.6-fold increase of Emax 1, 7 and 14 days p.i.,
respectively. In the pulmonary parenchyma, there was no
BHR to His and Ac 1 day p.1. whereas a significant increase
of Emax was observed for the two agonists 7 and 14 days
p.i. In Sephadex-treated animals an important infiltration
of EO in the epithelium of the lower bronchi was noted in
histological studies. A marked infiltration of EO was also
found in the pulmonary parenchyma but few (if any) EO
were seen in the bronchiolar epithelium 1 day p.i. How-
ever, 7 and 14 days p.i., a marked increase in the number
of EO was observed in the epithelium. In conclusion, the
Sephadex-induced BHR in guinea-pigs seems to be related
to the degree of EO infiltration in the airway epithelium
rather than to the presence of EO into the alveolar walls.
Bronchial epithelium desquamation was not apparent.
These results suggest that the airway eosinophils could
reduce or inhibit the release of relaxing factors by bron-
chial epithelial cells according to mechanisms not yet
understood. (Supported by the MRC.)
Correlation of bronchoalveolar cell influx, cell
activation and bronchial responsiveness after
chronic inhalation of ovalbumtn (OA) in
sensitized guinea-pigs
H. O. Heuer, B. Wenz, H. M. Jennewein, K. Urich
Department of Pharmacology, Boehringer Ingelheim KG,
W-6507 Ingelheim, and Faculty of Biology, Johannes
Gutenberg University of Mainz, W-6500 Mainz
The aim of the following study was to examine the asso-
ciation between inflammatory cell influx, cell activation
status and change of bronchial responsiveness to acetyl-
choline (ACh) after daily inhalation of ovalbumin (OA) in
sensitized guinea-pigs (GPs). Materials and Methods: (a)
Starting 3 weeks after sham (S-control; saline) or OA-
sensitization (OA at 50 mg/kg s.c. + i.p.) GPs were inhaled
daily with 2% OA (10 min; under cover of 0.5 mg/kg
mepyramine i.p. 15 min before OA) or saline (S-control)
for 2 weeks. (b) Concentration-response curves (CRCs) for
inhaled ACh were performed 24 h after the last OA-
challenge and 24 h after another single OA-inhalation 1
week later. (c) Bronchoalveolar lavage (BAL) with analysis
of inflammatory cell numbers (xl06/lung) and their activa-
tion status [eosinophil peroxidase, EPO (x absorption units
/107eos*ml-); myeloperoxidase, MPO (x 10-6U MPO/PMN)]
was performed after the last CRC. (d) Two treatment
groups of OA sensitized/inhaled GPs received either
methyl-prednisolone (NT group; 40 mg/kg i.p. 24 h before
first and very last and 1 h before each OA challenge) or
paf-antagonist WEB 2347 (WEB; 10 mg/kg i.p. 1 h before
each challenge) (n=7-10/group). Results (see Table;*units
in text): (1) BAL from repeatedly OA-sensitized/chal-
lenged GPs showed a significant increase of total cell count
by about 10-fold and increases in eosinophils (eos) by
about 20-fold, neutrophils (PMNs) by 30-fold, macro-
phages (macros) by about five-fold and lymphocytes
(lymphs) by about 10-fold (p<0.05, multiple Wilcoxon-
test). (2) In contrast, markers of cell activation (EPO, MPO)
were significantly decreased (p<0.05). (3) MP almost com-
pletely and the paf-antagonist WEB 2347 partially reversed
these changes in increased cell numbers and decreased cell
activation (vs. OA contr., p<0.05). (4) CRCs for inhaled
ACh were neither affected 24 h after the last OA challenge
(daily for 2 weeks) nor 24 h after another OA-inhalation
1 week later.
s-contr. OA-contr. OA/MP OA/WEB
total cells 16.2+0.8 164.1+/-20.8 24.8+/-3.9 110.6+/-14.9
eos 4.9+/-0.6 98.7+/-15.8 7.1+/-1.5 66.0+/-10,7
PMNs 0.46+/-0.23 15.0+/-2.9 1.2+/-0.4 9.9+/-3.0
macros 8.9+/-0.3 46.4+/-4.8 14.5+/-2.2 31.6+/-2.7
lymphs 0.2+/-0.03 1.9+0.7 0.35+/-0.09 0.62+/-0.27
EPO 7.8+/-2.0 0.64+0.09 5.0+/-1.1 1.4+/-0.1
MPO 39.5+/-8.1 0.61+/-0.1 97.9+/-60.5 2.68+/-0.6
In conclusion the dissociation between the massive
inflammatory cell influx into the BAL on the one hand and
decreased activation status of these (probably previously
activated, but presently exhausted) cells on the other hand
might explain the absence of bronchial hyperrespons-
iveness after chronic antigen-exposure in this model.
Effects of CS-18, a thromboxane synthase
inhibitor, on eosinophil accumulation and
activation
K. Itoh, O. Mukaiyama, E. Takahashi, Y. Satoh and
T. Yamaguchi
Biological Research Laboratories, Sankyo Co., Ltd., 1-2-
58 Hiromachi, Shinagawa, 140 Tokyo, Japan.
The effects of CS-518, a thromboxane A (TXA2) synthase
inhibitor, on eosinophil accumulation and activation were
investigated in an experimental asthmatic guinea-pig
model and in several cellular models, such as TXAa produc-
tion, eosinophil peroxidase (EPO) release/cell adherence
to serum coated plates and chemotaxis measured by modi-
fied Boyden method. In the in vivo studies, CS-518 inhib-
ited eosinophil accumulation and EPO release into the
bronchoalveolar lavage fluid (BALF) of the late asthmatic
guinea-pig model. This compound also inhibited PAF,
LTD and IL-5-induced eosinophil accumulation and LTD4-
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induced release of eosinophil chemotactic factor into
BALF. In the in vitro studies, CS-518 more markedly sup-
pressed TXA production, EPO release and cell adherence
than chemotaxis. This compound potentiated production
of prostaglandin 12 (PGI2), which inhibited chemotaxis and
EPO release from guinea-pig eosinophils. The present
studies provide further support that TXA,. and PGIa are
involved in modulation of the eosinophil functions and
indicate that CS-518 is a potent inhibitor of eosinophil
activation.
Models of bronchial allergic inflammation
induced by ovalbumin in guinea-pig, rat and
mouse
J. P. Tarayre, M. Aliaga, M. Barbara, N. Malfetes
Centre de Recherche Pierre Fabre, 17 avenue Jean-
Moulin, 81100 Castres, France.
Various in vivo models of bronchial allergic inflammation
have been induced in guinea-pigs, rats and mice after
sensitization and aerosol challenge with ovalbumin. In
guinea-pigs actively sensitized there was an increase, gen-
erally maximum 24-48 h after challenge, in the number of
eosinophils, neutrophils and mononuclears (with quantita-
tive differences according to the mode of sensitization) in
bronchoalveolar lavage fluid (BALF). After sensitization
with complete Freund’s adjuvant, the number of airways
epithelial cells was also increased at 24-48 h. Tie preven-
tion of the symptoms of anaphylactic shock by
pretreatment with mepyramine did not modify the spec-
trum of inflammatory cells in BALF at 24 h. The allergic
reaction induced in Brown Norway (BN) and Sprague-
Dawley rats actively sensitized with ovalbumin and
Bordetella pertussis suspension was characterized by an
increase in eosinophils and neutrophils in BALF maximum
also at 24-48 h. In guinea-pigs and rats, passive
sensitization and challenge induced no bronchial inflam-
mation (rat) or an inflammation inferior to that obtained
after active sensitization (guinea-pig). In Swiss mice ac-
tively sensitized with sc ovalbumin in incomplete Freund
adjuvant we did not obtain a bronchial inflammation supe-
rior to the non-specific increase in neutrophils in non-
sensitized animals. Drugs administered 5 min and 5 h after
challenge have been experimented on the 24-h inflamma-
tion in guinea-pigs and BN rats. Dexamethasone acetate
only reduced the number of eosinophils in guinea-pigs and
in rats its effects were superior on eosinophils than on
neutrophils. Cromoglycate invariably decreased the
eosinophils; its action on the other leucocytes was different
according to the model. Theophylline always reduced the
accumulation of eosinophils with activity on mononuclears
in guinea-pigs and neutrophils in rats. Cetirizine, ketotifen,
and salbutamol decreased eosinophils only in rats.
Mepyrarnine and indomethacin were inactive. Some drugs
have been experimented only in BN rats while
cyclosporine A, methotrexate, rolipram and furosemide
were active on eosinophils and neutrophils, chloroquine,
aurothiopropanol sulphonate and pinacidil decreased only
eosinophils; methysergide and atropine were inactive.
Dissociation between airway eosinophilia and
bronchial responsiveness in IL-5 transgenic
mice
J. Lefort, D. Leduc, C. M. Bachelet and B. B. Vargaftig
Unite de Pharmacologie Cellulaire, Unite Associee
Institut Pasteur-INSERM U285, 25, rue du Docteur Roux,
75015, Paris, France.
To determine if bronchopulmonary hyperresponsiveness
and eosinophil recruitment into the airways are associated
in mice, lung inflammation (histology and counts in
bronchoalveolar lavage fluid, BALF) was correlated to
bronchoconstriction by 10-320 btg/kg of 5HT or
methacholine i.v. in Swiss and IL-5 transgenic mice
(donated by Drs. C.J. Sanderson and C.M. Hetherington;
see Dent et al., J. Exp. Med., 172, 1425, 1990). After
immunization on days 0 and 7 with sc ovalbumin (100 g
in 1.6 mg of aluminium hydroxide), 1-100 l-tg OA were
instilled into both nostrils on day 14. Naive, sham immu-
nized and sham challenged Swiss mice contained no
eosinophils in their airways nor in the BALF, provocation
being followed at 24 and 96 h (but not 6 h) by a dose-
dependent increase up to 35% of eosinophils in the BALF,
which was suppressed by dexamethasone (2.5-5.0 mg/kg)
and returned to basal values in 14 days. Lungs had a
normal microscopic aspect up to 2 h after challenge, and
were inflamed 6 h to 7 days thereafter, with eosinophils
localized essentially around central airways and blood
vessels. IL-5 transgenics had eosinophils in lungs and
blood, but not in the BALF; saline-challenged immunized
animals had approximately 10%, and OA-challenged ani-
mals had 40-65%, eosinophils in the BALF. After anaesthe-
sia (i.p. urethane, 45 mg/10 g and pancuronium, 0.25 mg/
kg), the trachea was cannulated and lung resistance and
compliance were measured with a Mumed PR800 system.
The threshold for bronchoconstriction, peak effects and
PD20, PD60 and PD90 (doses which increased the re-
sponses by 20, 60 and 90%, respectively) were not signifi-
cantly modified 24 or 96 h after antigen challenge in both
Swiss and IL-5 mice, with a tendency for augmented
responses at 3 h, quite before eosinophil recruitment into
the BALF. Eosinophil recruitment alone does not cause
hyperresponsiveness, their further activation being prob-
ably required. Alternatively, early signs of
hyperresponsiveness, which will be further studied in
appropriate mice strains, suggest that hyperresponsiveness
may precede overt eosinophil infiltration.
The effects on andolast (CR 2039) on
Sephadex-induced eosinophilia and lung
hyperresponsiveness in the rat
F. Ferrari, L. Revel, O. Letari and F. Makovec
Rotta Research Laboratorium, Via Valosa di Sopra 7,
20052 Monza, Milano, Italy.
Lung eosinophilia and hyperreactivity are characteristic
of chronic asthma. We induced eosinophilia and
hyperreactivity in the lungs of rats by intravenous injection
of Sephadex particles, according to the method of Spicer
et al. and Cashin et al. Following single injection of
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Sephadex G100 or repeated injections of Sephadex G200,
we observed an increase in number of eosinophils and a
fall in number of mononuclear cells in the bronchoalveolar
lavage (BAL) fluids of the rats. Moreover, the animals were
hyperresponsive to the bronchoconstriction induced by
acetylcholine (Ach) in vivo and to the spasmogenic effect
of 5-hydroxytryptamine (5-HT) in vitro. In this context, we
examined the effect of andolast (4-(1H-tetrazol-5-yl)-N-[4-
(1H-tetrazol-5-yl] phenylbenzamide), a putative new
antiallergic compound in comparison with disodium
cromoglycate (DSCG). Andolast administered i.m. or s.c. in
a dose range of 3-30 mg/kg reduced the increase in
number of eosinophils in the BAL fluids of rats treated with
Sephadex i.v. Besides, at the same doses, it reduced
hyperreactivity to 5-HT in vitro and the hyperrespon-
siveness to Ach in vivo. DSCG was ineffective up to 100
mg/kg i.m. or s.c. in reducing lung eosinophilia. Hyper-
reactivity to 5-HT in vitro and hyperresponsiveness to Ach
in vivo were also not reduced by DSCG.
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Defensin-induced response of peripheral
blood monocytes in bronchial asthma: a new
diagnostic test
A. Kubatiev, O. Fesenko, S. Tkachenko and E. Gembitski
Department of General Pathology and Pathophysiology,
National Center of Postgraduate Medical Training, 2
Barrikadnaya Street 123836 Moscow, Russia.
Defensin (D) is referred to the family of non-fermentative
cationic peptides with a broad spectrum of microbicidal,
antiviral and cytotoxic activity. In experiments in vitro D of
human neutrophils (1 t.tg/ml-100 g/ml) causes a distinct
dose-dependent aggregation of donors monocytes (M)
intensifying under the influence of arachidonic acid (AA)
40 l.tM and phorbol myristate acetate (PMA) 10 nM. Addi-
tional stimulation of donor’s M by D exhibits no changes
of their aggregational degree. However, in patients with
bronchial asthma D exerts no essential influence on M
aggregational activity stimulated by AA and PMA. It ap-
pears to be accounted for by non-ability ofM activated by
D present in patient’s plasma to react to additional D
stimulation in vitro. Thus investigation data permit to
regard D-induced aggregation ofM as a new sensitive test
for estimating their functional condition in patients with
bronchial asthma.
Cytokine secretion by monocytes in patients
with primary immunodeflcent state
F. Abdullayev, A. Umnyashkin and O. Abdullayev
Quarter 2514, Zar dabi Street, Baku 370118, Azerbaijan
Republic, Institute of Phtisiology and Pulmonology.
Monocytes and macrophages play an important role in the
cellular immune response of inflammation and have
immunoregulatory properties by production and secretion
of cytokines in patients with primary immunodeficient
state (PIS). We have measured the production of
interleukin 1 (IL-1), interleukin 6 (IL-6), and tumour
necrosis factor (TNF) by unstimulated monocytes and
monocytes stimulated with lipopolysaccharide isolated
from the peripheral blood of patients with hereditary
glucose-6-phosphate dehydrogenase deficiency (G6PD),
which apply to PIS (89 persons) and healthy control (70
persons). Spontaneous and lipopolysaccharide-induced
cytokine production were not significantly different be-
tween patients and control. Median lipopolysacharide-
stimulated cytokine secretion for patients and control was
1.55 and 4.29 U/ml for IL-1,469 and 630 U/ml for IL-6, and
458 and 592 pg/ml for TNF. It has been speculated that
some clinical signs of PIS such as fever and cachexia could
be ascribed to the action of cytokines as IL-1 or TNF. In
addition, the high level of immunoglobulins observed in
the course of the PIS have been ascribed to increased
secretion of B cell differentiation factors such as IL-6
induced by PIS.
Elafin, a potent inhibitor of human leukocyte
elastase
o. Wiedow, J.-M. Schr6der and E. Christophers
Dept. of Dermatology, University of Kiel,
Schittenhelmstr.7, D-W-2300 Kiel, Germany.
In acute and chronic inflammation leukocyte infiltration
and tissue damage are the major events. In particular in
lung emphysema the inflammatory infiltrate is dominated
by neutrophils and macrophages. Both cells have potent
serine proteases, like human leukocyte elastase, proteinase
3, and cathepsin G, which are able to degrade a wide
variety of matrix proteins. Since human leukocyte elastase
and proteinase 3 are able to produce emphysema-like lung
destruction in animals, inhibitors of these enzymes are
suspected to have therapeutical effects in inflammatory
lung diseases like emphysema.
Elafin, a potent inhibitor of human leukocyte elastase
(app. Ki: 6 x 10-1M) and proteinase 3, had first been
purified from horny layers of patients suffering from pso-
riasis. This inhibitor is able to prevent the metabolism of
insoluble matrix proteins like elastin or keratin by
elastases. From investigations of Sallenave et al. (Biol
Chem Hoppe-Seyler 1992; 373: 27.) It became clear that
this inhibitor is also present in bronchial mucus. Elafin is
an acid and alkaline stable 57 amino acid peptide. We
could now isolate several elafins with N-terminal deletions
(up to 5 AA) and elongations (up to 19 AA) from human
skin with the same inhibitory activities. The N-terminus of
the elongated molecules contains transglutamination sites,
which make it likely that the native molecule is coupled to
matrix proteins. Therefore, elafin seems to be an important
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antiinflammatory compound in vivo. Since recombinant
elafin is now available, its potential for therapeutic use in
several diseases with neutrophil-mediated tissue damage
has to be investigated.
Neurotransmitters modify the responsiveness
of stimulated neutrophils
1M. Gajewski, 2H. Laskowska-Bozek, 1S. Maslinski and
J. Ryzewskie
1Departments of Biochemistry and apathophysiology,
Institute of Rheumatology, Warsaw, Poland
Reactive oxygen species (ROS) have attracted increasing
attention for their possible role in promoting inflammation.
However, ROS metabolism of phagocytic cells may be
substantially modified by neurotransmitters of the auto-
nomic system. Human peripheral neutrophils were studied
to assess the effect of adrenergic and muscarinic
cholinergic agonists (adrenaline and carbachol, respec-
tively) on neutrophils luminol-enhanced chemilumin-
escence (CL). Both agonists were ineffective when resting
neutrophils were tested. We confirmed that adrenaline
inhibited CL evoked in activated neutrophils. An unex-
pected further increase in CL of zymosan-activated
neutrophils was observed following carbachol treatment.
This increase correlated with effects of cholinergic agents
on neutrophil lysosomal enzyme release. Both effects were
prevented by 1 btM atropine. The increase in the luminol-
enhanced CL seems to correlate with the expression of
muscarinic receptors on neutrophils. We conclude that the
opposite effects of adrenergic and muscarinic receptor
agonists on the activity of neutrophils may reflect their
opposing influences on inflammation, and may support the
idea of ’proinflammatory’ effect of parasympathetic system.
5-1ipoxygenase-activating protein binds
arachidonate and increases its utilization by 5-
lipoxygenase
P. Vickers, J. Mancini, E. Wong, S. Charleson, M. Cox,
and M. Abramovitz
Merck Frosst Centre for Therapeutic Research, P.O. Box
1005, Pointe Claire-Dorval, Quebec H9R 4P8, Canada.
5-Lipoxygenase (5-LO) and 5-1ipoxygenase-activating pro-
tein (FLAP) are both essential for cellular leukotriene (LT)
synthesis and represent alternative targets for LT bio-
synthesis inhibitors. However, the mechanism by which
FLAP activates 5-LO has remained unclear. We have ex-
pressed human FLAP and human 5-LO to high levels, both
alone and in combination, in Spodoptera frugiperda (Sf9)
insect cells using recombinant baculoviruses. As 5-LO syn-
thesizes LTA and 5-HPETE in intact Sf9 cells in response
to exogenous arachidonic acid (AA) and calcium
ionophore A23187, analysis of 5-LO activity in Sf9 cells in
the absence or presence of FLAP provides a system to
study the specific effects of FLAP upon cellular 5-LO
activity. In this system, FLAP increased the total amount of
ETA and 5-HPETE synthesized from AA, allowed 5-LO
activity at low AA concentrations and increased the LTA4:5-
HPETE product ratio relative to cells expressing 5-LO
alone. These effects of FLAP upon 5-LO activity were
inhibited in a concentration-dependent manner by MK-
886, an LT biosynthesis inhibitor which specifically binds
to FLAP. We have also demonstrated that FLAP, both in
human leukocytes and expressed in Sf9 cells, specifically
binds pa5I]-L-739,059, a photoaffinity analogue of AA, with
this binding being inhibited both by unlabelled AA (IC50 of
10-20 mM) and MK-886, but not by analogues of MK-886
which are not effective as inhibitors. The demonstration
that FLAP specifically binds AA and increases the utilization
of this fatty acid suggests that FLAP may function as an
arachidonate transfer protein for 5-LO.
Ammonium chloride decreases cell surface
IL-8 receptor expression and chemotactic
responsiveness of neutrophils (PMN)
J. K. Shute, J. E. Parry, M. C. A. Clarke, J. O. warner,
M. K. Church and T. P. Dean
Immunopharmacology and Child Health Groups,
Southampton General Hospital, Southampton S09 4XY,
UK.
Neutrophils are the primary target of IL-8, a chemokine
associated with several inflammatory conditions, such as
psoriasis, rheumatoid arthritis and, as we have recently
shown, cystic fibrosis. In this study, we compared the
effects of red blood cell (RBC) lysis using isotonic NH4C1
or hypotonic NaC1 on the subsequent determination of cell
surface IL-8 receptors and chemotactic responsiveness of
PMN. PMN were purified from peripheral blood of normal
and atopic individuals by dextran sedimentation of RBC
followed by removal of mononuclear cells on
Lymphoprep. RBC contaminating the granulocyte pellet
were lysed in 0.15 M NH4CI for 15 min at 4C or 0.2% NaC1
for 45 s at 20C. Scatchard analysis of the binding of
radioiodinated IL-8 to granulocytes revealed no significant
difference between normal (n=5) and atopic (n=4) donors
when cells were prepared by either method. However,
both the number and theI of IL-8 receptors were signifi-
cantly (p <0.001) reduced when NH4Cl was used to lyse
RBC compared with NaCl (n=9). The number of receptors
on cells exposed to NH4Cl was less than 35% of that
measured on the same cells exposed to hypotonic NaCl.
Correspondingly, the in vitro chemotactic response ofPMN
to an optimum concentration of IL-8 was significantly
(p <0.01) reduced by 40% (n=10). NH4Cl is a weak base
that raises intralysosomal pH, interfering with recycling of
receptors to the cell surface following binding of ligand
and internalization. We conclude that the use of NH4C1-
should be avoided in the preparation of granulocytes for
investigation of IL-8 responsiveness and quantification of
surface receptors.
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Effect of chronic polymyxin B and
ovalbumin (OA) inhalation on
bronchoalveolar lavage (BAL) cell
influx and cell activation status in
sensitized guinea-pigs: massive
inflammatory cell infux contrasts
to bronchial hyporesponsiveness after
polymyxin B
H. O. Heuer, B. Wenz, 1R. H. Gundel, H. M. Jennewein
and K. Urich
Dept. of Pharmacology, Boehringer Ingelheim KG, W-
6507 lngleheim/Rhein, 1Boehringer Ingleheim Pharma-
ceuticals Inc., Ridgefield, CT, USA and Faculty of
Biology, Johannes Gutenberg University of Mainz, W-
6500 Mainz (FRG).
lymphocytes were not affected in a relevant manner
(p>0.05) (group II, polymyxin B + intermittent OA: total
50.2 + 14.7, eos 20.2 + 7.4, PMNs 7.7 + 3.1, macros 20.1 +
3.9, lymphs 1.1 + 0.2). (4) EPO-content per eos x absorp-
tion units/107 eos x m1-1) as a marker for eos activation was
significantly decreased in polymyxin B inhaled GPs (me-
dian group vs. III: 2.5 vs 10.1, p<0.05). MPO per PMN
(x 10-6U MPO/PMN) was not affected significantly between
groups (median group vs. III; 1.7 vs. 6.4, p>0.05). Con-
clusions (1) Massive inflammatory cell influx may not
necessarily result in bronchial, hyperresponsiveness. (2) In
contrast, decreased activation status of eo may explain the
observed significant bronchial hyporesponsiveness after
chronic polymyxin B inhalation. (3) The findings are still
consistent with a modulatory role of eos in regulation of
bronchial responsiveness.
The following study was aimed at studying the
effect of chronic/weekly polymyxin B inhalation on
bronchoalveolar cell influx and activation status, their
interaction with intermittent ovalbumin (OA) inhalation
and bronchial responsiveness in sensitized guinea-pigs
(GPs). Methods: (a) GPs were allocated to three groups (I,
II, III). GPs of group and II were sensitized three times
(week 3, 5, 20) with 10, 5 and 2 g ovalbumin (OA),
respectively, in 10 mg AI(OH)/GP. A treatment with
cyclophosphamid at 30 mg/kg i.p. preceded each
sensitization 2 days before. Weekly inhalations of
polymyxin B were performed for maximal recruitment
and activation of inflammatory cells, starting 2
weeks before (week 1) first sensitization and continued
throughout the study period. In difference to group I,
group II was exposed to additional and intermittent
(up to nine times) OA challenges. Group III received
sham-sensitization and sham-inhalations. (b) During
weeks 30-31 bronchial responsiveness to inhaled
acetylcholine (ACh) was determined 24 h after OA
(1% for 5 min under cover of 10 mg/kg i.p. mepyramine,
15 min before OA; group I) and compared to
sham-controls (group III). (c) Bronchoalveolar lavage
(BAL) was performed 24 h after another OA-/saline-
challenge during weeks 38-40 in all three groups
and analysed for cell numbers and status of cell
activation (eosinophil peroxidase, EPO; myeloperoxidase,
MPO). Results: (1) 24 h after OA-challenge in
multiple polymyxin B inhaled GPs (group 1) a significantly
reduced responsiveness to inhaled ACh occurred
(hyporesponsiveness!) compared to sham sensitized/sham
challenged GPs (Group III) (median ECs0: group 0.072
mg/ml ACh, n=13; group III 0.025 mg/ml ACh, n=14;
p<0.05). (2) Repeated and weekly inhalation of polymyxin
B (without intermittent OA-challenge; group I) led to an
unspecific increase of all inflammatory cells (xl06/lung)
including eosinophils (eos), neutrophils (PMNs)
macrophages (macros), lymphocytes (lymphs) (Group 1,
polymyxin B: total 88.1 + 10.1, eos 19.7 + 4.7, PMNs
21.1 + 5.5, macros 42.8 + .2, lymph 2.8 + 1.4, n=6; vs
group III, sham: total 26.9 + 2.5, eos 3.8 + 0.7, PMNs 4.2
+ 1.7, macros 17.8 + 1.7, lymphs 0.7 + 0.2, n=14; p<0.05).
(3) In contrast, repeated and weekly inhalation of
polymyxin B combined with intermittent OA-challenge
(group II) led to a preferential and significant influx of eos
(group II vs. III; p<0.01). Neutrophils, macrophages and
Inhibition by rapamycin of LPS-induced
leukocyte infdtration in guinea-pig airways
J. Francischi*, D. M. Conroy and P. Sirois
Department of Pharmacology, Faculty of Medicine,
University of Sherbrooke, PQ, Canada
The effect of rapamycin, a new immunosuppressive drug
(Morris, 1992) was studied on LPS-induced cell infiltration
in .guinea-pig lung. Twenty-four hours following the
intratracheal injection (i.t.) of LPS (E. coli 0111:B4, 8 lttg/
kg) to anaesthetized guinea-pigs (Dunkin-Hardey, 300-
350 g) there was a significant increase in leukocyte number
in blood (2933 + 452 to 4667 + 417 cells/mm) and
bronchoalveolar lavage fluid (BAL; 20 + 5 x 106 to 117 +
20 x 106, n=6) when compared to an i.t. injection of
apyrogenic saline. The increase in leukocyte number in
BAL was related to a marked neutrophil influx which
comprised approximately 60% of the total cells. A two-fold
increase in the maximal contraction of superfused strips of
bronchial tissues to histamine and acetylcholine (ACh) was
observed 24 h following LPS injection although this
increase in bronchial reactivity was not statistically
significant. Rapamycin (5 m/kg) administered intramus-
cularly 2 h before LPS injection significantly reduced the
leukocyte count in blood (3210 + 165 cells/mm) and BAL
(32 + 6 x 106 cells). The decrease in BAL leukocyte total
count was related to a significant inhibition on both
neutrophil (72 + 14 to 9 + 3 x 106 cells) and macrophage
(36 + 5 to 19 + 3 x 106 cells) infiltration. These results show
that rapamycin is an effective inhibitor of leukocyte
migration induced by LPS in guinea-pig airways. In
addition, we have shown that neutrophil infiltration of
guinea-pig airways induced by LPS is not associated with
a significant increase in bronchial reactivity to either
histamine or ACH.
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Oxidative activity of pulmonary phagocytes in
acute pulmonary infection
K. Dalhoff, J. Braun, M. KOrber, H. Kothe, K. J. WieJgann
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The generation of reactive oxygen species (ROS) by pul-
monary phagocytes is a critical step in non-specific host
defence against pulmonary pathogens.We investigated the
relative contribution of alveolar macrophages (AM) and
neutrophils (PMN), which have different oxidant-forming
capacity, to the production of ROS in BAL of 43 patients
with acute pulmonary infection and ten controls. The
chemiluminescence (CL) of 105 phagocytes/0.5 ml was
measured on a LB 953 luminometer (Berthold) continously
during 30 min after enhancing with luminol (total Cl incl.
halides) and lucigenin (mainly O,.); peak levels were
taken for calculation. The neutrophil percentage in the
BAL differential was markedly elevated in pneumonia (45
+ 34% vs 0.6 + 0.4% in controls). The basal level of
luminol-enhanced CL in patients 103 (controls) was 104.3
+ 123.7 (18.7 + 9.7) cpm, p<0.01, and 1 678.7 + 2 240.3
(169.7 + 380.8) 103 cpm,p<0.01 after stimulation with PMA.
In contrast lucigenin-enhanced CL was not different be-
tween the two groups: 76.5 + 101.3 (69.9 + 55.1) 103 cpm
and 284.8 + 334.5 (206.7 + 183.8) 103 cpm. Luminolo
enhanced CL correlated strongly to the percentage ofPMN
in BAL (r=0.77, p<0.001). The increased oxidative activity
in the alveolar compartment in acute pneumonia is mainly
due to the influx of activated neutrophils, whereas_the
contribution of the resident AM to the pi’oduction of ROS
is only marginal.
Effects of tobacco smokers’ bronchoalveolar
lavage fluid (sBALF) on neutrophil migration
A. Verma, 1T. J. Lockington, N. Walcot, T. D. Tetley,
IM. C. Barrett and S. F. Smith
Departments of Medicine & 1Histopathology, Charing
Cross & Westminster Medical School, London W6 8RF,
LTK.
As polymorphonuclear neutrophil (PMN) numbers are in-
creased in the lungs of tobacco smokers, we hypothesize
that sBALF stimulates PMN recruitment into the lung. We
studied the effects of sBALF from four patients on PMN
chemotactic (CT) and undirected chemokinetic (CK) mi-
gration from heparinized venous blood. PMN were al-
lowed to migrate under agarose from a central well for 4
h at 37C towards graded doses of sBALF (CT stimulus)
and 0.15 M NaCl (control stimulus). PMN were fixed and
stained by conventional means. PMN numbers and linear
distances moved towards control and CT stimuli were
quantified in five fields by image analysis, sBALF had no
effect on the distance moved by PMN, but at the highest
dose ([total protein] 625 + 288 btg/ml, Mean + SD) it
increased the number of migrating PMN by 25% from 128
+ 11 to 163 + 11 cells/field (mean _+ SEM, n=4, p<0.05,
Student’s t-test). When sBALF was premixed with blood
and PMN were then allowed to migrate under agarose
towards a known CT stimulus, 10-6M N-formyl-met-leu-phe
(FMLP) or towards a control to test for CK, sBALF at the
lowest dose ([total protein] 6 + 3 g/ml), inhibited the
number of PMN migrating towards FMLP (CT) from 184 +
19 (mean + SEM; 216% of control) to 164 + 29 cells/field
(186% of control), but had a positive CK effect on control
migration (+sBALF, 50% migrating PMN moved 250 btm;
sBALF, 50% migrating PMN moved 100 l.tm). Hence one or
more components of sBALF have CT and CK properties
which could increase PMN migration into the lung, but
once there, the cells may be less able to respond to other
CT stimuli such as bacteria.
Inflammatory cells in bronchoalveolar lavage
fluid in asthma and COPD
J. Malolepszy, A. M. Fal and R. Dobek
Dept of Internal Medicine and Allergology, Medical
Academy of Wroclaw, ul. Traugutta 57/59, Wroclaw,
Poland.
Bronchoalveolar lavage (BAD fluid is a reliable tool to
assess the inflammatory mechanisms underlying the
pathophysiology of obstructive pulmonary diseases. The
aim of our study was to evaluate the value of BAL fluid in
differentiating COPD from asthma and to identify a link
between cell counts and the severity of airflow obstruction.
Thirty-five patients entered the study: ten atopic asthmatics
(AA), ten non-atopic asthmatics (NA) and 15 subjects with
COPD. The diagnosis was based on clinical history,
physical examination, spirometry and specific IgE-level
determinations (FAST). Each subject underwent
bronchofiberoscopy with BAL fluid collection. The number
of neutrophils was significantly higher in COPD as com-
pared to AS and NA (p=0.01 and 0.05, respectively); on the
contrary more eosinophils were found in AA (p=0.0016)
and in NA (p=0.0013), as compared to COPD We did not
find statistical differences in the percentage of lymphocytes
in BAL fluid between COPD and the two groups of asthma
patients, such a difference being observed between AA
and NA (p=0.0248).
Our study confirms the predominant role of neutrophils
in COPD and of eosinophils in asthma. Nevertheless,
neutrophils seem to play an important role in the
pathophysiology of non-atopic asthma. BAL fluid analysis
may be of some value for the differential diagnosis of AA,
NA and COPD, but it does not seem to be useful for the
prognosis of these diseases.
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